



Drug Accumulation in Gram-negative Bacteria is Growth 
Phase Dependent 
by 
Emily Elizabeth Whittle 
 
A thesis submitted to the University of Birmingham for the degree of  
DOCTOR OF PHILOSOPHY 
 
 
Institute of Microbiology and Infection 
College of Medical and Dental Sciences 
University of Birmingham 















This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 






For antibiotic classes with intracellular targets, effective treatment of bacterial 
infections requires the drug to accumulate to a high concentration inside cells. 
Decreased permeability of the cell envelope and increased efflux pump activity 
causes low intracellular accumulation of antibiotics, contributing to the development 
of antimicrobial resistance. Here, the aim was to identify whether the balance 
between influx and efflux differs depending on bacterial growth phase in Salmonella 
enterica serovar Typhimurium. A novel flow cytometry assay was developed and 
used to measure accumulation of ethidium bromide (EtBr) in S. Typhimurium SL1344 
and ∆acrB strains during growth. In SL1344, EtBr accumulation remained low, 
regardless of growth phase and did not correlate with acrAB transcription. EtBr 
accumulation in ∆acrB was high in exponential phase but dropped sharply later in 
growth and by stationary phase, EtBr accumulation was not significantly different 
from SL1344. Low EtBr accumulation in both strains was shown not to be due to the 
upregulation of other efflux pumps, but instead, due to decreased permeability of the 
membrane in stationary phase. RNAseq identified changes in expression of several 
pathways that are associated with decreased membrane permeability in stationary 
phase. This study shows that efflux is only important for maintaining low drug 
accumulation in actively growing cells, and that membrane permeability is the 
predominant factor in stationary phase. This conclusion means that (i) more 
consideration may be required when prescribing existing antibiotics that have 
intracellular targets in complex non-growing or slow-growing bacterial infections 
where accumulation concentration may be low, and (ii) efflux inhibitors may be 
successful in potentiating the activity of existing antibiotics, but potentially only for 
bacterial infections where cells are actively growing.  
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Chapter 1 - Introduction 
1.1 The burden of Antimicrobial Resistance 
Antimicrobial resistance (AMR) is one of the biggest public health threats faced in the 
21st century (O' Neill, 2016, Davies, 2011). In 2017, the WHO published a report 
which prioritised several pathogens including Acinetobacter baumannii, 
Pseudomonas aeruginosa, Enterobacteriaceae, Salmonella and Mycobacterium 
tuberculosis which are considered to be the biggest challenge when combatting AMR 
(WHO, 2017b, WHO, 2017a). The O’Neill report predicted that by 2050, there will be 
10 million deaths a year due to AMR infections (O' Neill, 2016) if no solutions are 
found to curb the rise in antimicrobial resistance.  
Although the burden of AMR is increasing, the discovery of new antibiotic classes 
has been limited in this century, with only some new antibiotics introduced clinically. 
These more recent classes of antibiotics include oxazolidinones, namely linezolid, 
which became clinically available in 2000 (Senior, 2000), and glycyclines, namely 
tigecyline, which although related to tetracycline, has an increased spectrum of 
activity (Greer, 2006). The timeline of the discovery of antibiotic classes is shown in 
Figure 1-1. Antibiotic drug discovery is constantly ongoing, but research has also 
focused on alternatives to antibiotics, such as inhibitors to the mechanisms of 
resistance, anti-virulence drugs and vaccines. 
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Figure 1-1 Timeline of Antibiotic Discovery in the 20th and 21st century. 
 
 
The blue arrow highlights a timeline with key dates for the discovery of the antibiotic classes labelled. In 1935, the first antibiotic 
class, sulphonamides, were discovered. There was a ‘golden age’ of antibiotic discovery in the 20th century. In the last decade, 
no new antibiotic classes have been available for use clinically. Figure is adapted from Hogberg et al. (2010)
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1.2 Mechanisms of AMR 
There are several mechanisms bacteria use to confer AMR. These include target 
modification, metabolic bypass, enzymatic degradation, reduced permeability and 
increased efflux of antibiotics (Figure 1-2). 
Figure 1-2 Mechanisms of AMR. 
 
This schematic diagram illustrates the mechanisms by which bacteria develop resistance to antibiotics. (i) 
Increased expression of efflux pumps leads to an increase in export of antibiotics from cells. (ii) Bacteria can alter 
metabolic pathways to circumvent the need for the target of the antibiotic. (iii) Enzymes can degrade the antibiotic 
inside the bacterial cell. (iv) Antibiotic targets can mutate and modify so that antibiotics are not longer effective. 
(v) Reduced permeability means that antibiotics cannot enter the cell and reach their target. Figure adapted from 
Singh et al. (2014) 
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1.2.1 Target modification 
The mechanism of action of most antibiotics relies on binding to a specific target 
within a bacterial cell, either for inhibition of bacterial growth or to kill bacterial cells 
(Lambert, 2005). Resistance to antibiotics can develop when the gene encoding the 
target of the antibiotic within bacteria mutates; this mechanism is target modification 
(Figure 1-2iv). This prevents the antibiotic from effectively binding to and inhibiting 
its target. In Streptococcus sp., the accumulation of mutations in penicillin binding 
protein 2 (PBP2), a target for β-lactams, reduces the susceptibility to this drug class 
(Laible and Hakenbeck, 1991). In Salmonella enterica serovar Typhimurium (Eaves 
et al., 2004a) and a large number of Enterobacteriaceae clinical isolates (Weigel et 
al., 1998), mutations in the deoxyribonucleic acid (DNA) gyrase genes, gyrA and 
gyrB, confer resistance to fluoroquinolones. Rifampicin targets RNA polymerase, 
however, substitutions in Mycobacterium RNA polymerase confers resistance to 
rifampicin (Telenti et al., 1993). Modifications in lipopolysaccharides (LPS) in Gram-
negative bacteria confer resistance to polymyxins and colistin (Olaitan et al., 2014). 
The plasmid-mediated mcr-1 gene, which encodes a phosphoethanolamine 
transferase, modifies bacterial LPS within the inner membrane by adding 
phosphoethanolamine to lipid A (Liu et al., 2016, Sabnis et al., 2020). This target 
modification subsequently leads to bacteria developing resistance to colistin 
treatment (Liu et al., 2016).  
1.2.2 Metabolic bypass 
Bacteria have evolved ways to acquire antibiotic resistance by bypassing the target 
of the drug using a different metabolic pathway to carry out the same function (Figure 
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1-2ii). Staphylococcus aureus becomes resistant to methicillin through acquisition of 
the SSCmec chromosomal cassette carrying the mecA gene, which encodes for 
PBP2A (Katayama et al., 2000). The increased expression of mecA is linked to an 
increase in methicillin resistance but a decrease in toxin-mediated virulence (Rudkin 
et al., 2012). Like other PBPs, PBP2A can form peptidoglycan crosslinks in bacterial 
cells, but it has low affinity for β-lactams, bypassing the requirement for β-lactam 
susceptible PBPs (Hartman and Tomasz, 1984), therefore causing Methicillin 
Resistant Staphylococcus aureus (MRSA). Metabolic bypass mechanisms have also 
been described in Enterococcus sp. Glycopeptides such as vancomycin are large 
antibiotics with activity against Gram-positive bacteria. Their action is to inhibit 
peptidoglycan synthesis by binding to the D-ala of the peptidoglycan pentapeptide 
(Bugg et al., 1991). However, the van cluster of genes replace D-alanine with 
D-serine or D-lactate, reducing the susceptibility to glycopeptides (Bugg et al., 1991, 
Munita and Arias, 2016). 
1.2.3 Enzymatic degradation 
Degradation of antibiotics is a key mechanism of AMR (Figure 1-2iii). Resistance to 
penicillins, cephalosporins and carbapenems of the β-lactam class has been 
commonly described in clinical isolates. Enzymes named β-lactamases or 
carbapenemases degrade the antibiotic by hydrolyzing the β-lactam ring, either 
through enzyme acylation (serine β-lactamases) or by zinc ions aiding in hydrolysis 
(metallo-β-lactamases) (Bush, 2018). The first penicillinase was discovered as early 
as 1940 (Abraham and Chain, 1988). These enzymes are often found on plasmids 
and are spread by horizontal gene transfer. Examples include Temoneira (TEM) 
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(Heffron et al., 1975) and Sulphydryl variant (SHV) (Heritage et al., 1999) enzymes, 
followed by more prevalent CTX-M (Bonnet, 2004) classed as Extended Spectrum 
β-lactamases (ESβLs). Global dissemination of ESβLs led to increased use of potent 
carbapenems, leading to the rise in carbapenemases. Of high concern are Klebsiella 
pneumoniae carbapenemases (KPC) and New Delhi β-lactamase (NDM-1) (Yong et 
al., 2009) disseminating through Enterobacteriaceae.  
1.2.4 Outer membrane permeability 
Gram-negative bacteria are intrinsically more resistant to antibiotic treatment 
because they have an outer membrane (OM) barrier which prevents access to larger 
antibiotics (Blair et al., 2015b). Hydrophilic antibiotics, including commonly used 
β-lactams and fluoroquinolones, enter Gram-negative bacterial cells through small 
membrane protein channels called porins (Blair et al., 2015b, Nikaido, 1989, Masi et 
al., 2019). OmpF and OmpC are the major porins found in Enterobacteriaceae 
including Salmonella (Pratt et al., 1996). Resistance due to membrane permeability 
can arise in numerous ways including downregulation of porin genes (Dupont et al., 
2017), replacement of non-specific porins with more specific porins, substitutions in 
the porin protein which can change the diameter of the protein channel (De et al., 
2001, Bajaj et al., 2016) or by changing the electric field and blocking translocation 
of the drug across the membrane (Bajaj et al., 2016). OmpF can be replaced with the 
more specific OmpC, or both can be downregulated or mutated, playing a 
fundamental role in β-lactam resistance, including resistance to more potent, last line 
carbapenems (Masi et al., 2019). 
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1.2.5 Efflux 
Bacteria have specialised pumps that are able to remove substrate molecules, 
including antibiotics, from inside cells to outside. The balance between the prevention 
of drug entry and the removal of antibiotics can lead to low intracellular accumulation 
of drugs in bacterial cells (Bolla et al., 2011).  
In clinical isolates, overexpression of efflux pumps is commonly described. This leads 
to increased efflux activity and decreased susceptibility to antibiotics. AcrAB-TolC 
and MdfA are examples of efflux pumps in Escherichia coli that have been 
overexpressed in clinical isolates, causing resistance to fluoroquinolones (Swick et 
al., 2011). During tigecycline clinical trials, reduced susceptibility of the drug to E. coli 
clinical isolates was shown to be caused by the overexpression of MarA and therefore 
the overexpression of AcrAB-TolC (Keeney et al., 2008). S. Typhimurium DT104 has 
been isolated from cattle with overexpression of AcrAB-TolC (Baucheron et al., 
2004). A number of studies have shown that overexpression of the AdeABC pump 
leads to multidrug resistance of clinical isolates of Acinetobacter baumanii (Yoon et 
al., 2013, Rumbo et al., 2013), including one study using isolates from a paediatric 
intensive care unit (ICU) (Chen et al., 2018). In Pseudomonas aeruginosa, multidrug 
resistant (MDR) isolates overexpress MexAB-OprM (Ziha-Zarifi et al., 1999, Llanes 
et al., 2004) and SmeABC and SmeDEF are overexpressed in clinical isolates of 
Stenotrophomonas maltophila (Chang et al., 2004). The overexpression of efflux 
pumps can itself lead to multidrug resistance as certain pumps remove multiple 
classes of antibiotics from cells. 
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1.3 Salmonella  
1.3.1 Classification 
Belonging to the family Enterobacteriaceae, Salmonella sp. are Gram-negative bacilli 
and are generally motile due to the presence of peritrichous flagella (Shu-Kee Eng, 
2015, Riley et al., 2018). Based on 16S RNA sequence analysis, Salmonella are 
classified into two main species, S. enterica, known to infect humans and other 
mammals, and S. bongori, infecting mainly cold-blooded animals (Reeves et al., 
1989, Fookes et al., 2011, Giammanco et al., 2002). Salmonella enterica is further 
divided into six subspecies named S. enterica subspecies enterica, S. enterica 
subspecies arizonae, S. enterica subspecies salamae, S. enterica subspecies indica, 
S. enterica subspecies houtenae and S. enterica subspecies diarizonae (Ryan et al., 
2017). Salmonella is also categorised into serovars, based on the antigens a strain 
possesses, such as O- antigen on LPS of the bacterial membrane, H- flagellar 
antigens and K- capsular antigens. This categorisation is known as the 
Kauffman-White scheme (Salmonella Subcommittee of the Nomenclature 
Committee of the International Society for, 1934). There are now over 2500 serovars 
described (Ryan et al., 2017).  
1.3.2 Infection and pathogenesis 
Salmonella is a common human pathogen and is responsible for disease worldwide. 
Its most common manifestation is gastroenteritis, prevalent in both developed and 
developing countries. Salmonellosis, the infection caused by Salmonella enterica, 
can be separated into two clinical diagnoses depending on the serovar. S. Typhi and 
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S. Paratyphi cause enteric fever, classified as Typhoidal infection (Shu-Kee Eng, 
2015). In 2014, the WHO estimated that typhoid fever accounts for around 222,000 
deaths globally per year (WHO, 2015). Salmonellosis is also caused by non-typhoidal 
Salmonella (NTS) such as S. Typhimurium and S. Enteritidis (Gal-Mor et al., 2014), 
with the most common manifestation being gastroenteritis causing nausea and 
vomiting, abdominal cramps and diarrhoea. Salmonellosis is transmitted by the 
ingestion of infected food or water and, along with Campylobacter, is one of the most 
frequently isolated pathogens from a gastrointestinal infection, estimated at just over 
93 million cases per year (Majowicz et al., 2010).  
In 2017, Public Health England (PHE) recorded 306 symptomatic cases of typhoidal 
S. Typhi and S. Paratyphi in England, Wales and Northern Ireland, of which 93% 
were confirmed as imported cases as typhoidal Salmonella is not endemic to the UK 
(PHE, 2017). However, non-typhoidal Salmonella infection is more common with 
8,558 cases recorded in 2016 in England and Wales (PHE, 2018), the most common 
causative agents being S. Enteritidis and S. Typhimurium (Figure 1-3). From 2015 
to 2016, there was a decrease in the cases of S. Enteritidis (from 2495 to 2356 cases) 
but an increase in S. Typhimurium (from 1702 to 1770 cases) (PHE, 2018). This 
study will use Salmonella enterica serovar Typhimurium strain SL1344, both because 
it is a clinically relevant pathogen that causes a large number of infections in the UK 
each year (PHE, 2018) and due to the high level of multi-drug resistance in S. 
Typhimurium (Wang et al., 2019). 
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Figure 1-3 Laboratory confirmed cases of non-typhoidal Salmonella in England and Wales from 
2007-2016 
 
This graph shows the total cases of non-typhoidal Salmonella (black dotted line) of which the cases caused by 
S. Enteritidis (grey) and S. Typhimurium (blue) are shown. Data is taken from the PHE report on Salmonella 
cases (PHE, 2018). 
 
1.3.3 Antibiotic treatment 
Salmonellosis is normally a self-limiting infection and treatment is limited to 
rehydration unless severe. In more severe cases and for immunocompromised 
patients at high risk of invasive infection, an antibiotic such as ciprofloxacin or 
ceftriaxone may be prescribed (Kariuki et al., 2015, Lin et al., 2003). 
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1.4 The Gram-negative bacterial cell envelope 
Gram-positive and Gram-negative bacteria have distinct cell envelopes. 
Gram-positive bacteria have a single phospholipid membrane with a thick outer layer 
of peptidoglycan (Silhavy et al., 2010). The Gram-negative envelope is comprised of 
two membranes separated by a periplasmic space containing a thin peptidoglycan 
layer (Beveridge, 1999), as shown in Figure 1-4. 
1.4.1 The inner membrane 
Gram-negative bacteria contain an inner membrane (IM) composed of phospholipids, 
like that of a eukaryotic cell membrane and membrane bound organelles (Ruiz et al., 
2008, Silhavy et al., 2010). It also contains proteins with α-helical transmembrane 
domains and lipoproteins (Ruiz et al., 2008). Functions of membrane proteins located 
in the IM include energy production and lipid biosynthesis as well as protein secretion 
and translocation using transport systems such as Sec, YidC and the Tat translocon 
(Kudva et al., 2013). The IM is key in maintaining the proton motive force (PMF), 
which is required for a number of cellular processes (Huisman et al., 1996). 
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Figure 1-4 Schematic of the membrane of Gram-negative bacteria. 
 
The schematic shows the OM, with LPS on the extracellular side and outer membrane porins. A thin layer of mature peptidoglycan is located in the periplasm. The IM 
phospholipid bi-layer separates the cytoplasm from the periplasm and also contains membrane proteins (Ruiz et al., 2008). This figure is taken from Ruiz et al. (2008). 
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1.4.2 The periplasm 
The periplasm is the space between the inner and outer membranes of 
Gram-negative bacteria. The periplasm in both Salmonella and E. coli contributes 
20-40% of the cells total volume (Stock et al., 1977). This compartment is densely 
populated with enzymes and other proteins (Silhavy et al., 2010). It is important for 
functions such as protein oxidation, secretion and folding, LPS secretion to the OM 
and peptidoglycan synthesis (Asmar et al., 2017). 
1.4.3 The peptidoglycan layer 
The shape and rigidity of a Gram-negative cell envelope is dictated by the thin layer 
of peptidoglycan located within the periplasm (Silhavy et al., 2010). Peptidoglycan is 
composed of repeating N-acetyl glucosamine GlcNAc) and N-acetyl muramic acids 
(MurNAc) that form glycan chains (Vollmer et al., 2008) which are covalently 
anchored to the OM of Gram-negatives by Lpp, which is an abundant lipoprotein 
sometimes known as murein or Braun’s lipoprotein (Braun, 1975, Suzuki et al., 1978). 
Penicillin binding proteins (PBPs) are the enzymes required for production of the 
peptidoglycan macromolecule. PBPs are involved in the reaction to assemble the 
glycan chains, GlcNAc and MurNAc. Peptidoglycan also relies on crosslinking. 
MurNAc has a pentapeptide chain, with the final 2 amino acids commonly composed 
of D-alanine. PBPs involved in the transpeptidation of the penultimate D-ala (position 
4) to the amino acid at position 3 on an adjacent strand, therefore forming crosslinks 
(Figure 1-5). Mature peptidoglycan does not have the final D-ala, and PBPs act as 
carboxypeptidases in this reaction (Macheboeuf et al., 2006, Vollmer et al., 2008).  
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Figure 1-5 Schematic of the crosslinking of peptidoglycan. 
 
This figure outlines the crosslinking reaction of peptidoglycan. MurNAc has pentapeptide chains which are 
required for crosslinking. Diaminopimelic acid at position 3 of the pentapeptide crosslinks with the penultimate 
D-Ala (position 4) of an adjacent pentapeptide, called transpeptidation. D,D-carboxypeptidation results in the loss 
of the terminal D-Ala, forming mature peptidoglycan. Figure adapted from Macheboeuf et al. (2006). 
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1.4.4 The outer membrane 
The OM of Gram-negative bacteria is an asymmetric protective barrier (Kamio and 
Nikaido, 1976). The OM contains phospholipids on the periplasmic facing side of the 
membrane, but is not classed as a phospholipid bilayer because the outer leaflet 
contains glycolipids such as lipopolysaccharide (LPS) (Silhavy et al., 2010). LPS 
plays a vital role in decreasing the permeability of the cell to toxic compounds and 
antibiotics (Nikaido, 2003). LPS has three components: a hydrophobic lipid A 
attached to the membrane, an O- antigen, and an oligosaccharide which connects 
them (Bertani and Ruiz, 2018). LPS provides a protective barrier to lipophilic 
antibiotics. The protective hydrophobic barrier is formed by densely packing the OM 
with LPS, and by the negative charges of LPS which form crossbridges with divalent 
cations (Nikaido, 2003). 
The majority of proteins in the OM are classed as lipoproteins and β-barrel 
transmembrane proteins (Silhavy et al., 2010). Transmembrane β-barrels include 
porins which allow for the diffusion of small molecules through the membrane. In S. 
Typhimurium, OmpC, OmpF and OmpD (Liu and Ferenci, 2001, Santiviago et al., 
2003) are considered the major porins, but other porins include OmpS1 and OmpS2 
(Rodriguez-Morales et al., 2006). 
1.5 How do antibiotics get into cells? 
1.5.1 Porins 
As discussed, antibiotics can enter cells via porin channels, which are required to 
control permeability and for the entrance of hydrophilic nutrients through the OM. In 
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1990, the first structure of a porin was established using X-ray crystallography from 
Rhodobacter capsulatus (Weiss et al., 1990). Porins are β-barrel trimeric structures 
inserted in the OM. In general, non-substrate specific porins have 16 strands 
whereas substrate specific porins have 18 strands (Galdiero et al., 2012). Common 
to all porins is an L3 loop which causes constriction of the barrel structure (Soares et 
al., 1995), contributing to substrate specificity (Galdiero et al., 2012). 
1.5.1.1 The major porins, OmpF and OmpC 
OmpF and OmpC are considered major porins in E. coli and Salmonella enterica (Liu 
and Ferenci, 2001), and are structurally similar, with OmpF having a larger channel 
than OmpC. They allow the entrance of small hydrophilic solutes into the bacterial 
cell, so have been implicated in the development of antibiotic resistance. The main 
role of OmpF has recently been found to be the entrance of molecules into the cell 
whereas OmpC was also found to be involved in the maintenance of membrane 
integrity (Choi and Lee, 2019). These porins are differentially regulated depending 
on the osmolarity of the environment (Lan and Igo, 1998). This regulation is mainly 
controlled by the histidine kinase, EnvZ and the response regulator OmpR. EnvZ 
phosphorylates OmpR, activating the regulator, or dephosphorylates OmpR, 
deactivating it, dependent on the environmental osmolarity (Aiba and Mizuno, 1990, 
Lan and Igo, 1998). Phosphorylated OmpR induces expression of OmpC porin under 
high osmolarity (Yoshida et al., 2006). In low osmolarity, phosphatase activity is 
higher, meaning OmpR is dephosphorylated and there is increased expression of 
OmpF (Yoshida et al., 2006). OmpF also appears to have a more enhanced role 
during glucose limitation, whereas OmpC is upregulated in nitrogen starved 
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environments (Liu and Ferenci, 2001). Apart from local regulation, upregulation of 
the multiple antibiotic regulator marA leads to the production of micF. micF is a stress 
response antisense RNA that binds to ompF mRNA, leading to downregulation of the 
OmpF porin (Cohen et al., 1988, Pratt et al., 1996), reducing permeability and leading 
to an increase in resistance to hydrophilic antibiotics (Delcour, 2009). 
1.5.1.2 OmpS1 and OmpS2 
OmpS1 and OmpS2 are porins found in S. enterica serovars Typhi and Typhimurium. 
In comparison to OmpC and OmpF, they are expressed at low levels in normal 
laboratory growth conditions (Rodriguez-Morales et al., 2006) but they are also 
regulated by the EnvZ/OmpR system (Rodriguez-Morales et al., 2006). Although 
OmpS1 and OmpS2 have high sequence similarity (Fernandez-Mora et al., 2004, 
Flores-Valdez et al., 2003), OmpS1 is also negatively regulated by H-NS (Flores-
Valdez et al., 2003) and OmpS2 positively regulated by the LeuO activator 
(Fernandez-Mora et al., 2004). 
1.5.1.3 OmpD 
OmpD is the most abundant porin in S. Typhimurium, contributing 1% of the total 
protein found in the cell in laboratory conditions (Santiviago et al., 2003). OmpD 
differs to the major porins, OmpC and OmpF, because expression does not change 
in response to osmolarity (Santiviago et al., 2003). Instead, ompD expression 
increases in anaerobic conditions, and is regulated post-transcriptionally by Fnr in 
this environment (Santiviago et al., 2003). The ompD promoter has been shown to 
be repressed in either low pH or bile rich conditions (Santiviago et al., 2003, Prouty 
et al., 2004). The chaperone, Hfq, has been implicated in the post-transcriptional 
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regulation of ompD, possibly by binding the 5’-UTR of ompD mRNA (Sittka et al., 
2007). The roles of the OmpD porin are still disputed, however, it has been shown to 
be involved in the efflux of methyl viologen in combination with YddG (Santiviago et 
al., 2002), as well adherence to macrophages and intestinal epithelial cells (Hara-
Kaonga and Pistole, 2004). OmpD also facilitates the uptake of hydrogen peroxide, 
produced in phagocytic oxidative burst (Calderon et al., 2011, Ipinza et al., 2014). 
More recently, ompD has been shown to be downregulated in macrophages. Ipinza 
et al. (2014) showed that the deletion of the porin increased the bacterial survival 
within a macrophage. 
1.5.1.4 OmpW 
OmpW is a small minor porin found in Salmonella sp, E. coli and Vibrio sp (Gil et al., 
2009). OmpW is involved in osmoregulation as well as being affected by 
environmental signals such as temperature and availability of nutrients (Gil et al., 
2009). Although considered to be a porin, OmpW has been implicated in the efflux of 
the superoxide generating compound, paraquat or methyl-viologen (Gil et al., 2007), 
and regulation is dependent on the transcriptional regulator, SoxS (Gil et al., 2009). 
The porin has also been shown to associate with the small multidrug resistance 
(SMR) efflux protein, EmrE to export quaternary ammonium compounds such as 
methyl viologen (Beketskaia et al., 2014). 
1.5.2 Self-promoted uptake through the outer membrane 
Not all antibiotics are hydrophilic and so cannot enter Gram-negative cells through 
porins; but are able to enter by diffusion across the OM. Self-promoted uptake is a 
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mechanism of influx that bypasses the use of porins. Polymyxin B, 
Ethylenediaminetetraacetic acid (EDTA), cationic peptides and the antibiotic class, 
aminoglycosides, have been shown to use this uptake mechanism (Hancock and 
Bell, 1988, Delcour, 2009, Hancock et al., 1981).  
Cross bridges between the negatively charged regions (phosphate or carboxyl group) 
of LPS and divalent cations such as Mg2+ or Ca2+ are essential for the stability of LPS 
and the OM (Hancock, 1984, Hancock and Bell, 1988). Displacement of these cations 
results in instability and lateral movement of LPS across the OM (Delcour, 2009). A 
well-studied disruptor of LPS cross-bridges is the chelator, EDTA, which displaces 
the divalent cations increasing the permeability of the OM (Leive, 1974, Alakomi et 
al., 2003) (Figure 1-6). Polymyxin B and colistin are also classed as ‘permeabilisers’ 
of the OM, as well as aminoglycosides. Although colistin is able to bind LPS in the 
OM, and allows antibiotic uptake, cell lysis and bactericidal activity is as a result of 
colistin targeting the LPS in the inner membrane (Sabnis et al., 2020). Fleroxacin, a 
fluoroquinolone, has also been shown to weaken the membrane in this way to allow 
for self-promoted uptake (Chapman and Georgopapadakou, 1988). 
Fluoroquinolones are hydrophilic compounds that enter cells via porins but may also 
acts as chelators in this case (Chapman and Georgopapadakou, 1988, Delcour, 
2009). Permeabilisation of the OM by compounds such as EDTA, may also lead to 
the uptake of some of the more hydrophobic antibiotics which are otherwise unable 
to pass the Gram-negative OM (Hancock and Bell, 1988).  
In S. Typhimurium, a pmrA mutant has been described which is resistant to EDTA 
and polymyxin B, possibly due to alterations in the negative charges of LPS. PmrA is 
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part of the PmrAB two-component regulatory system, which induces lipid A 
modification, and therefore resistance to polymyxins and antimicrobial peptides 
(Gunn et al., 1998). This is important when considering AMR to last-line drugs such 
as colistin (Vaara et al., 1981, Nikaido, 2003). 
Figure 1-6 Self-promoted uptake. 
 
A schematic of the OM of Gram-negative bacteria. LPS usually forms crosslinks for stability using divalent cations. 
Permeabilisers such as EDTA, displace the cations, permeabilising the membrane and allowing the entrance of 
some antibiotic compounds through the membrane. 
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The contribution of Gram-negative impermeability to AMR has led to the concept of 
synthesising a hybrid of two antibiotics (Gorityala et al., 2016a). The development of 
a tobramycin-ciprofloxacin hybrid was shown to have anti-pseudomonal properties 
by tobramycin permeabilising the membrane and allowing ciprofloxacin to reach its 
target to carry out its bacteriostatic and bactericidal mode of action (Gorityala et al., 
2016a). Another hybrid, tobramycin-moxifloxacin has also been produced and 
studied, suggesting that it can destabilise the membrane and inhibit efflux through 
dissipation of the PMF (Gorityala et al., 2016b). 
1.5.3 Antibiotic transport across the inner membrane 
Some antibiotics, such as b-lactams, target the peptidoglycan therefore do not need 
to pass the cytoplasmic IM (Tipper and Strominger, 1965, Yocum et al., 1980). Other 
antibiotics do need to cross the IM to reach their target however there are limited 
studies of this (Hancock and Bell, 1988). It is thought that the majority of antibiotics 
with targets in the cytoplasm enter by passive diffusion and the IM does not act as a 
barrier to drugs (Hancock and Bell, 1988). Tetracycline and aminoglycoside transport 
across the IM have been studied.  
The porins, OmpC and OmpF allow tetracycline influx into the periplasm (Chopra and 
Roberts, 2001). Tetracycline is lipophilic, so can diffuse through the IM via active 
transport using the PMF (Chopra and Roberts, 2001, Hancock and Bell, 1988). 
Accumulation of tetracyclines within cells is determined by the pH gradient, and 
diffusion by this mechanism was found to be similar for fluoroquinolones (Nikaido and 
Thanassi, 1993).  
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The aminoglycoside influx mechanism in Gram-negative bacteria is disputed. 
However, it is accepted that it occurs in three stages: 1. binding and diffusion through 
the outer membrane, 2. Energy-Dependent Phase I (EDPI), 3. Energy-Dependent 
Phase II (EDPII) (Bryan and Van Den Elzen, 1977). EDPI involves a slow rate of 
uptake into the cytoplasm and is dependent on the concentration of antibiotics in the 
environment (Bryan and Van Den Elzen, 1977). Entrance of aminoglycosides during 
EDPI, allows the drugs to reach their target (ribosomes) and this is followed by protein 
translation mismatches leading to the misfolding of membrane proteins, 
subsequently increasing membrane permeability and the rapid influx of 
aminoglycosides into the cytoplasm by EDPII, a step clearly dependent on the action 
EDPI (Davis et al., 1986, Sabeti Azad et al., 2020). 
1.6 How are antibiotics removed from cells? 
Antibiotics are removed from cells by efflux pumps of which there are 6 classes: small 
multidrug resistance (SMR) pumps, major facilitator superfamily (MFS), multidrug 
and toxic compound extrusion (MATE) pumps, proteobacterial antimicrobial 
compound efflux (PACE) pumps, resistance nodulation division (RND) and ATP 
binding cassette (ABC) pumps (Figure 1-7). 
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Figure 1-7 A schematic of the efflux pump classes. 
 
The 6 efflux pump classes and the energy they use to export compounds. (i) MFS, (ii) SMR, (iii) MATE and (iv) PACE are located in the inner membrane and utilise the 
PMF. (v) The ABC pump, MacAB forms a tripartite complex with TolC which uses ATP hydrolysis for translocation from the periplasm (Greene et al., 2018). (vi) RND 
pumps also form tripartite complexes with TolC that span the inner and outer membranes but use the PMF. 
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1.6.1 Major Facilitator Superfamily (MFS) efflux pumps 
MFS pumps are small, hydrophobic transmembrane proteins (Kumar et al., 2016) 
found in Gram-positive bacteria, and the IM of Gram-negatives. The MFS family is 
one of the two largest classes of transporters and is conserved among bacteria (Pao 
et al., 1998). MFS pumps use the PMF to export a range of distinct substrates 
including solutes, sugars, secondary metabolites as well as antimicrobial agents 
(Kumar et al., 2016). In S. Typhimurium, two MFS pumps, EmrAB and MdfA, have 
been described (Horiyama et al., 2010). The EmrAB pump is dependent on the outer 
membrane channel, TolC, to provide resistance to antibiotics including novobiocin 
and nalidixic acid (Horiyama et al., 2010). MdfA is not dependent on TolC but 
overexpression provides resistance to tetracycline, chloramphenicol, norfloxacin and 
doxorubicin. 
1.6.2 Multidrug and toxic compound extrusion (MATE) pumps 
MATE pumps require an electrochemical gradient to extrude substrates (Kuroda and 
Tsuchiya, 2009). The MATE class of pumps is universal across bacteria with the first, 
NorM, being identified in Vibrio parahaemolyticus (Morita et al., 1998, Brown et al., 
1999). Most MATE pumps can extrude fluoroquinolone antibiotics and also the 
removal of cationic dyes such as ethidium bromide (EtBr) has been described 
(Kuroda and Tsuchiya, 2009). The only MATE pump in S. Typhimurium to be 
identified is MdtK which has been shown to remove norfloxacin, doxorubicin and the 
dye, acriflavine (Nishino et al., 2006). 
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1.6.3 ATP Binding Cassette (ABC) pumps 
ABC pumps differ from all other efflux pump classes because they require adenosine 
triphosphate (ATP) hydrolysis for export of substrates, rather than PMF (Davidson 
and Chen, 2004). They are a major family of transporters within mammalian cells as 
well as bacterial cells (Kobayashi et al., 2001). In Gram-negative bacteria, the HlyB 
and MacB ABC pumps are well studied. The HlyB, exporter forms a tripartite complex 
with HlyD and TolC, to export the haemolysin, HlyA (Greene et al., 2018). In 2001, 
the MacB transporter was the first ABC transporter to be identified in Gram-negative 
bacteria, which forms a tripartite complex with the periplasmic subunit, MacA, and 
TolC in E. coli (Kobayashi et al., 2001). It is dependent on the outer membrane 
protein channel, TolC, to function and is involved in the export of macrolides, and its 
deletion from a cell leads to increased susceptibility to macrolides (Horiyama et al., 
2010). It has been suggested that substrate export is via the periplasm rather than 
the IM (Greene et al., 2018). MacAB-TolC is the only drug ABC transporter in S. 
Typhimurium. In S. Typhimurium, macAB deletion has been implicated in reduced 
virulence, as well as increased resistance to macrolides, and has been found to be 
relevant to survival in macrophages which is important for Salmonella infection 
(Nishino et al., 2006, Bogomolnaya et al., 2013). MacAB homologs have also been 
identified in Stenotrophomonas maltophila, Pseudomonas aeruginosa, Acinetobacter 
baumanii and Vibrio cholerae (Greene et al., 2018). In 2020, an inhibitor to the 
MacAB-TolC pump was successfully identified (Yamagishi et al., 2020), which may 
be critical in the future when considering macrolide resistant infections. 
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1.6.4 Proteobacterial antimicrobial compound efflux (PACE) 
pumps 
The most recent family of efflux pumps discovered are the PACE pumps. 
Transcriptomic analysis of Acinetobacter baumanii in the presence of chlorhexidine 
led to the identification of AceI (Acinetobacter chlorhexidine efflux protein) (Hassan 
et al., 2015, Hassan et al., 2013). It is predicted that the pump functions as an 
oligomer and that it contains four transmembrane α-helices that forms a two-tandem 
transmembrane pair domain (Hassan et al., 2018, Finn et al., 2016). Regulation of 
aceI in the presence of chlorhexidine is by the adjacent LysR-type transcriptional 
regulator (LTTR) family regulator, AceR (Liu et al., 2018). PACE pumps share high 
sequence similarity and are found in a number of pathogens including Salmonella, 
Klebsiella, Pseudomonas, Enterobacter and Burkholderia (Hassan et al., 2018). The 
physiological substrates of this family have been identified as polyamines (Hassan 
et al., 2019). Short chain diamines (e.g. cadaverine) were found to strongly induce 
the expression of aceI, and long chain polyamines (e.g. spermidine) had weaker 
induction (Hassan et al., 2019). Naturally occurring polyamines are substrates of the 
pumps, along with the structurally similar biocide, chlorhexidine (Hassan et al., 2019, 
Hassan et al., 2015, Hassan et al., 2013). 
1.6.5 Resistance Nodulation Division (RND) pumps 
RND efflux pumps are common amongst Gram-negative organisms. They span both 
membranes allowing export of compounds from periplasm to the extracellular 
environment. Like some ABC pumps, RND pumps are formed of three components, 
classifying them as tripartite pumps (Daury et al., 2016). Outer membrane proteins 
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(OMPs) form the component located on the OM, joined to the pump protein in the IM 
by periplasmic adaptor proteins (PAPs). The most studied systems are the 
AcrAB-TolC pump in E. coli and the MexAB-OprM system in Pseudomonas 
aeruginosa (Li et al., 1995). AcrAB-TolC in S. Typhimurium is highly homologous to 
the AcrAB-TolC pump in E. coli (Piddock et al., 2000).  
Five RND systems have been described in S. Typhimurium, differing from E. coli (six 
systems) (Anes et al., 2015) and Pseudomonas aeruginosa (12 systems in PA01) 
(Lister et al., 2009). In S. Typhimurium, TolC is the common OMP for seven efflux 
pumps in total, including MacAB (ABC transporter) and EmrAB (MFS transporter) 
(Horiyama et al., 2010). The RND pumps are AcrAB-TolC, AcrAD-TolC, AcrEF-TolC, 
MdtABC-TolC and MdsABC (Figure 1-8) (Blair et al., 2015a). AcrA is the PAP 
required for both the AcrB and AcrD pumps, meaning there are only 4 PAPs present 
in S. Typhimurium (Yamasaki et al., 2011). RND efflux pumps are important in the 
development of multidrug resistance and are the class of pump most commonly 
found to be overexpressed in MDR clinical isolates. Each pump has a distinct 
substrate profile however common substrates include multiple classes of antibiotics 
e.g. fluoroquinolones, aminoglycosides and β-lactams but also disinfectants, 
detergents, dyes and virulence factors (Blair et al., 2015a). 
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Figure 1-8 The 5 RND efflux systems of S. enterica serovar Typhimurium 
 
This schematic shows the AcrAB-TolC, AcrAD-TolC, AcrEF-TolC, MdsABC/TolC and MdtABC/TolC efflux systems. Figure adapted but produced by the author of this 
thesis for publication (Colclough et al., 2020) 
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1.7 AcrAB-TolC 
AcrAB-TolC is the major RND efflux pump system that has been implicated in the 
development of AMR (Webber and Piddock, 2001). For this reason, it is important 
that the AcrAB-TolC system is well understood so that there are ways to prevent its 
export of antibiotics and its contribution to AMR in infections. 
1.7.1 Structure and mechanism of transport 
AcrAB-TolC is a tripartite complex that spans the IM, the periplasmic space and the 
OM (Figure 1-9A) (Symmons et al., 2009).  
The OMP, TolC, can form tripartite complexes with other proteins, not just AcrAB 
(Paulsen et al., 1997). TolC, formed of three identical protomers, acts as a channel. 
The b-barrel is located in the OM with an a-helical bundle which protrudes into the 
periplasm (Koronakis et al., 2000). TolC remains in a closed formation when not in 
contact with AcrAB, preventing access of compounds from the extracellular 
environment (Shi et al., 2019). The a-helical domain of TolC interacts with the 
a-hairpin of the PAP protein AcrA, and both interact with peptidoglycan (Shi et al., 
2019). AcrA is composed of three domains: the lipoyl, b-barrel and the membrane 
proximal domains (Mikolosko et al., 2006). 
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Figure 1-9 Structure of AcrAB-TolC and the mechanism of drug export. 
 
(A) shows the tripartite complex of AcrAB-TolC. Pink shows the AcrB protein, interacting with AcrA (green) which interacts with TolC (red and yellow). Figure from Shi et 
al. (2019).(B) Top panel depicts the conformational changes of AcrB from L, T and O states in the presence of drug. Entrance to the binding pocket (dashed lines) and 
opening and closing of pockets (red lines) are shown. The bottom panel shows how the conformation of AcrB changes due to the PMF interaction with the transmembrane 
domain. Figure reproduced from Du et al. (2018). 
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The inner membrane pump protein, AcrB, is formed of three identical protomers and 
each protomer is comprised of twelve transmembrane a-helices and two large 
hydrophilic loops which protrude into the periplasm (Murakami et al., 2006). AcrB has 
three domains: the docking, pore and transmembrane domains. For AcrB to export 
drugs from the periplasm, the structure goes through three conformational changes 
powered by the PMF (Du et al., 2018, Takatsuka and Nikaido, 2009). Drug binding 
occurs in the pore domain of the AcrB protomer, comprising three channels for drug 
entry and two channels for drug binding. Drug export through RND efflux pumps is 
via a functionally rotating mechanism (Murakami et al., 2006), and is shown in Figure 
1-9B. When drugs gain entrance to the protomer binding pocket, the structure is in a 
loose (L) conformation. This L state then undergoes a conformational change to a 
tight (T) state as the drug moves further into the binding pocket. At this point, drugs 
can be extruded into the docking domain of AcrB for further export of the drug, and 
this is known as the open (O) conformation (Murakami et al., 2006, Du et al., 2018).  
Shi et al. (2019) showed that AcrA and AcrB form a stable bipartite complex using 
electron cryo-tomography (Cryo-ET), with the a-hairpin of AcrA associating with the 
peptidoglycan to form a stable structure. It was suggested that this bipartite structure 
may move along the membrane until it comes into contact with TolC (Shi et al., 2019). 
This complex then changes conformation in the presence of antibiotics, and recruits 
a ‘closed’ TolC protein which then opens to expel antibiotics. Tripartite structures 
were obtained by Cryo-ET in the closed state in the presence of antibiotics, and in 
the open state in the presence of the AcrB inhibitor, MBX3132 (Shi et al., 2019). Prior 
to this in situ study, protein structure was limited to single components of the 
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AcrAB-TolC pumps, but now this study suggests the overall stoichiometry of an 
assembled pump is 3 TolC: 6 AcrA: 3 AcrB (Shi et al., 2019).  
1.7.2 Regulation of AcrAB-TolC 
The contribution of AcrAB-TolC to AMR is commonly due to overexpression of the 
pump, leading to increased export of antimicrobials (Yasufuku et al., 2011, Keeney 
et al., 2008, Swick et al., 2011). For this reason, understanding the global regulation 
of the AcrAB-TolC pump is key to targeting its activity. Transcriptional regulation of 
AcrAB-TolC is complex, with local and global regulation (Figure 1-10), but less is 
known about post-transcriptional and translational control of AcrAB-TolC. 
1.7.2.1 Local regulation 
The AcrAB pump is locally regulated by the TetR family transcriptional regulator, 
AcrR (Ramos et al., 2005). The acrR gene is situated upstream of the acrAB operon 
and acts to repress the operon to prevent overexpression of the efflux pump (Ma et 
al., 1996). As well as being present in S. Typhimurium (Olliver et al., 2004), AcrR is 
present in E. coli (Ma et al., 1996). In E. coli, the local repressor of the RND efflux 
pump gene AcrEF, EnvR, has also been shown to repress the acrAB operon 
(Hirakawa et al., 2008).  
Mutations in AcrR have been described in clinical and veterinary isolates causing 
overexpression of AcrAB-TolC (Weston et al., 2018, Webber et al., 2005, Ma et al., 
1996).
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Figure 1-10 The local and global regulation of acrAB 
 
AcrR is the local repressor of the acrAB operon. The repressor of the acrEF operon, EnvR, can also repress acrAB. The increased transcription of global regulators RamA, 
MarA, SoxS and Rob lead to the upregulation of efflux pump expression.  
Chapter 1 - Introduction 
 34 
1.7.2.2 Global regulators of AcrAB-TolC  
Global regulators are defined as regulators or activators that are not fixed to 
regulation within their own operon. They can control multiple genes or operons that 
are within other metabolic pathways, contributing to multiple regulatory networks 
(Duval and Lister, 2013). Several regulators of the AraC-XylS family have been 
shown to activate expression of efflux pumps including AcrAB-TolC. In E. coli, these 
activators include MarA, Rob and SoxS (McMurry et al., 1998, White et al., 1997) and 
an additional RamA regulator can be found in Salmonella sp. and Klebsiella 
pneumoniae (van der Straaten et al., 2004, George et al., 1995, Bailey et al., 2010). 
The AraC-XylS family regulate genes through the binding of their helix-turn-helix 
motifs to sequences of DNA (Rhee et al., 1998, Sharma et al., 2017). In the case of 
MarA, Rob, SoxS and RamA, they bind to DNA sequences named ‘marboxes’, found 
in the promoters of genes to allow for activation (Sharma et al., 2019). 
MarA is locally repressed by its local regulator MarR which inhibits transcription of 
marA (Alekshun and Levy, 1997). This repression is relieved in response to an 
environmental signal such as the presence of antibiotics or if mutation of MarR stops 
the repressor binding (Seoane and Levy, 1995, Maneewannakul and Levy, 1996). 
Increased expression of marA leads to increased expression of acrAB and tolC 
(Okusu et al., 1996). SoxS is upregulated by oxidative stress (Hidalgo et al., 1998) 
and Rob by antibiotics and organic solvents (Nakajima et al., 1995). RamR represses 
ramA expression and is released by the presence of environmental signals, like 
MarA, and is able to activate the expression of acrAB-tolC (Abouzeed et al., 2008, 
Ricci and Piddock, 2009, Weston et al., 2018). 
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1.7.2.3 Post-transcriptional regulation of AcrAB-TolC 
Regulation of AcrAB-TolC also occurs at the post-transcriptional level. Carbon 
storage regulator A, CsrA, is an RNA binding protein that is able to bind to the acrAB 
mRNA transcript and controls translation of the gene by preventing the ribosome 
accessing the 5’-UTR of the transcript (Figure 1-11A). CsrA consequently 
contributes to controlling the level of AcrAB-TolC efflux pump in a cell (Ricci et al., 
2017). 
Another RNA binding protein, Hfq has also been described as playing a role in the 
translational control of AcrB (Yamada et al., 2010). The main role of Hfq is to act as 
a chaperone protein, and facilitate the interactions of small regulatory RNAs (sRNAs) 
to mRNAs (Vogel and Luisi, 2011). Hfq can facilitate the function of sRNAs therefore 
preventing access of the ribosome to the transcript (Yamada et al., 2010, Vogel and 
Luisi, 2011). One sRNA which has been identified as a post-transcriptional control of 
AcrAB-TolC is SdsR. Parker and Gottesman (2016) used AcrA, AcrB and TolC 
translational fusions to study expression in the presence of overexpressed 
Hfq-dependent sRNAs. Only SdsR was found to repress tolC translation by binding 
upstream of the ribosomal binding site. No sRNA was found to modulate expression 
of acrAB (Figure 1-11B) (Parker and Gottesman, 2016).  
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Figure 1-11 Post-transcriptional regulation of AcrAB-TolC. 
 
(A) The translation of acrAB transcripts is controlled by the CsrA protein. CsrA binds the 5’ end of mRNA, stabilising it and preventing entry of the ribosome and in turn controlling 
translation. (B) The translation of acrAB transcripts is controlled by the binding of regulatory RNA, SdsR, to the 5’ untranslated region of the tolC transcript and is directed to 
the transcript with the aid of the Hfq chaperone protein. This in turn, prevents the access to the ribosome. Figure was made by E. Whittle for Colclough et al. (2020).
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It has been shown that the Lon protease is involved in degrading RamA (Ricci et al., 
2014), which activates transcription of acrAB (Ricci et al., 2014, Bailey et al., 2008, 
Nikaido et al., 2008, Ruzin et al., 2005). Lon is also important for unfolding misfolded 
proteins (Van Melderen and Aertsen, 2009). If Lon degrades RamA, it is then unable 
to activate the transcription of acrAB. Recognition of the N-terminus of RamA by Lon, 
aids protein degradation. 
1.7.3 AcrAB-TolC and AMR 
As previously discussed in Section 1.2.5, overexpression of efflux pumps can lead 
to increased AMR. A number of studies suggest that removal of AcrAB-TolC from S. 
Typhimurium or E. coli leads to increased susceptibility to antibiotic treatment 
(Nishino et al., 2006, Blair et al., 2009). It has also been shown that cells lacking acrB 
lead to an increase in ompF expression, in turn, decreasing cellular permeability 
(Webber et al., 2009). 
Overexpression of AcrAB-TolC in clinical isolates leads to ineffective treatment due 
to increased export of antibiotics. A large-scale study of fluoroquinolone-resistant 
clinical and veterinary isolates of E. coli from Spain and Argentina showed that most 
mutations leading to overexpression of AcrAB-TolC were found in the regulators 
(Webber and Piddock, 2001). In around 50% of the isolates, the local repressor AcrR 
had a single point mutation (Arg45Cys) leading to reduced repression of acrAB 
(Webber and Piddock, 2001). Mutations were also found in global regulators marR 
and soxR (Webber and Piddock, 2001). Similarly, the Arg45Cys mutation in AcrR 
was also found in MDR E. coli isolated from urinary tract infections (UTIs) 
(Chowdhury et al., 2019). Mutations in acrR and ramA overexpression in clinical 
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isolates of Klebsiella pneumoniae have been described, leading to overexpression 
of acrB and increased resistance to fluoroquinolones (Schneiders et al., 2003). 
Increased expression of acrB has been linked to a decrease in mutS expression (El 
Meouche and Dunlop, 2018). The mutS gene encodes a DNA mismatch repair 
protein, and decreased expression of this leads to an increase in mutations (El 
Meouche and Dunlop, 2018), possibly to accumulate more mutations that are 
beneficial for resistance during antibiotic treatment. 
AcrAB-TolC overexpression in MDR clinical isolates is present and a driver of further 
development of resistance and therefore it is important to understand the mechanism 
of AcrAB-TolC to target it and reduce AMR. 
1.7.4 Physiological roles of AcrAB-TolC 
The presence of bacterial efflux pumps in bacteria precedes the clinical introduction 
of antibiotics. For this reason, it is well known that the intrinsic role of AcrAB-TolC 
and other RND pumps is not the extrusion of antibiotics or the contribution to AMR 
(Colclough et al., 2020). 
A number of studies have shown the involvement of AcrAB-TolC in the formation of 
biofilms and motility. S. Typhimurium was shown to have impaired biofilm formation 
(Baugh et al., 2012), either by lacking a number of efflux pumps or by inhibiting efflux 
function. Impaired biofilm formation was linked to the repression of genes involved in 
curli biogenesis (Baugh et al., 2014). Curli are proteins present in the extracellular 
matrix and are involved in cell adhesion, and are therefore important in the 
development of biofilms (Barnhart and Chapman, 2006). Removal of AcrAB-TolC and 
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other efflux pumps in E. coli reduces biofilm formation (Kvist et al., 2008). It was 
shown that in S. Typhimurium acrB::aph, there was decreased expression of genes 
involved in motility and chemotaxis (Webber et al., 2009). More recently, in S. 
Typhimurium and E. coli, strains lacking acrB protein or function increases 
expression of genes involved in flagella biosynthesis, and strains lacking pump 
function can swim and are more motile (Wang-Kan et al., 2017, Ruiz and Levy, 2014).  
In S. Typhimurium, AcrAB-TolC has been identified as important in invasion (Blair et 
al., 2009, Wang-Kan et al., 2017, Virlogeux-Payant et al., 2008), colonisation 
(Buckley et al., 2006) and for virulence in mice and in Galleria mellonella (Nishino et 
al., 2006, Wang-Kan et al., 2017, McNeil et al., 2019).  
A number of studies highlight the importance of AcrAB-TolC in surviving sublethal 
concentrations of bile salts, therefore suggesting bile salts are a substrate of the 
pump (Nishino et al., 2009b, Lacroix et al., 1996, Urdaneta and Casadesus, 2018). 
In S. Typhimurium, bile salts activate the expression of ramA, therefore increasing 
expression of acrAB (Baucheron et al., 2014). The survival of S. enterica in high bile 
salts allows for colonisation and biofilm formation in the gallbladder (Crawford et al., 
2010). Bile salts and fatty acids also induce the activator Rob, therefore increasing 
the expression of acrAB (Rosenberg et al., 2003). Bile salts and fatty acids are also 
substrates of AcrAB-TolC and promote survival of E. coli in the intestinal tract 
(Rosenberg et al., 2003). 
Inactivated or overexpressed AcrAB-TolC in E. coli significantly changes the 
tricarboxylic (TCA) cycle suggesting that the pump plays a physiological role in 
metabolism. Roles in amino acid metabolism, the export of lysine, as well as fatty 
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acid and carbohydrate metabolism have also been highlighted (Cauilan et al., 2019, 
Colclough et al., 2020).  
Enterobactin is a siderophore with affinity to iron. Enterobactin is also considered a 
substrate of AcrAB-TolC. Previously, it was suggested that only TolC was required 
for Enterobactin secretion (Bleuel et al., 2005), but more recently, RND pumps such 
as AcrAB have been implicated in its export (Horiyama and Nishino, 2014). 
Siderophores such as enterobactin have been proposed as important for colonisation 
of E. coli and S. Typhimurium in the intestinal tract (Pi et al., 2012) and macrophages 
(Saha et al., 2019), respectively. 
1.7.5 RND efflux inhibitors 
Overexpression of efflux pumps confers AMR, and is fundamental for biofilm 
formation and virulence, so inhibition of these systems is an attractive strategy for 
treating drug resistant infections. By inhibiting the pumps, the intracellular 
accumulation of antibiotics is increased, and activity of already prescribed antibiotics 
may be potentiated. A few inhibitors have already been identified that can potentiate 
existing antibiotics, but none have been approved for use clinically. 
The peptidomimetic, phenylalanyl arginyl b-naphthylamide (PAbN) was identified 
(Renau et al., 1999), and found to have inhibitory activity against the MexAB pump 
in Pseudomonas aeruginosa, potentiating the activity of fluoroquinolones. This 
compound was also found to have some activity against AcrAB (Lomovskaya et al., 
2001) but not with the same level of potency as it does in Pseudomonas aeruginosa. 
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In 2006, the RND pump inhibitor 1-(1-Naphthylmethyl)-Piperazine (NMP) was 
identified in E. coli (Kern et al., 2006). It was not a successful inhibitor but was 
identified to potentiate levofloxacin, similar to PAbN (Opperman and Nguyen, 2015).  
The class, pyranopyridines, namely MBX2319 (Opperman et al., 2014) were 
discovered to have potency against AcrAB in E. coli. Using a high throughput inhibitor 
screen, MBX2319 was found to potentiate the activity of ciprofloxacin. The activity of 
other fluoroquinolones and β-lactams were also potentiated by the presence of 
MBX2319 (Opperman and Nguyen, 2015). 
Repurposing already clinically used drugs, with efflux inhibiting properties, has also 
been studied. Phenothiazines are used to treat psychological conditions, however 
these compounds such as chlorpromazine and amitriptyline, have also been shown 
to act as efflux inhibitors of the AcrAB-TolC efflux pump in Salmonella sp. and E. coli, 
potentiating the activity of antibiotics (Grimsey and Piddock, 2019, Grimsey et al., 
2020).  
Recently, eleven novel efflux inhibitors have been identified using a high-throughput 
assay measuring ramA expression (Marshall et al., 2020). These inhibitors were 
shown to potentiate the activity of some antibiotics in at least one of the following 
species: E. coli, S. Typhimurium, Pseudomonas aeruginosa and Acinetobacter 
baumanii, without bactericidal activity themselves These inhibitors were identified 
from already existing Prestwick and Roche chemical compound libraries and shows 
the importance of assessing already available compounds for efflux inhibitory 
properties (Marshall et al., 2020). 
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Efflux pump inhibition is widely researched; however, toxicity is often an issue and 
may explain why inhibitors have not been approved for use clinically (Tegos et al., 
2011, Sharma et al., 2019). This has not prevented ongoing efforts to find efflux 
inhibitors to help to overcome AMR. As S. Typhimurium has 5 different RND systems 
and E. coli has 6 RND systems, inhibitors should be designed to have broad 
spectrum activity against all RND pumps to potentiate existing antibiotics.  
1.8 Bacterial Growth 
To study micro-organisms in a laboratory under controlled conditions, methods of 
batch culture or continuous cultures are most commonly used. However, bacterial 
growth during infection is complex, not only due to environmental conditions 
compared to laboratory medium, but also the fact that the environment changes 
during an infection due to the inflammatory response, and infection in new host sites 
(Smith, 1998). Changes in environment will also lead to a change in the growth rate. 
In terms of infection, actively growing cells may be found during initial mucosal 
interactions, tissue invasion and acute infection to produce a large population with 
the ability to overcome the host immune response (Smith, 1998). Slow bacterial 
growth and non-growing bacteria (stationary phase) is archetypal to chronic bacterial 
infection (Smith, 1998), which is more resistant to antimicrobial treatment (Eng et al., 
1991). 
1.8.1 Continuous culture 
The concept of continuous culture is that bacteria grows at a constant rate with 
controlled concentration of nutrients, pH and metabolic waste products (Herbert et 
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al., 1956, Hoskisson and Hobbs, 2005). For this growth in a laboratory, a chemostat 
is used which can maintain the conditions required for constant bacterial growth 
(Hoskisson and Hobbs, 2005).  
1.8.2 Batch culture 
The most common method of bacterial growth in a laboratory is batch culture, which 
involves growth of a single colony of bacteria in a defined volume of nutrient media. 
There are different growth phases during batch culture growth with physiological 
changes due to environment and nutrient supply depletion (Figure 1-12A).  
1.8.2.1 Lag phase 
The earliest stage of bacterial growth in batch culture is lag phase. This phase of 
growth is poorly understood due to the low concentration of cells present (Rolfe et 
al., 2012). It represents bacterial cells that are inoculated in fresh media and it has 
been assumed that cells are physiologically adapting to fresh culture conditions 
(Madigan, 2000, Rolfe et al., 2012). Entrance into lag phase leads to a drastic change 
in transcriptome of S. Typhimurium, with 1119 gene expression changes within 4 
minutes of sub-culturing into fresh medium (Rolfe et al., 2012, Bertrand, 2019). It has 
also been assumed that the process involves repair of damage from stationary phase 
cultures (Dukan and Nystrom, 1998), as well as the expression of genes and the 
synthesis of proteins required for growth. Lag phase cells are metabolically active 
(Martin, 1932) and precedes the exponential doubling of cells in culture. An extended 
lag phase period has also been linked to the development of tolerance to antibiotics 
(Li et al., 2016, Bertrand, 2019, Fridman et al., 2014).  
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Figure 1-12 Bacterial growth phases. 
 
(A) shows a standard growth curve for bacteria in batch culture with an initial lag phase, cell division in exponential phase and stationary phase. This figure has been 
adapted from Maier (2009). (B) highlights the different phenotypes that can result from stationary phase and ‘Long term stationary phase’. This figure was adapted from 
Jaishankar and Srivastava (2017).
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1.8.2.2 Exponential phase 
During exponential phase, cells divide by binary fission resulting in exponential 
growth. The doubling time of cells in batch culture during exponential phase varies 
but typically E. coli and S. Typhimurium take around 20 minutes to divide in rich 
media at 37°C. Doubling time is dependent on environment and availability of 
nutrients as well as the organism. 
1.8.2.3 Stationary phase 
In batch culture, there are points where cells cease to divide and grow (Kolter et al., 
1993). The entrance into this phase, stationary phase, is a tightly regulated process 
(Navarro Llorens et al., 2010). Stationary phase signifies the reduction in growth rate 
(and a constant optical density (Gefen et al., 2014)), however cells are still 
metabolically active (Jaishankar and Srivastava, 2017). This stage is entered due to 
a reduction in nutrients, therefore leading to nutrient deprivation, accumulation of 
toxic metabolites and cell response to stress such as pH and temperature 
(Jaishankar and Srivastava, 2017). Stationary phase is not limited to a batch culture 
phenomenon. Bacterial populations, in soil, air, and water are almost entirely in a 
non-growing metabolically active state due to constant nutrient deprivation (Gefen et 
al., 2014). 
In early stationary phase, survival under stress can be achieved in several ways. In 
Gram-positive cells, sporulation to endospores is a key way to survive nutrient 
deprivation and stress (Abel-Santos, 2015). Activation of the stringent response is 
common under nutrient deprivation such as stationary phase, leading to the formation 
of persister cell populations, and cells that can survive large amounts of stress 
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(Jaishankar and Srivastava, 2017). Although not strictly a phenotype of stationary 
phase, biofilms composed of bacterial cells and exopolysaccharide are largely 
non-growing and survive stressful environments and nutrient deprivation (Donlan, 
2002). All these non-growing bacterial cell phenotypes add to the difficulty of 
antibiotic treatment due to their high tolerance and intrinsic resistance to toxic 
compounds and antimicrobials (Jaishankar and Srivastava, 2017). 
Bacterial cells can be maintained in stationary phase for an extremely long period of 
time in the environment to survive harsh conditions. This becomes ‘long term 
stationary phase’ and 4 different adaptations for survival have been described due to 
prolonged starvation: viable non-culturable state (VNBC), growth advantage in 
stationary phase (GASP), constant activity at stationary phase (CASP) and 
Stationary Phase Contact Dependent Inhibition (SCDI) (Figure 1-12B).  
The VNBC state defines cells that are dormant and alive, however cannot be cultured 
(Jaishankar and Srivastava, 2017). These cells are considered metabolically active 
(Navarro Llorens et al., 2010) and this state was identified as an adaptation of 
starvation, as cells can regrow with the addition of pyruvate or catalase (Na et al., 
2006, Mizunoe et al., 1999). This state is of concern in chronic human infection but 
also in food, as contamination may go undetected (Navarro Llorens et al., 2010, 
Jaishankar and Srivastava, 2017). Bacteria that have been shown to do this include 
but are not limited to E. coli (O157:H7 on lettuce) (Tyagi et al., 2019), S. Typhimurium 
(Rocard et al., 2018) and Campylobacter jejuni (Jones et al., 1991, Ferro et al., 2018). 
Cells in this state also remain resistant to antibiotic treatment (Hu and Coates, 2012). 
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The GASP state is defined as a phenotype where old stationary phase cells 
outcompete younger stationary phase cells (Navarro Llorens et al., 2010). This state 
involves mutations in genes important in stationary phase, giving bacterial cells an 
advantage to nutrient limited environments. Mutations of the GASP phenotype 
include stationary phase sigma factor rpoS (Zambrano et al., 1993), followed by the 
leucine responsive regulator, lrp (Zinser and Kolter, 2000), both identified in E. coli. 
Other bacteria such as Salmonella, Shigella (Martinez-Garcia et al., 2003) and 
Pseudomonas sp as well as some Gram-positive bacteria (Navarro Llorens et al., 
2010). 
In liquid culture, it has been shown that bacteria can acquire mutations in stationary 
phase which allow for the killing or inhibition of growth of their parental strains and is 
dependent on the physical contact between cells named SCDI (Lemonnier et al., 
2008). In this state, bacteria that were outcompeting parent cells were found to 
overproduce glycogen due to mutations in glgC, a gene required for glycogen 
biosynthesis (Lemonnier et al., 2008). 
CASP state is the most recent stationary phase phenotype to be described (Gefen 
et al., 2014). It is a state in which bacteria can maintain constant protein expression 
for 60 hours of stationary phase and starvation, therefore constant activity of 
ribosomes and RNA polymerase. This state is likely to end due to the requirement 
for energy conservation (Gefen et al., 2014). 
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1.9 Changes that occur in stationary phase cells 
1.9.1 Regulation 
1.9.1.1 The stationary phase sigma Factor, RpoS 
RNA polymerase (RNAP) is required for transcription. The RNAP enzyme consists 
of 5 subunits (ββ'α2ω) and a further subunit called sigma (σ) which associates with 
the RNAP and is involved in promoter recognition and transcription of specific genes 
(Paget and Helmann, 2003).  
In stationary phase, rpoS encodes the RpoS sigma factor or σS (σ38), described as 
the stationary phase or stress sigma factor (Lange and Hengge-Aronis, 1991b). 
Although expressed in exponential phase, it is upregulated at the onset of stationary 
phase (Lange and Hengge-Aronis, 1994, Navarro Llorens et al., 2010). Upregulated 
expression of σS has also been described in unfavourable conditions such as nutrient 
starvation, high osmolarity, low pH and heat- and cold- shock (Jaishankar and 
Srivastava, 2017). These environmental signals guide σS-dependent transcription of 
genes involved in morphological changes (Lange and Hengge-Aronis, 1991a), cell 
envelope changes (Mitchell et al., 2017) and for survival in starvation (Navarro 
Llorens et al., 2010). 
RpoS translation is, in part, controlled by small non-coding RNAs (sRNAs). sRNAs 
control translation and stabilise mRNA, often in the presence of a chaperone such as 
Hfq (Vogel and Luisi, 2011). sRNAs DsrA, RprA and ArcZ are activators and unfold 
mRNA allowing access of the ribosome for translation (Mandin and Gottesman, 
2010). CyaR sRNA has been shown to repress RpoS translation, but binds to ArcZ 
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(Kim and Lee, 2020). The binding to ArcZ signals for CyaR degradation therefore 
activating RpoS translation (Kim and Lee, 2020). RpoS has also been shown to 
transcribe an sRNA, SraL, in S. Typhimurium (Silva et al., 2013). This sRNA is highly 
expressed in stationary phase and interacts with Rho mRNA, the transcription 
terminator (Silva et al., 2019). 
1.9.1.2 Leucine responsive regulator protein (Lrp) 
The leucine responsive regulator protein (Lrp) in E. coli is a well-studied example of 
a global transcriptional regulator of the Lrp family (Brinkman et al., 2003). Expression 
level of this regulator is inversely related to growth rate (Landgraf et al., 1996) and 
can be negatively or positively regulated in response to leucine (Calvo and Matthews, 
1994) but also methionine and alanine (Hart and Blumenthal, 2011). Lrp has been 
found to control expression of 10% of genes in E. coli, the majority of these genes 
are transcribed on entrance to stationary phase (Tani et al., 2002), but also indirectly 
regulates genes (Kroner et al., 2019). Lrp plays vital roles in metabolism namely the 
anabolism of amino acids and reduction of catabolism during starvation (Calvo and 
Matthews, 1994, Navarro Llorens et al., 2010), and is upregulated by ppGpp (Calvo 
and Matthews, 1994), an inducer of the stringent response.  
1.9.1.3 Nucleoid compaction via Dps and IHF 
DNA protection during starvation (Dps) protein compacts the bacterial cell nucleoid 
protecting the cells from stress (Janissen et al., 2018). It is the most abundant protein 
in the nucleoid in stationary phase (Azam and Ishihama, 1999). Dps has been shown 
not to play a global role in transcription (Janissen et al., 2018). By condensing the 
nucleoid in stationary phase, it prevents external environmental stresses from killing 
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the cell (Janissen et al., 2018). Stresses include carbon and nitrogen starvation as 
well as oxidative stress (De Martino et al., 2016). In S. Typhimurium, Dps was shown 
to protect bacterial cells from oxidative stress, therefore surviving in a murine 
macrophage and accounting for an increase in virulence (Halsey et al., 2004). 
It has been shown that increasing pH switches Dps from binding to DNA to another 
DNA binding protein abundant in stationary phase, IHF (Lee et al., 2015). IHF 
(Integration Host Factor) affects gene expression of stationary phase genes (Navarro 
Llorens et al., 2010). IHF binds to DNA and bends it, contributing to the condensation 
of the nucleoid as well as contributing to gene expression (Lee et al., 2015). As with 
Dps, in S. Typhimurium, IHF is important in the expression of virulence genes 
(Mangan et al., 2006). 
1.9.1.4 The Stringent Response 
Gram-negative bacteria can survive amino acid starvation due to the stringent 
response. The transcription of rRNA and tRNAs are stopped and instead expression 
turns in favour of amino acid biosynthesis (Traxler et al., 2008, Navarro Llorens et 
al., 2010). The stringent response is regulated by the accumulation of guanosine 5’,3’ 
bispyrophosphate (ppGpp), described as an alarmone (Traxler et al., 2008). ppGpp 
is synthesised by RelA in response to amino acid starvation (Traxler et al., 2008, 
Gentry and Cashel, 1996) and the turnover of ppGpp is also controlled by SpoT 
(Gentry and Cashel, 1996) in carbon starvation as well as decreased concentrations 
of fatty acids (Seyfzadeh et al., 1993). ppGpp signals not only the shutdown of RNA 
synthesis but also the upregulation of RpoS and stress proteins at the entrance to 
stationary phase (Gentry et al., 1993, Navarro Llorens et al., 2010). 
Chapter 1 - Introduction 
 51 
1.9.2 Physiological changes 
1.9.2.1 Morphological changes 
In stationary phase, bacterial cells change from bacilli to coccoid in shape, combined 
with a reduction in size (Nystrom, 2004). Cells shrink in stationary phase as a result 
of nutrient starvation, known as ‘dwarfing’. Cell size reduces through the degradation 
of cell material such as protein (Reeve et al., 1984), however the OM is not degraded 
in E. coli and S. Typhimurium, therefore increasing the volume of the periplasmic 
space (Nystrom, 2004).  
The RpoS-dependent, bolA, is responsible for the overall coccoid shape of bacterial 
cells in stationary phase (Lange and Hengge-Aronis, 1991a). BolA is a transcriptional 
regulator which controls genes encoding for PBP4 and PBP5, and ampC, which 
contribute to the change in cell shape (Santos et al., 2002). Coccoid cells through 
expression of BolA, are also produced in nutrient deprived conditions (Santos et al., 
1999). BolA also plays a vital role in reduced expression of motility (Dressaire et al., 
2015) and increased production of biofilms in E. coli (Vieira et al., 2004, Moreira et 
al., 2017), virulence in S. Typhimurium (Mil-Homens et al., 2018), and decreasing the 
permeability of the OM (Freire et al., 2006). 
1.9.2.2 Protein Synthesis 
With the onset of starvation and stationary phase, there is an 80% reduction in the 
rate of protein synthesis (Reeve et al., 1984). As previously mentioned, the stringent 
response plays a role in survival in starvation because empty ribosome acceptor sites 
are bound by uncharged tRNAs promoting the synthesis of ppGpp and the shut down 
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in transcription of ribosomes (Traxler et al., 2008). tRNAs also differ in abundance 
depending on growth rate (Huisman et al., 1996). As described above, there is a 
phenotype of stationary phase (CASP) in which bacteria can maintain constant 
protein expression for 60 hours of stationary phase and starvation (Gefen et al., 
2014). New protein can also be synthesised in stationary phase by utilising amino 
acids from degraded proteins of exponential phase (Reeve et al., 1984). Although 
protein synthesis rate decreases, already synthesised proteins can prolong their 
activity into stationary phase, this is true of AcrB which has a 6-day half-life (Chai et 
al., 2016).  
1.9.2.3 Metabolism 
The entrance into stationary signals the conservation of energy. The PMF decreases 
in stationary phase (Kashket, 1981) and the cytochrome oxidases of the electron 
transport chain change from cytochrome o, to cytochrome d and cytochrome bd 
complexes (Huisman et al., 1996). 
As bacteria such as E. coli grow in glucose rich conditions, they do not utilise it all, 
but instead conserve glucose in the form of acetate (Luli and Strohl, 1990). Acetate 
is excreted from the cell in large amounts but re-enters the cell on its entrance to 
stationary phase (Luli and Strohl, 1990, Huisman et al., 1996). In stationary phase, a 
variation of the TCA cycle, called the glyoxylate shunt is upregulated (Huisman et al., 
1996). Shown in Figure 1-13, the glyoxylate pathway is similar to the TCA cycle but 
circumvents the CO2 producing step in the TCA cycle (Ahn et al., 2016). The 
glyoxylate shunt can then use acetate or fatty acids to synthesise glucose in carbon 
limited stationary phase (Ahn et al., 2016, Huisman et al., 1996). This cycle has also 
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been shown to be upregulated in oxidative stress (Ahn et al., 2016). It has also been 
found that pyruvate oxidase, poxB, converts pyruvate to acetyl-CoA, via acetate 
synthesis in cultures with low growth rate (Abdel-Hamid et al., 2001). 
 
Figure 1-13 The TCA cycle and the Glyoxylate Shunt. 
 
Above shows the TCA cycle and the glyoxylate cycle. The TCA cycle is shown but in stationary phase, the cell 
converts isocitrate to glyoxylate and succinate rather than using a step that wastes carbon as CO2. Glyoxylate 
feeds back into the citric acid cycle. Figure has been adapted from Dunn et al. (2009). 
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Another metabolic pathway essential for survival in carbon limiting conditions is the 
accumulation and storage of glycogen, which is synthesised from glucose (Wilson et 
al., 2010). Glycogen synthesis can be controlled by an number of stationary phase 
signals such as ppGpp (Romeo and Preiss, 1989) and the upregulation of RpoS 
dependent genes (Hengge-Aronis and Fischer, 1992). The cell also scavenges for 
sugar by upregulating sugar transport systems (Huisman et al., 1996) and as 
previously stated, degrades protein to scavenge for amino acids (Reeve et al., 1984). 
1.9.2.4 Membrane changes 
During stationary phase, the inner and outer membranes of Gram-negative cells, and 
the peptidoglycan layer undergoes extensive changes. 
In the OM, the concentration of LPS increases (Huisman et al., 1996). The increase 
in LPS increases the overall negative charge on the bacterial cell membrane. It is 
possible that this may reduce the susceptibility of the cell to membrane acting agents 
(Agrawal et al., 2019). The concentration of OMPs are reduced (Allen and Scott, 
1979), however there is an increase in some proteins including those involved in curli 
biogenesis. The csg operon involved in curli biogenesis is directly regulated by RpoS 
which is bound by Crl, directing transcription (Arnqvist et al., 1994, Barnhart and 
Chapman, 2006). Other OMPs upregulated include flagellin and pili (Huisman et al., 
1996). There is also an increased concentration of murein lipoprotein, which 
increases the connection between the OM and the peptidoglycan layer in stationary 
phase (Wensink et al., 1982, Pisabarro et al., 1985). 
The peptidoglycan layer adjusts in both thickness and composition in stationary 
phase. In actively growing cells in rich media, the peptidoglycan accounts for 0.7% – 
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0.8% of the dry weight of the bacterial cell, but this increases during stationary to a 
dry weight of 1.4% to 1.9% of the bacterial cell (Mengin-Lecreulx and van Heijenoort, 
1985). The transition from exponential to stationary phase also comes with gradual 
modification of the peptidoglycan, in which glycan chains become shorter but with 
increased crosslinks between peptides (Pisabarro et al., 1985). Although most cell 
wall components do not change significantly, there has been shown to be an increase 
in PBP6 in stationary phase cells, helping to stabilise the peptidoglycan in 
non-growing cells (Buchanan and Sowell, 1982, Huisman et al., 1996). The 
disaccharide, trehalose, has been shown to accumulate within the periplasm 
(Huisman et al., 1996). The otsAB genes involved in its biosynthesis are regulated 
osmotically but also by RpoS on entrance to stationary phase (Hengge-Aronis et al., 
1991). Trehalose has been shown to be important in carbon stress (Moruno Algara 
et al., 2019) and osmotic stress (Giaever et al., 1988, Purvis et al., 2005), and 
increases tolerance to temperature in stationary phase (Hengge-Aronis et al., 1991, 
Kandror et al., 2002).  
The IM undergoes drastic changes to its composition in stationary phase (Huisman 
et al., 1996). Within the IM of Gram-negative bacteria such as E. coli and S. 
Typhimurium, monounsaturated fatty acids comprise the majority of fatty acids within 
the IM (Huisman et al., 1996). With the onset of starvation and stationary phase, the 
concentration of monounsaturated fatty acids reduce (El-Khani and Stretton, 1981). 
Cyclopropane fatty acid concentration increases and accounts for 50% of the fatty 
acids within the IM in stationary phase (Cronan, 1968, Huisman et al., 1996). 
Cyclopropane fatty acid biosynthesis from unsaturated fatty acids is aided by the 
RpoS regulated synthase, cfa (Wang et al., 1992, Charoenwong et al., 2011). The 
Chapter 1 - Introduction 
 56 
increase in these fatty acids has been linked to acid resistance in E. coli (Chang and 
Cronan, 1999) and S. Typhimurium (Kim et al., 2005). Along with cyclopropane fatty 
acids, cardiolipin increases in stationary phase (Cronan, 1968). All these changes to 
the membrane contribute to survival during starvation as well as osmotic stress, 
oxidative stress and tolerance to pH and temperature. 
As it is known that the membrane is important for antibiotic entry and it is known that 
both the membrane and efflux expression changes through growth, the initial aim of 
this work was to see whether bacterial growth phase altered drug accumulation, and 
the importance of the interplay between influx and efflux in different growth phases. 
1.10 Aims 
1. Develop a method to measure drug accumulation in single cells using flow 
cytometry. 
2. Measure ethidium bromide accumulation capacity of S. Typhimurium WT and 
a DacrB strain over a batch culture growth curve to assess accumulation in 
different growth phases.  
3. To analyse the importance of efflux pumps for drug accumulation in 
exponential and stationary phase bacteria. 
4. To determine the role of decreased outer membrane permeability in stationary 
phase, and whether this phenotype means that stationary phase accumulation 
is efflux-dependent. 
5. Use RNAseq to distinguish changes in the transcriptome of a WT and a DacrB 
strain in different growth phases to explain the accumulation patterns seen. 
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Chapter 2 - Materials and Methods 
2.1 Bacterial strains, growth and storage 
For the majority of this study, Salmonella enterica serovar Typhimurium SL1344 was 
used as the wild-type (WT) strain (Wray and Sojka, 1978). A complete list of strains, 
including those previously made or constructed for this study are shown in Table 2-1. 
All S. Typhimurium strains were stored using protect beads (Technical Services 
Consultants (TSC)) at -20 ˚C. Escherichia coli MG1655, Klebsiella pneumoniae ecl8 
and Pseudomonas aeruginosa PA01 were stored using protect beads at -80 ˚C 
(Table 2-1). 
When these bacterial strains were required, protect beads were spread on Luria 
Bertani (Lennox) (LB) agar plates and incubated at 37˚C overnight. These agar plates 
were then stored at 4˚C for up to a week. When the strains were required for 
experiments, they were grown in 5 mL LB broth at 37˚C overnight, unless otherwise 
stated. A list of the media types used is shown in Table 2-2. Some experiments used 
filter sterilised MOPs minimal media (Teknova) for which the composition is shown 
in Table 2-2. SL1344 is a histidine auxotroph therefore L-histidine was added to 
MOPs minimal media to give a final concentration of 0.4 mg/mL. For minimum 
inhibitory concentration (MIC) assays, a semi-defined iso-sensitest agar/broth was 
required and some phenotypic assays required salt-free media. All are shown in 
Table 2-2.  
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Table 2-1. S. Typhimurium Strain list 
Laboratory 
Code 
Genotype  Resistance Reference 
SE01 S. enterica Serovar 
Typhimurium SL1344 
 Wray and Sojka (1978) 
SE44 S. Typhimurium 14082s  ATCC 
EC19 E. coli Colindale NCTC 10418 
MIC control strain 
 NCTC 
SE02 SL1344 ∆acrB  Eaves et al. (2004b) 
SE365 SL1344 ∆tolC  Buckley et al. (2006) 
SE10 SL1344 ∆acrA ∆acrE ∆mdsA 
∆mdtA 
 McNeil et al. (2019) 
EC07 E. coli MG1655  Blattner et al. (1997) 
EC29 MG1655 ∆acrB  Wang-Kan et al. (2017) 
KP02 Klebsiella pneumoniae ecl8  Forage and Lin (1982) 
KP03 Ecl8 acrB::Gm  Whittle et al. (2019) 
PA19 Pseudomonas aeruginosa 
PA01 
 Held et al. (2012) 
PA20 PA01 ∆mexA  Held et al. (2012) 
PA22 PA14  Liberati et al. (2006) 
(pa14.mgh.harvard.edu) 
PA23 PA14 ∆mexA  Liberati et al. (2006) 
(pa14.mgh.harvard.edu) 
SA01 Staphylococcus aureus 
ATCC29213 
 ATCC 
EC10 E. coli BW1125 + pKD4 AmpR, 
KanR 
Datsenko and Wanner 
(2000) 
SE160 SL1344 + pCP20 AmpR Datsenko and Wanner 
(2000); Cherepanov and 
Wackernagel (1995) 
SE67 SL1344 + pSIM18 HygR Chan et al. (2007) 
SE258 SL1344 ∆acrB + pSIM18 HygR This study 
SE270 SL1344 rpoS::aph KanR This study 
SE271 SL1344 ∆acrB rpoS::aph KanR This study 
SE273 SL1344 ∆rpoS  This study 
SE274 SL1344 ∆acrB ∆rpoS  This study 
SE368 SL1344 ompF::aph KanR This study 
SE369 SL1344 ∆acrB ompF::aph KanR This study 
SE373 SL1344 ∆ompF  This study 
SE374 SL1344 ∆acrB ∆ompF  This study 
SE387 SL1344 ompC::aph KanR This study 
SE388 SL1344 ∆acrB ompC::aph KanR This study 
SE392 SL1344 ∆ompC  This study 
SE393 SL1344 ∆acrB ∆ompC  This study 
SE403 SL1344 ∆ompC + pSIM18 HygR This study 
SE406 SL1344 ∆ompC ompF::aph  This study 
SE408 SL1344 ∆ompC ∆ompF  This study 
SE404 SL1344 ∆acrB ∆ompC + 
pSIM18 
HygR This study 
SE407 SL1344 ∆acrB ∆ompC 
ompF::aph 
 This study 
SE409 SL1344 ∆acrB ∆ompC ∆ompF  This study 
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SE59 SL1344 + pMW82-ramA AmpR Lawler et al. (2013) 
SE205 SL1344 + pMW82-acrA AmpR A gift from E. Trampari and 
M. Webber 
SE206 SL1344 + pMW82-acrE AmpR A gift from E. Trampari and 
M. Webber 
SE207 SL1344 + pMW82-acrD AmpR A gift from E. Trampari and 
M. Webber 
SE208 SL1344 + pMW82-mdsA AmpR A gift from E. Trampari and 
M. Webber 
SE209 SL1344 + pMW82-mdfA AmpR A gift from E. Trampari and 
M. Webber 
SE210 SL1344 + pMW82-mdtK AmpR A gift from E. Trampari and 
M. Webber 
SE211 SL1344 + pMW82-emrA AmpR A gift from E. Trampari and 
M. Webber 
SE212 SL1344 + pMW82-macA AmpR A gift from E. Trampari and 
M. Webber 
SE213 SL1344 + pMW82-mdtA AmpR A gift from E. Trampari and 
M. Webber 
SE236 SL1344 + pMW82-acrA AmpR A gift from E. Trampari and 
M. Webber 
SE237 SL1344 ∆acrB + pMW82-acrE AmpR This study 
SE238 SL1344 ∆acrB + pMW82-acrD AmpR This study 
SE239 SL1344 ∆acrB + pMW82-mdsA AmpR This study 
SE240 SL1344 ∆acrB + pMW82-mdfA AmpR This study 
SE241 SL1344 ∆acrB + pMW82-mdtK AmpR This study 
SE242 SL1344 ∆acrB + pMW82-emrA AmpR This study 
SE243 SL1344 ∆acrB + pMW82-macA AmpR This study 
SE244 SL1344 ∆acrB + pMW82-mdtA AmpR This study 
EC85 E. coli DH5α + pET GFP LIC 
cloning vector (u-msfGFP)  
AmpR A gift from Scott Gradia 
(Addgene plasmid # 29772) 
EC90 NEB5α + pET LIC cloning 




SE342 SL1344 AcrB-GFP (aph) KanR This study 
SE344 SL1344 AcrB-GFP  This study 
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Table 2-2 Growth media 
Media Components  Product code 
LB (Lennox) broth 
(500 mL) 
10 g LB (Lennox) powder  L3022; Sigma 
LB (Lennox) agar 
(500 mL) 
17.5 g LB agar powder  L2897; Sigma 
MOPs minimal 
media (1 L) 
100 mL of 10X MOPS M2101; Teknova 
10 mL 0.132 M K2HPO4 M2102; Teknova 
10 mL 20% Glucose G0520; Teknova 
400 mg L-histidine (98%) 10665602; Fisher 
Salt Free LB broth 
(500 mL) 
5 g Tryptone 10158962; Fisher 
2.5 g yeast extract 10108202; Fisher 
500 mL H2O  
Salt Free LB agar 
(500 mL) 
5 g Tryptone 10158962; Fisher 
2.5 g yeast extract 10108202; Fisher 
7.5 g agar DS662; Beckton Dickinson 
500 mL H2O  
Iso-sensitest agar 
(2 L) 
31.4 g Iso-sensitest agar 10661475; Oxoid 
Iso-sensitest 
broth (1 L) 




Table 2-3 Antibiotics used for cloning  
Antibiotic Stock concentration Final concentration Product code 
Kanamycin 10,000 μg/mL (H2O) 50 μg/mL K1876; Sigma 
Ampicillin 10,000 μg/mL (NaHCO3) 50 μg/mL A9393; Sigma 
Hygromycin 10,000 μg/mL (H2O) 150 μg/mL H7772; Sigma 
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When SL1344 contained plasmids, it was grown with appropriate antibiotics 
supplemented in LB agar or LB broth. The plasmids, pKD4, pSIM18 and pCP20 
(Table 2-4) used for homologous recombination and gene deletion, required 
kanamycin, hygromycin and ampicillin respectively. The final concentrations for these 
antibiotics are shown in Table 2-3. The pSIM18 and pCP20 plasmids were 
temperature sensitive, and therefore strains containing these were grown at 30˚C. 
Strains that contained pMW82 plasmids were grown on agar/broth containing 
ampicillin (Table 2-1). 
 
Table 2-4 Plasmids 
Plasmid Description Resistance Reference 
pKD4 Used to amplify a PCR product 
with homology to the KO gene of 
interest at the 5’ and 3’ end of the 
gene. 
aph is a FRT-flanked kanamycin 
resistance cassette. 
AmpR, KanR Datsenko and 
Wanner (2000) 
pSIM18 Encodes the λ red recombinase for 
homologous recombination of FRT 
sites (temperature sensitive: 30 
°C) 
HygR Chan et al. (2007) 
pCP20 Encodes the FLP recombinase for 
removal of aph at the FRT sites 
(temperature sensitive: 30 °C) 





pMW82 Contains GFP; Promoters can be 
fused to GFP to produce 
transcriptional reporters 





This plasmid contains a GFP 
described by Pedelacq et al. 
(2006) with SNPs that enhance 
brightness and solubility and 
inhibits dimerisation 
 A gift from Scott 
Gradia (Addgene 





Insertion of the aph kanamycin 
resistance cassette into the pET 
LIC vector (u-msfGFP) 
downstream of GFP 
AmpR, KanR This study 
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2.2 Measuring ethidium bromide accumulation using flow 
cytometry in mid-exponential phase 
The method discussed was developed as part of this thesis and has been published 
(Whittle et al., 2019). For all flow cytometry assays, unless otherwise stated, 4 
biological replicates have been analysed. 
2.2.1 Set up of the flow cytometer 
The Attune® NxT Acoustic Focusing Cytometer (Invitrogen) was calibrated according 
to the manufacturer’s instructions using Attune® Performance Tracking Beads 
(4449754; Fisher) and Attune Focusing Fluid (448862; Fisher). The Yellow laser was 
set at 561 nm; channel YL1, 585/16 nm filter for fluorophore SYTO-84 Orange 
Fluorescent Nucleic Acid Stain (SYTO-84) (Lot no: 1890520; Invitrogen) which has 
excitation/emission maxima of 567 nm / 582 nm. The blue laser was set at 488 nm; 
channel BL3, 695/40 nm filter for ethidium bromide (EtBr) (excitation 482 nm 
emission 616 nm). The Sip Sanitize function with 4% bleach was used to clean the 
machine between samples and a deep clean was performed at the end of each 
experiment. 
2.2.2 Measurement of EtBr accumulation in Gram-negative 
bacteria 
Bacterial strains were grown in 5 mL LB broth at 37˚C, shaking overnight. Bacterial 
overnight cultures were used to re-inoculate fresh LB at 4 %, and grown for 1 hour at 
37˚C. After 1 hour of growth, cells from 300 µL culture were harvested by 
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centrifugation. Cells were then re-suspended in 100 µL of 1 x HEPES buffered saline 
(HBS) (J61239.AK; Alfa Aesar). Phosphate buffered saline (PBS) could not be used 
because it is not compatible with SYTO-84.  
The dyes, SYTO-84 and EtBr were added to 500 µL of 1 × HBS giving final 
concentrations of 10 µM and 100 µM respectively. The previously prepared 100 µL 
bacterial cell suspension was then added to the 1 × HBS and dyes, and incubated 
for 10 minutes at room temperature. Accumulation of EtBr could then be measured 
in each cell within a population using flow cytometry. Information about the dyes used 
in this method can be found in Table 2-5. 
Using the gating strategy shown in Figure 2-1, EtBr accumulation was measured. 
Initially, cells emitting SYTO-84 fluorescence were visualised (Figure 2-1A) using a 
forward scatter-height (FSC-H) vs SYTO-84 emission plot. This dye was used to gate 
around cells and omit background cell debris. The SYTO-84 fluorescence emission 
was collected in the YL1-H channel. This channel collects 585/16 nm emissions using 
561 nm yellow laser. Using the red gate (Figure 2-1A), 10,000 SYTO-84 positive 
events could be counted. This population was then plotted on a logarithmic 
histogram, and EtBr fluorescence emission measured in the BL3-H channel. The blue 
gate (Figure 2-1B) showed EtBr accumulation by using the X-median value as 
relative fluorescent units (RFU). For this and following experiments, the PMT 
voltages were: FSC at 700, SSC at 500, YL1 at 500 and BL3 at 400. 
Compensation corrected for spill-over in fluorescence. Spill-over is defined as an 
overlap in excitation or emission maxima. Based on the fluorescence excitation and 
emission of the SYTO-84 and EtBr (Figure 2-2), compensation was configured.   
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Figure 2-1 Gating strategy to measure EtBr fluorescence/accumulation 
 
(A) SYTO-84 fluorescence is plotted vs FSC-H to separate fluorescence emission from background cell debris 
(black). 10,000 SYTO-84+ events were collected within the red gate. (B) SYTO-84+ events within the red gate 
were then plotted on a logarithmic histogram collecting fluorescence in the BL3-H filter for EtBr. The blue gate 
value was the X-median for fluorescence and was used as the measure of accumulation. This figure was 
produced by EE Whittle and previously published in Whittle et al. (2019). 
 









SYTOTM 84 Orange 
(SYTO-84) 
Fisher  567/582 Yellow 585/16 YL1 
SYTOTM 9 Green 
(SYTO-9)  
Fisher 485/498 Blue 590/40 BL2 
Ethidium bromide 95%, Fisher 482/616 Blue 695/40 BL3 
Nile red 99%, Fisher 549/628 
510/580 
Yellow 585/16 YL1 
GFP (pMW82) A gift from 
Mark Webber 
488/510 Blue 530/30 BL1 
GFP (msfGFP) Addgene 
plasmid # 
29772 
488/510 Blue 530/30 BL1 
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Figure 2-2 Excitation/Emission of SYTO-84 and EtBr. 
 
(A) represents the excitation (dashed line)/emission spectra (solid orange line) of EtBr. EtBr is excited by a blue laser (488 nm) and its emission is within the BL3 channel 
for emissions of 695/40 filter. (B) represents the excitation (dashed line)/emission spectra (solid red line) of SYTO-84. SYTO-84 dye is excited by the yellow laser (561 
nm) and its emission is within the YL1 channel for an emission of 585/16 nm. This figure was created and adapted using ATT Bioquest’s interactive Spectrum Viewer 
(https://www.aatbio.com/spectrum/).  
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Compensation of BL3-H and YL1-H channels was set using Attune NxT software. 
For this, an unstained control of 100 μL cells was added to 500 μL of filtered HBS. 
YL1-H compensation was set using 100uL cells with 10 μM SYTO-84 in 500 μL HBS 
and BL3-H by 100 μL cells with 100 μM EtBr. Compensation was set to ensure data 
quality but the SYTO-84 and EtBr were excited using differing channels so spill-over 
in fluorescence emission was minimal. 
2.2.3 Measuring EtBr accumulation with GFP fluorescence  
EtBr accumulation and GFP fluorescence were measured in parallel in the same 
cells. RamA is a transcriptional activator of the acrAB-tolC operon. Using SL1344 
pMW82-ramA, the transcription of ramA was measured alongside EtBr accumulation. 
In this experiment, indole, an inducer of ramA was added to act as a control for the 
transcriptional reporter. Due to the presence of the pMW82 plasmid, cultures were 
initially grown for 2 hours at 37˚C in LB supplemented with ampicillin (final 
concentration shown in Table 2-3). After 2 hours of growth, cells from 200 µL of 
culture were harvested and then resuspended in 1 × HBS and then sample set up 
continued as previously described. For the samples which were induced, the 200 µL 
culture was incubated with a final concentration of 2 mM indole for 30 minutes. Cells 
were then harvested after 30 minutes and samples were set up as previously 
described. 
To measure GFP, additional gating and compensation were required. An SL1344 
negative control strain with no GFP fluorescence was used to identify when no GFP 
was expressed. It was then possible to correctly measure fluorescence of GFP in 
those cells where it was expressed. As previously shown, a gate was added to select 
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for SYTO-84+ populations (Figure 2-3A+D) and then a further gate was added to 
measure EtBr accumulation in a SYTO-84+ population using the BL3-H filter. 
SYTO-84+ populations were also used to analyse GFP. Initially, GFP was identified 
using a BL1-H fluorescence (for GFP) vs YL1-H (for SYTO-84) dot plot. Comparing 
SL1344 to a GFP producing strain (Figure 2-3B+E), a quadrant gate was added to 
the dot plot. Those cells emitting GFP were shown in the GFP+ gate in Figure 2-3E. 
The population within the GFP+ gate was then plotted on a logarithmic histogram and 
the X-median value was taken as GFP fluorescence. Compensation was set for the 
emission of each fluorophore against an unstained control using the Attune NxT 
software.  
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Figure 2-3 Gating strategy for the measurement of GFP. 
 
(A-C) shows SYTO-84 and GFP fluorescence in SL1344. (D-F) shows SYTO-84 and GFP fluorescence in SL1344 pMW82-ramA. (A+D) show initial collection of 10,000 
SYTO-84+ events within the red gate. Using the red gated population, (B+E) shows GFP vs SYTO-84 fluorescence. (B) is the non-GFP control and therefore was 
considered GFP-. (E) using the quadrant gate, GFP+ cells were gated and the population appears red. (C+F) show the GFP+ populations on a logarithmic histogram using 
the BL1-H filter for GFP fluorescence. This figure was created by the author of this thesis but taken from Whittle et al., 2019.
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2.2.4 Measuring Nile Red accumulation using flow cytometry 
The method described above for measuring EtBr accumulation was adapted to 
measure accumulation of Nile Red. The final concentration of Nile Red used was 75 
µM. SYTO-84 was replaced with SYTO-9 in these experiments because SYTO-84 
fluorescence ex/em overlaps with the ex/em of nile red when it is staining both 
triglycerides and phospholipids (Greenspan and Fowler, 1985). SYTO-9 
fluorescence was collected using the BL2-H channel for green fluorescence, in order 
to separate from background cell debris. Using the SYTO-9+ population, nile red 
emission was then measured using the YL1-H channel. In this case, compensation 
was again set using the Attune software. 
2.2.5 Measuring EtBr accumulation in the presence of inhibitors 
Using SL1344, this assay was optimised to measure accumulation of EtBr and Nile 
Red in the presence of compounds that inhibit efflux. The examples used were the 
PMF inhibitor, carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and the RND 
inhibitor PaβN.  
To analyse the effect that CCCP (Fisher) had on dye accumulation, CCCP was added 
to 500 µL of 1 × HBS to give a final concentration of 100 µM CCCP (Smith and Blair, 
2014), followed by the addition of EtBr and SYTO-84. Cell suspension was added 
and samples were incubated for 10 minutes before analysing using flow cytometry.  
With PaβN, EtBr was not used due to previous studies that suggest the inhibitor does 
not prevent EtBr export (Lomovskaya et al., 2001, Kern et al., 2006). Nile Red 
accumulation was used to study the effects of PaβN on substrate accumulation. The 
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set up followed that described in Section 2.2.4, where a final concentration of 50 
µg/mL PaβN was added to 500 μL of 1 × HBS. 
2.3 Measurement of Accumulation of EtBr over growth using 
Flow Cytometry 
The method discussed below is an adaptation of the previously described method to 
allow measurement of accumulation in cells taken from different points in the growth 
curve. Unless otherwise stated, accumulation was measured in 4 biological replicates 
for these flow cytometry assays. 
2.3.1 Accumulation assay in cells taken from different time points 
across the growth curve 
Cultures were grown at 37°C overnight in 5 mL of LB. Strains were then sub-cultured 
using a 4 % inoculum in 25 mL of LB or MOPs in a 250 mL Duran bottle and grown 
for 6 hours at 37°C with aeration. At every hour for 6 hours (including time point 0), 
samples were taken (of different volumes), cells harvested, and resuspended in 1 × 
HBS at differing volumes stated in Table 2-6. Samples were set up, as previously 
stated in Section 2.2.2. Both SYTO-84 and EtBr were added to 500 µL of 1 × HBS 
and then the cell suspension was added. Cultures were grown in drug-free broth and 
dyes were only ever added to samples that were harvested, dyes were never added 
to the growing cultures. 
The volume of culture that was removed was dependent on the time point, as diluted 
samples with a low cell count are required for flow cytometry (Table 2-6). Initial 
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experiments using SL1344 compared to ∆acrB, ∆acrAE, ∆tolC and ∆4PAP took a 
100 μL sample from cultures which were grown for 4 to 6 hours. However, cultures 
which were grown for longer than 4 hours contained far more cells and so the sample 
volume was reduced to 50 μL Samples were incubated with SYTO-84 and EtBr for 
10 minutes at room temperature before analysis by flow cytometry. 
 
Table 2-6 Sample collection from 0-6 hours  
Sample time (h) culture taken (μL) HBS re-suspended in 
(μL) 
0 400 100 
1 300 100 
2 200 200 
3 200 1000 
4  100 1000 
5-6 50 1000 
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2.3.2 Gating strategy for measuring EtBr across the growth curve  
A flow cytometric gating strategy for measuring EtBr accumulation was described in 
Section 2.2.2. However, in stationary phase cells, the SYTO-84+ cells did not form a 
simple defined and separated population from background cell debris and became 
more difficult to gate. Therefore, an extra gating step was added to increase the 
reliability of the EtBr accumulation results. Briefly, the YL1-H channel detected the 
presence of SYTO-84 stain as previously mentioned. Gating via dot plot again 
allowed for separation of cells from background particles based on SYTO-84 
fluorescence. A gate was added to collect the SYTO-84+ population (gate name: 
SYTO 84+) on a YL1-H vs FSC-H plot (Figure 2-4B). The SYTO-84+ population was 
plotted on a dot plot showing forward scatter (FSC-H) and side scatter (SSC-H) 
based on size and granularity (Figure 2-4C). This extra gate allowed EtBr 
accumulation to be correctly measured in stationary phase as size and granularity 
did not differ between time points. A new gate from this plot (Cells) was plotted on a 
logarithmic histogram for EtBr fluorescence. The final gate was added to measure 
the X-median fluorescence per cell (‘EtBr’ gate) using the BL3-H channel (Figure 
2-4D), confirm EtBr fluorescence and therefore accumulation. 
The gating strategy described in this section was used for all experiments where 
accumulation of dyes was measured across the growth curve. 
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Figure 2-4 Gating Strategy for accumulation assay over time. 
 
 
(A) Cells are gated in purple with the name ‘SYTO 84’ and appear purple on YL1-H vs count histogram plot. (B) Using a FSC-H vs YL1-H dot plot, SYTO 84+ cells were 
gated (yellow) to separate them from background cell debris. (C) The SYTO-84+ population was further gated (blue) on an FSC-H vs SSC-H dot plot for a single cell 
population. FSC vs SSC dot plot shows size vs granularity. (D) Cells are gated in red and the peak appears blue based on ‘Cells” and gives the X-median value of EtBr 
fluorescence used as a measure of accumulation. 
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2.3.3 Adaptation of flow cytometry assay across growth curve to 
test other variables 
The flow cytometry assay measuring EtBr across the growth curve described in 
Section 2.3.1 was adapted for use with the Nile Red dye and also to test other 
hypotheses. The details are outlined below. 
2.3.3.1 Nile Red 
Nile Red accumulation was measured in S. Typhimurium across the growth curve in 
place of EtBr. Using a final concentration of 75 µM Nile Red and SYTO-9 in place of 
SYTO-84, as stated in Section 2.2.4, the method for accumulation across the growth 
curve (2.3.1) was repeated. 
2.3.3.2 Addition of CCCP 
Measuring EtBr accumulation in the presence of CCCP was described in Section 
2.2.5. Samples of growing culture were taken every hour (Table 2-6). A final 
concentration of 100 µM CCCP was added to 500 µL HBS, followed by EtBr and 
SYTO-84. Samples were incubated for 10 minutes and then analysed. 
2.3.3.3 EtBr accumulation measured with GFP fluorescence 
The promotor of acrAB has been cloned upstream of green fluorescent protein (gfp) 
on the pMW82 plasmid. This plasmid can report on the level of acrAB transcription 
as GFP is expressed when acrAB is transcribed (this pMW82 plasmid was a gift from 
Dr. Mark Webber (Webber et al., 2017)). SL1344 with the pMW82-acrA plasmid was 
used in this method. This strain was also grown for 6 hours in 25 mL LB, but was 
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supplemented with ampicillin due to the plasmid. The sample set up was carried out 
as in Section 2.3.1. However, GFP fluorescence using flow cytometry was measured 
as stated in Section 0. 
2.3.3.4 Assay in the presence of EDTA to disrupt the membrane 
This assay was carried out in a similar way to Section 2.3.1. However, samples were 
only taken at 1, 3 and 5 hours and only 3 biological replicates were carried out.  
Cell pellets were resuspended in volumes of 1 × HBS (Table 2-6) with a final cell 
suspension of 500 μL. Then samples were treated with 0 μM, 1 μM, 10 μM, 100 μM, 
200 μM or 500 μM of EDTA at pH 8. EtBr and SYTO-84 dyes were then added. The 
volume of these dyes was adjusted to maintain final concentration. Samples were 
then analysed by flow cytometry. 
2.3.4 Measurement of cell viability 
2.3.4.1 Cells grown in LB for 0-6 hours 
The samples collected for flow cytometry (section 2.3.1) were serially diluted 1 in 10 
to a final ratio of 1:100000 and 5 μL of each dilution was plated on LB agar in 
triplicate. Agar plates were incubated at 37°C overnight and colony forming units/mL 
(CFU/mL) were calculated the following day. 
2.3.4.2 Cells incubated in the presence of EDTA for 10 minutes 
To determine whether bacterial viability was affected by EDTA concentration, 
samples from the experiment described in Section 2.3.3.4 were taken before 
SYTO-84 and EtBr were added. Following addition of EDTA, samples were incubated 
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for 10 minutes and then viable counts were performed as described in Section 
2.3.4.1. 
2.4 Statistical analysis of Flow Cytometry data 
2.4.1 Statistical analysis of accumulation at a single time point 
For data produced based on the methods that measure EtBr accumulation at only 
mid-exponential phase (Section 2.2), all graphs were produced using Prism 
GraphPad software. To compare EtBr accumulation of SL1344 to ΔacrB, ΔtolC, 
ΔacrAE, and Δ4PAP (ΔacrA, ΔacrE, ΔmdtA, ΔmdsA) strains, a one-way ANOVA and 
Dunnett’s multiple comparisons test was used. A one-way Analysis of Variance 
(ANOVA) was used in this case because EtBr accumulation was measured in more 
than two strains. For EtBr accumulation of E. coli, K. pneumoniae and P. aeruginosa 
compared to a single efflux mutant, unpaired T-tests were used for analysis. 
Unpaired T-tests were also used for the analysis of nile red accumulation, the 
fluorescence of GFP and the presence and absence of inhibitors.  
Most graphs shown in this thesis, contain asterisks that relate to significant p-values 
and is shown in Table 2-7. 
Table 2-7 How asterisks relate to p-value  
P-value Asterisk 
>0.05 ns 
0.01 - 0.05 * 
0.001 - 0.01 ** 
0.0001 - 0.001 *** 
<0.0001 **** 
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2.4.2 Statistical analysis of EtBr accumulation over time 
The average EtBr fluorescence per cell collected in the BL3-H channel equated to 
EtBr fluorescence. The X-median was used as a statistic for the average 
accumulation of EtBr per cell. The events per μL statistic was used to calculate 
CFU/mL using the following equation. 
1"#$$%	'#(	)*	+,	"-$.-(# = 0#1#,.%	'#(	2* ∗	(5 + 515)9 ∗	:;5< ∗	=
1000
? @ 
1 x μL volume of culture taken; y μL HBS resuspended in; z μL added to the 515 μL sample. 
The median of EtBr accumulation and the number of cells were plotted using Prism 
software. When measuring EtBr accumulation at different timepoints in a single strain 
(SL1344), a one-way ANOVA and multiple comparisons test was used. A two-way 
ANOVA and multiple comparison tests were required when comparing EtBr 
accumulation between two strains at a number of different time points due to the 
number of variables. Statistical tests used are stated with each result in the 
proceeding chapters. 
2.5 Disruption of genes in S. Typhimurium 
The rpoS, ompC and ompF genes were disrupted in S. Typhimurium using the 
homologous recombination method described by Datsenko and Wanner (2000). The 
rpoS gene was deleted in SL1344 and SL1344 ∆acrB to produce a single and double 
knockout respectively (Table 2-1). The major porin genes, ompC and ompF, were 
deleted from SL1344 and SL1344 ∆acrB to produce a single and double knockout 
respectively. The ompF gene was also deleted from SL1344 ∆ompC and SL1344 
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∆acrB ∆ompC to produce a suite of porin deleted strains that can be found in Table 
2-1. 
2.5.1 Generation of PCR product for gene disruption 
Oligonucleotides (Table 2-8) were designed with approximately 40 base pairs (bp) 
of homology upstream or downstream of the gene to be disrupted and approximately 
20 bp homology to the aph (which encodes aminoglycoside phosphotransferase) 
cassette of the pKD4 plasmid. The template pKD4 plasmid was purified from E. coli 
strain BW1125 (Table 2-1) using a plasmid miniprep kit according to manufacturer’s 
instructions (Qiagen). Oligonucleotides (Invitrogen) were reconstituted in Ultrapure 
H2O to a concentration of 100 μM, and then diluted for use to 25 μM. Polymerase 
chain reaction (PCR) samples contained 12.5 μL MyTaq DNA polymerase (Bioline), 
9.5 μL Ultrapure H2O and 1 μL of both forward and reverse primers with 2 μL of pKD4 
as a template. The cycling conditions for this and all PCR reactions can be found in 
Table 2-9. Agarose gel electrophoresis was used to separate 50 μL of PCR product, 
and DNA was then excised from the gel and purified using a Gel extraction kit 
(Qiagen). The concentration of DNA was measured using a nanodrop. 
Agarose gels were made by making 1 % agarose (Sigma) in Tris-acetate EDTA 
(TAE) buffer (Sigma), and 10 µL Midori Green stain was added to aid visualisation. 
DNA was separated on agarose gels at 100 V for 1 hour, unless not well separated. 
Agarose gels were imaged with UV on an Amersham Imager 680.
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Table 2-8 List of oligonucleotides 
Code Description Sequence (5’-3’) 
82 acrB check (F) GCTCAGCCCAGGTCTTAACTT 
83 acrB check (R) CTCACTGTTGATAAGGCCGC 
36 K2; internal aph check (F) CGGTGCCCTGAATGAACTGC 
37 Kt; internal aph check (R) GGATTCATCGACTGTGGCCG 
191 (F) to knockout rpoS (aph insertion) TTGCTAGTTCCGTCAAGGGATCACGGGTAGGAGCCACCTTGTGTAGGCTGGAGCTGCT
TC 
192 (R) to knockout rpoS (aph insertion) GGACCATGGCTAATTCCCTAAGTACCCTTGTCAAAAAAAGGCCAGTCTGTCGACTGGC 
193 rpoS check (F) AGGGGAAATCCGTAAACCCG 
194 rpoS check (R) ATCGCGCCAGGTATACAGAC 
242 (F) for inserting aph into msfGFP 
with upstream AscI site 
TATATTGGCGCGCCGTGTAGGCTGGAGCTGCTTC 
243 (R) for inserting aph into msfGFP 
with downstream KpnI site 
AGGATATTCATATGGACCATGGCTAATTCCCATGGTACCCCGATA 
246 aph insertion into msfGFP (F) GTCCAAGCTGAGCAAAGACC 
247 aph insertion into msfGFP (R) TGAATGAACTGCAGGACGAG 
261 (F) to insert msfGFP-aph 
downstream of acrB  
GAGCATAGTCATTCGACAGAACATCGCGGTAGCGGTAACAAAGGTCAGGGCGTGAGC
AAGGGCGAGGAGCTGTT 
249 (R) for the insertion of msfGFP-aph 
downstream of acrB 
GGACCATGGCTAATTCCCATTTTGCTCACTGTTGATAAGGCCGCGCAAGCGGCCTTTTT
TACGCAAAAATCT 
254 acrB-gfp check (F) TGGTCTATCCCGTTCTCCGT 
255 acrB-gfp check (R) GGGCACAAGCTGGAGTACAA 
260 (F) to insert a 6xHis tag + aph 
downstream of acrB  
GAGCATAGTCATTCGACAGAACATCGCCATCACCATCACCATCACTAAGTGTAGGCTG
GAGCTGCTTC 
268 ompC check (F) AATGGACTTGCCGACTGGTT 
269 ompC check (R) CCTCATCGCAGCCCATAAGT 
270 ompF check (F) TAGCACTTTCACGGTAGCGA 
271 ompF check (R) AAAGCCCGCCTGTTTTTGAA 
272 (F) to knockout ompF (aph insertion) GCAGGTGTCATATAAAAAAACCAATGAGGGTAATAAATAGTGTAGGCTGGAGCTGCTTC 
273 (R) to knockout ompF (aph insertion) ATGGCTAATTCCCATTGATCAGCAGACCCCTTTGTTTTATGCCTCAAAAACAGGA 
307 (F) to knockout ompC (aph insertion) AAAGCAATAAAGGCATATAACAGAGGGTTAATAACGTGTAGGCTGGAGCTGCTTC 
308 (R) to knockout ompC (aph insertion) ATGGCTAATTCCCTAATCAGCAAAAGATGTTGCTAAAGGGCCTGCGGGCCCTT 
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Table 2-9 PCR cycling times and temperatures 
PCR cycle name Initial Denaturation Denaturation Annealing Extension Final extension 
  (x30 cycles)  
rpoS check  95°C (1 min) 95°C (15s) 65°C (15s) 72°C (30s) 72°C (10 min) 
acrB check 95°C (1 min) 95°C (15s) 51°C (15s) 72°C (40s) 72°C (10 min) 
AscI and KpnI insertion 98°C (30s) 98°C (10s) 65°C (15s) 72°C (30s) 72°C (10 min) 
acrB-gfp check 95°C (1 min) 95°C (15s) 60°C (15s) 72°C (30s) 72°C (10 min) 
  (x35 cycles)  
aph product for KOs 95°C (1 min) 95°C (30s) 50°C (30s) 72°C (40s) 72°C (10 min) 
gfp-aph homologous 
recombination 
95°C (1 min) 95°C (15s) 61°C (15s) 72°C (3 mins) 72°C (10 min) 
gfp-aph check 95°C (1 min) 95°C (30s) 65°C (15s) 72°C (30s) 72°C (10 min) 
ompF and ompC check 95°C (1 min) 95°C (15s) 58°C (15s) 72°C (2 mins) 72°C (10 min) 
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2.5.2 Bacterial transformation  
To transform recipient strains with the plasmids required for the gene disruption 
method (pSIM18 or pCP20 shown in Table 2-4), bacteria were made 
electro-competent. Overnight cultures were prepared as described in Section 2.1 
and 2 mL was used to inoculate 50 mL of LB broth in a 500 mL Duran bottle. The 
culture was grown at 37°C, with shaking until an OD600 of 0.6 was reached. Cells 
were transferred to a 50 mL falcon tube and chilled on ice for 10 minutes followed by 
centrifugation at 2250 x g for 10 minutes at 4°C. The supernatant was discarded and 
cells were resuspended in 25 mL of ice cold 15 % glycerol and harvested by 
centrifugation a further 3 times. Cells were resuspended in a final volume of 500 μL 
of 15 % glycerol. A maximum volume of 2 μL of plasmid DNA was added for final 
volume of 50 μL of competent cells in a chilled 0.2 cm electroporation cuvette. 
Electroporation was performed at 2.5 kV (25 μF, 200 Ω), then 950 μL of warm LB 
broth was immediately added to the cuvette and then cells were transferred to a 
universal tube and recovered at 30°C with shaking for 1 hour. Cells were then spread 
on LB agar plates with 150 μg/ml hygromycin to select for transformed strains and 
incubated overnight at 30°C. 
2.5.3 Lambda red recombination 
Strains containing pSIM18, were transformed with the PCR products made in 
Section 2.5.1. The pSIM18 encodes a l red recombinase system which mediates 
homologous recombination (Table 2-4). As a result, the PCR product containing the 
aph cassette incorporates into the target gene and disrupts it. 
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Overnight cultures were prepared with 150 μg/mL of hygromycin, and incubated at 
30°C. This was used to inoculate 50 mL of fresh LB at 4 %, and this culture was 
grown to OD600 nm of 0.3. Cells were transferred to a 50 mL falcon tube and heat 
shocked at 42°C for 15 minutes in a water bath, then cooled on ice for 10 minutes. 
Cells were made competent by washing 3 times in 15 % ice cold glycerol as 
described in Section 2.5.2 and resuspended in a final volume of 200 μL. 
Electroporation was performed as described in Section 2.5.2 using 45 μL of cells 
and 5 μL of PCR product. Cells were incubated for 2 hours at 37°C in universal tubes 
and then plated on LB agar with 50 μg/mL kanamycin to select for incorporation of 
the aph cassette by homologous recombination. The plates were incubated at 37°C 
overnight and successful transformants were streaked onto fresh LB agar with 50 
μg/mL kanamycin. To cure pSIM18 from gene disruption candidates, they were 
grown in 5 mL of LB overnight at 37˚C and then streaked onto LB agar without 
antibiotics, and grown overnight at 37˚C. A colony from each candidate was then 
streaked onto kanamycin and hygromycin. Colonies which grew on kanamycin, but 
not hygromycin, confirmed the loss of pSIM18. 
2.5.4 aph removal by pCP20 
Knock-out strains containing aph were made competent as in Section 2.5.2 and 
resuspended in 400 μL of glycerol followed by electroporation with 5 μL pCP20 
plasmid (Datsenko and Wanner, 2000, Cherepanov and Wackernagel, 1995). 
Electroporated cells were recovered in 950 μL of LB broth and incubated at 30°C for 
1 hour to recover. The cells are then spread on LB plates with 50 μg/mL ampicillin 
(Table 2-3) and incubated for 24-48 hours at 30°C. To cure the plasmid, candidate 
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colonies were inoculated in 10 mL of LB and grown overnight with aeration at 43°C. 
A loop of culture was then streaked onto LB and incubated overnight at 37°C. The 
loss of pCP20 was screened by plating colonies on LB only, LB with kanamycin and 
LB with ampicillin. The cells that lost both pCP20 and aph do not grow on ampicillin 
or kanamycin. 
2.5.5 Verification of aph insertion and removal by PCR 
Correct insertion and pCP20 removal of the aph gene into the recipient strain was 
confirmed by PCR. The correct size for all genes, knockouts and ∆ strains are shown 
in Table 2-10.  
Primers were created upstream and downstream of the gene of interested to confirm 
the size if aph was present or absent. Primers are shown in Table 2-8. Cycling 
conditions for PCRs are shown in Table 2-9. Successful insertions and pCP20 
removals of aph into the recipient gene were confirmed by visualising 5 μL of the 
PCR products by agarose gel electrophoresis. These PCR products were then 
purified using the PCR purification kit protocol (Qiagen) and then the concentration 
measured by nanodrop. 
Table 2-10 Sizes (bp) of PCR products 
Gene WT (bp) + aph (bp) D (bp) 
acrB 3214 1583 386 
rpoS 1289 1793 400 
ompF 1355 1762 367 
ompC 1405 1765 300 
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2.5.6 Sequencing 
All KO and ∆ strain PCR products were sequenced using TubeSeq from the Eurofins 
genomics service (Sanger sequencing). 
2.6 Chromosomal insertion of gfp downstream of acrB 
To measure the protein level of AcrB in S. Typhimurium, a gene encoding a 
monomeric super-folder GFP (msfGFP) was inserted downstream of acrB on the 
chromosome to produce a AcrB-msfGFP fusion protein. Strain construction was 
based on the method used by Bergmiller et al. (2017) in E. coli. Using restriction and 
ligation, the aph gene was inserted into pET LIC vector (u-msfGFP), so that strains 
containing the plasmid could be selected for. Using this plasmid as template, gfp and 
aph were inserted into the chromosome downstream of acrB in SL1344 to produce a 
protein fusion strain.  
2.6.1 Insertion of aph into pET LIC vector (u-msfGFP) 
The restriction sites downstream of the gfp gene that enable cutting by AscI and 
KpnI-HF (NEB) restriction enzymes, were used to insert aph into the msfGFP 
encoding plasmid. The msfGFP plasmid was purified using the Qiagen plasmid prep 
kit protocol. Enough plasmid was purified for 1 μg DNA in the restriction digest 
reaction. 
The aph gene was amplified from the pKD4 plasmid. Oligonucleotides (Table 2-8) 
were designed with homology to the aph gene. The forward oligonucleotide 
contained the AscI restriction site at the 5’ end, where the KpnI restriction site was 
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present at the 5’ end of the reverse oligonucleotide. This DNA product was amplified 
using PCR with Phusion polymerase (ThermoFisher). The mastermix for this reaction 
is in Table 2-12 and the PCR cycle times in Table 2-9.The DNA was separated by 
agarose gel electrophoresis and the size of the DNA product was 1522 bp which was 
then purified using the Qiagen gel extraction kit protocol.  
Restriction digest was carried out on the msfGFP plasmid and the aph DNA product 
using the enzymes stated above to produce overhangs of DNA for re-ligation. Both 
restriction enzymes had 100% activity in CutSmart® Buffer. The following restriction 
digest reactions were set up as in Table 2-11, with an uncut control, single cuts 
controls (AscI or KpnI-HF), double cut plasmid and aph product.  
 
Table 2-11 Sample set up for restriction digest 
 Uncut Single (AscI) Single 
(KpnI-HF) 
Double (GFP)  Double (aph) 
DNA 0.5 μg 
(14 μL) 
0.5 μg (14 
μL) 
0.5 μg (14 
μL) 
1 μg (9.5 μL) 235 ng (15 μL) 
10 x buffer 5 μL 5 μL 5 μL 5 μL 5 μL 
AscI 
 
0 μL 1 μL 0 μL 1 μL 1 μL 
KpnI 
 
0 μL 0 μL 1 μL 1 μL 1 μL 
H2O 31 μL 30 μL 30 μL 33.5 μL 0 μL 
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The samples were made as described in Table 2-11 and then incubated at 37°C for 
1 hour. After 1 hour, 1 μL of alkaline phosphatase (NEB) was added to the tubes 
containing double cut msfGFP plasmid to prevent re-ligation of the plasmid to itself. 
The samples were then incubated at 37°C for 1 hour. As the aph PCR product already 
had a low concentration of DNA, the sample was then purified using the PCR 
purification kit protocol (Qiagen) to prevent more loss of DNA by gel electrophoresis. 
The DNA from all other samples was separated by size using agarose gel 
electrophoresis with a 6 x loading buffer to visualise the DNA. The double cut plasmid 
was then purified using the gel extraction kit protocol (Qiagen). 
For the ligation reaction, the following ratios were used for plasmid to PCR product: 
1:1, 3:1 and 9:1 in order to optimise and obtain successfully ligated aph into the 
msfGFP plasmid. The ligation reactions were incubated overnight at 16°C. Figure 
2-5 shows the plasmid map for the msfGFP-aph plasmid. 
The ligation reactions were then transformed in to NEB 5- a E. coli (C29871) using 
the NEB transformation protocol. Transformations were spread on LB agar plates 
containing kanamycin and incubated overnight at 37°C. Candidates were checked 
for correct insertion of aph using PCR and sequencing.  
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Figure 2-5 Plasmid map of msfGFP-aph plasmid. 
 
This plasmid had an AmpR cassette. A KanR (aph) cassette was inserted into the plasmid using restriction-ligation 
downstream of msfGFP. Schematic made using Snapgene software. 
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2.6.2 PCR amplification of gfp-aph 
The msfGFP + aph plasmid was purified using the Qiagen plasmid prep protocol.  
Oligonucleotides were designed to amplify GFP and aph from the plasmid with 
homology to acrB. The forward oligonucleotide shown in Table 2-8, was designed to 
have homology to the 3’ end of acrB, a codon optimised polylinker 
(GgtAgcGgtAacAaaGgtCagGgc) used by Bergmiller et al. (2017) and homology to 
the 5’ of gfp (Figure 2-6).The reverse oligonucleotide had homology to the end of 
aph and a non-coding downstream region of acrB. 
The DNA was amplified using PCR and Phusion polymerase (mastermix in Table 
2-12) with a cycle time shown in Table 2-9. The correct band size was 2356 bp and 
the DNA was concentrated using gel extraction (Qiagen). 
 
Table 2-12 Phusion polymerase mastermix set-up (50 μL) 
Component Volume (μL) 
10 μM forward primer  2.5 
10 μM reverse primer 2.5 
DMSO 1.5 
2x Phusion polymerase mastermix 25 
Template 2 
H2O 16.5 




Figure 2-6 Schematic of gfp inserted downstream of acrB on the chromosome. 
 
This schematic shows acrA (purple), acrB (blue) where the stop codon has been removed and a polylinker (yellow) and GFP (green) fused to it. Schematic produced using 
Snapgene software. 
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2.6.3 Homologous recombination 
Insertion of gfp and aph downstream of acrB was done using homologous 
recombination, and the method used was previously described in Section 2.5.3. PCR 
and sequencing confirmed correct fusion of gfp to acrB and then aph was removed 
using pCP20 described in Section 2.5.4. 
2.6.4 Confirmation of construction of SL1344 AcrB-GFP 
Successful candidates were checked by amplification using oligonucleotides within 
acrB, gfp and aph. Amplification of a product containing part of acrB, the polylinker 
and gfp was done using primers p254 and p255 for a 920 bp product. The 
oligonucleotides and cycling times can be found in Table 2-8 and Table 2-9 
respectively. Sequencing confirmed the removal of aph and correct construction of 
SL1344 AcrB-GFP. 
2.7 Phenotypic characterisation of mutant strains 
2.7.1 Growth kinetics 
Overnight cultures of strains were grown in 5 mL of LB at 37°C. Strains were diluted 
1:10000 in either LB or MOPs minimal media and this was then diluted 1:10. Cultures 
were added to a flat bottomed, clear 96-well plate with lid (Greiner), with 200 μL per 
well and 3 technical replicates of each. LB or MOPs alone were added as blanks. 
The plate was then covered with a ‘BreatheEasy’ membrane (Diversified Biotech) to 
prevent evaporation. Absorbance was measured at 600 nm using a FLUOstar 
Omega at 37°C. Absorbance was taken using well-scan mode and shaking of the 
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plate occurred between readings. Absorbance readings were taken every 20 minutes 
for 12 hours. There were three biological replicates for each strain where growth 
kinetics was measured. Generation times were calculated for each biological 
replicate and a one-way ANOVA and Tukey’s multiple comparison test was used for 
statistical analysis. 
2.7.2 Antimicrobial susceptibility 
The Minimum Inhibitory Concentrations (MICs) of a number of antibiotics and dyes 
were established by the agar dilution method of Clinical and Laboratory Standards 
Institute (CLSI, 2018). Antibiotic and dye stocks were freshly made and used to 
supplement Iso-sensitest agar. The list of antibiotics and dyes used are shown in 
Table 2-13.The MIC data was the modal value of 3 biological replicates. A control 
strain, E. coli Colindale NCTC 10418 (Table 2-1), with defined MIC values was used 
to confirm consistency of MICs data. 
 
Table 2-13 Antibiotics and dyes used for MICs 
Compound Company Solvent Concentration  
Ampicillin Sigma; A0166 NaHCO3 0.008 μg/mL – 8 μg/mL 
Ciprofloxacin Fisher; 13531640 Acetic acid + H2O 0.008 μg/mL – 8 μg/mL 
Crystal violet Fisher; AC447570500 H2O 1 μg/mL – 1024 μg/mL 
Erythromycin Fisher; AC227330050 70 % ethanol 1 μg/mL – 1024 μg/mL 
EtBr Fisher; 10042120 H2O 1 μg/mL – 1024 μg/mL 
Fusidic acid Sigma: F0881 H2O 1 μg/mL – 1024 μg/mL 
Norfloxacin Alfa Aesar; J6265203 Acetic acid + H2O 0.008 μg/mL – 8 μg/mL 
Rhodamine 
6G 
Fisher; AC419010050 H2O 1 μg/mL – 1024 μg/mL 
Rifampicin Sigma; R3501 H2O 1 μg/mL – 1024 μg/mL 
SDS Fisher; 10593355 H2O 1 μg/mL – 1024 μg/mL 
Vancomycin Alfa Aesar; J62790.06 H2O 1 μg/mL – 1024 μg/mL 
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2.7.3 Broth microdilution MICs 
Fresh antibiotic and dye stocks were prepared. Overnight cultures were grown at 
37°C with aeration. E. coli NCTC 10418 was included as a control strain. The 
overnight cultures were then diluted 1:100 and then again 1:20 to give ~5 x 105 
cfu/mL for inoculation into a 96-well plate. Bacteria are incubated with no antibiotic 
and 11 different concentrations of the antibiotic MIC being measured. To measure 
the MIC, 12 wells in a 96-well plate (1 row) were used. 50 μL iso-sensitest broth was 
added to wells 2-12. Antibiotic was diluted in iso-sensitest broth to the twice the 
required top concentration for measurement. 50 μL of this dilution is added to well 1 
and well 2. Well 2 containing 100 μL of broth + antibiotic is the starting point for a 
serial dilution where 50 μL is removed and added to the next well until well 11, where 
the 50 μL is removed. No antibiotic is added to well 12. 50 μL bacterial suspension 
is then added to each of the 12 wells. This process is repeated for each antibiotic 
and each strain where the MIC is measured. The 96-well plate is then incubated at 
37°C overnight. The MIC value is then taken and is the first well where bacterial 
growth is not observed. Results were only accepted if the observed MIC of E. coli 
NCTC 10418 was within 1 doubling dilution of the expected result as defined by 
Andrews and Testing (2006). The MIC data was the modal value of 3 biological 
replicates. 
2.7.4 Broth microdilution MIC from 3 different time points of 
growth 
Briefly, the assay is carried out as above in Section 2.7.3, except that MIC value is 
not based on the dilution of an overnight culture. Antibiotics used were ciprofloxacin, 
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EtBr, SDS and vancomycin. Overnights are sub-cultured at a 4% inoculum and grown 
for 5 hours. After 1,3 and 5 hours of growth, samples were taken and MIC 96-well 
plates set up from these cultures. At each hour, the bacterial culture was diluted to 
~5 x 105 cfu/mL, so that MICs could be compared to the standard MIC of an overnight. 
CFU/mL for each time was based on CFU/mL result from flow cytometry assays. 
2.7.5 Direct efflux assay 
As well as measuring EtBr accumulation, efflux activity can also be measured using 
EtBr. In this method, the efflux substrate EtBr accumulates within bacterial cells in 
the presence of an efflux inhibitor, and then when efflux pumps are re-energised with 
glucose, fluorescence of EtBr can be measured as it is exported from cells. 
Overnight cultures were sub-cultured in 10 mL fresh LB and grown shaking at 37°C 
until an OD600 nm of 0.4. Cells were harvested at 3000 x g for 10 minutes at 23°C. 
Pellets were resuspended in 10 mL of PPB buffer (50 mL 0.1 M potassium phosphate 
buffer; 200 mL H2O; 250 µL MgCl2) and OD600 nm was adjusted to 0.15 in 10 mL. 
Then, 100 µM CCCP and 50 µg/mL EtBr were added to 10 mL suspension which 
was then incubated shaking at 23°C for 1 hour. Cells were then harvested again as 
above and resuspended in fresh PPB buffer + 5% glucose. Then, 200 µL was added 
to a black bottomed 96-well plate and fluorescence intensity was measured using a 
FLUOstar Omega. EtBr fluorescence gain was set to 1460. 
For all efflux assays, results for each strain were based on three biological replicates. 
For each biological replicate, 3 technical replicates were averaged and then the data 
was normalised such that the first fluorescence value at time point 0 was equal to 1. 
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From this, the time taken for a 10%, 25% and 50% drop in fluorescence was 
measured. Unpaired T-tests were used to measure statistical differences between 
drops in fluorescence. 
2.7.6 Adaptation of efflux assay to three time points 
Briefly, overnight cultures of SL1344 and SL1344 ∆acrB were sub-cultured into 100 
mL fresh LB and then grown for 5 hours at 37 °C. At the 1, 3 and 5-hour time points, 
10 mL of culture was taken and the OD600 nm measured. The harvested cell pellet 
was then resuspended in PPB buffer and OD600 nm adjusted to 0.15 in 10 mL. From 
this point, efflux assays were carried out as previously described as above (Smith 
and Blair, 2014, Paixao et al., 2009). Data and statistical analysis were carried out 
as in Section 2.7.5. 
2.7.7 Membrane leakage 
To measure membrane leakage, the above efflux assay (Section 2.7.6) was 
repeated. However, at the point where EtBr and CCCP are washed in fresh buffer 
with glucose, glucose was not added. This means that cells were not re-energised 
and any decrease in fluorescence shows what has leaked out of the cell membrane. 
2.7.8 Crystal violet biofilm quantification 
Biofilm formation by bacteria can be measured after 48 hours of growth using the 
dye, crystal violet. Overnight cultures of strains were grown in 5 mL of LB without salt 
at 37°C. The positive control strain 14082s which produces a high level of biofilm was 
included. Overnight cultures were then sub-cultured into 25 mL LB (4% inoculum) 
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and samples were then taken at 1, 3 and 5 hours. Overnight cultures were diluted 
1:10 in fresh salt free broth and OD600 nm adjusted to 0.1. 200 µl of diluted cell 
suspension was added to a clear 96-well plate. For each strain, three biological 
replicates were included. Each biological replicate was based on the averaged values 
of three technical replicates. 
After 1, 3 and 5 hours of growth, samples were adjusted to an OD600 nm of 0.1 and 
added to the 96-well plate. The 96-well plate was then incubated at 30°C for 48 hours 
with gentle shaking. After 48 hours, the biofilms were washed with water to remove 
unattached cells. Then, 200 µl of 0.1 % crystal violet was added to the wells with 
biofilms and incubated for 15 minutes at room temperature. Crystal violet was then 
removed from the plate by washing the wells with water. The biofilm was then 
resolubilised in 200 µl of 70% ethanol. The remaining crystal violet equated to the 
biofilm that was present. The OD600 nm was measured using the FLUOstar OMEGA 
(BMG labtech). 
2.7.9 Curli biogenesis 
Using congo red supplemented agar, the biogenesis of curli can be visualised based 
on colony morphology and colour. Cultures of strains were grown in 5 mL of LB 
overnight at 37°C. Salt-free agar was cooled to 50°C and congo red (B24310; Alfa 
Aesar) added to make a final concentration of 40 μg/ml and poured into petri dishes. 
Overnight cultures were diluted 1:10 and the OD600 nm then adjusted to 0.1. Cultures 
were then spotted onto plates at a volume of 5 μL and incubated at 30°C for 48 hours. 
Plates were then imaged using a SMZ1000 zoom stereomicroscope (Nikon) at 1x 
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magnification. Red, dry and rough colonies indicated the production of curli and 
cellulose. Pink colonies indicated strains that produced cellulose but no curli. 
This assay was adapted to measure curli production at 1, 3 and 5 hours. 25 mL of 
SL1344 and SL1344 DacrB was grown and at each of the above time points, the 
culture was OD600 nm adjusted to 0.1 in salt free media and then plated onto congo 
red agar plates. 
2.7.10 Measuring transcription using pMW82 reporters in a 
whole population 
The transcription levels of each efflux pump in SL1344 could be measured using the 
pMW82 plasmid. The promoter of each efflux pump (acrA, acrD, acrE, mdsA, mdtA, 
macA, emrA, mdfA and mdtK) was fused upstream of gfp on the pMW82 plasmid 
(these plasmid constructs were a gift from E. Trampari and M. Webber). These 
pMW82 plasmids, which were efflux transcriptional reporters were transformed into 
SL1344 and SL1344 ∆acrB. In both strains, GFP fluorescence could be measured 
across the growth curve and this equated to the level of transcription of each pump. 
When measuring transcription, overnight cultures containing pMW82 transcriptional 
reporter plasmids (SE205-213 and SE236-244) were diluted 1:10000 in minimal 
media, supplemented with 50 µg/ml ampicillin. Then, 200 µL of each strain was 
added to a 96-well plate and incubated at 37˚C. OD600 nm and GFP fluorescence 
were measured every 20 minutes for 12 hours using a FLUOstar Omega. OD600 nm 
and GFP fluorescence were then analysed, with a background blank minimal media 
control subtracted from the data. For GFP fluorescence, SL1344 fluorescence was 
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subtracted from the pMW82 strains to remove background autofluorescence of the 
strain. GFP divided by OD600 nm was calculated to account cell density across 
growth. The transcription data is based on 3 biological replicates for each strain. 
2.7.11 Whole population measurement of GFP from SL1344 
AcrB-GFP 
As in Section 2.7.10, overnight cultures were grown in LB and then diluted 1:10000 
in MOPs minimal media. SL1344 AcrB-GFP was analysed in this experiment, and 
SL1344 was used as a control to account for Salmonella autofluorescence. Then, 
200 µL of each strain was added to a 96-well plate and incubated at 37˚C. OD600 nm 
and GFP fluorescence were measured every 20 minutes for 16 hours using a 
FLUOstar Omega. The gain for GFP measurement was increased to 2260. Gain 
adjustment is the control of voltage, therefore increasing the signal, as this variant of 
GFP was found to have low signal. Gain was chosen based on the auto-gain 
adjustment. OD600 nm and GFP fluorescence were then analysed, with a background 
blank minimal media control subtracted from the data. 
2.8 Microscopy 
Overnights of SL1344 and SL1344 AcrB-GFP were grown shaking at 37°C and 
sub-cultured at 4% inoculum into 25 mL of fresh LB. Cultures were grown for 5 hours. 
After 1 hour (1 mL), 3 hours (500 µL) and 5 hours (100 µL) of growth, samples were 
taken and cells harvested at 14,000 x g for 5 minutes. The supernatant was removed 
and the pellet re-suspended in 300 µL 4 % PFA, which was then incubated on ice for 
30 minutes. Cells were then harvested at 14,000 x g for 1 minute and PFA removed 
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followed by 3 x wash steps in 500 µL 1x PBS. Microscope slides were prepared by 
adding 5 µL of bacterial suspension onto a glass slide, adding 1 drop ProLong® Gold 
antifade reagent (Molecular probes; Life Technologies) then placing a 1.8 mm square 
glass coverslip on top. The coverslip was sealed in place with nail varnish. Cells were 
imaged using the Zeiss Axio Observer widefield microscope using the 100x oil 
objective. Phase contrast DIC images were taken for images of bacterial cells. GFP 
fluorescence images were taken using LED illumination at 488 nm with a 10 second 
exposure time. Figure images were made using Fiji/ImageJ.  
To measure cell length using ImageJ, a line equalling 10 microns was drawn on 
microscope images as a calibration. Lines were then drawn across each bacterial 
cell and compared to the 10 micron calibrated line to calculate length of each cell. 
From this, 100 cells were measured in each time point. Cells considered in the 
process of cell division were not measured.  
2.9 RNAseq 
2.9.1 Production of samples 
To analyse and compare the transcriptome of SL1344 and SL1344 ∆acrB at different 
time points (1, 3 and 5 hours), samples were prepared for next generation RNA 
sequencing. There were 4 biological replicates of each strain. The method described 
here was developed to produce cell pellets at different time points, but RNA 
extraction, rRNA depletion, sequencing and bioinformatics analysis was done by 
GENEWIZ Inc. GENEWIZ Inc recommend 1x108 cells for micro-organisms and the 
Chapter 2 - Materials and Methods 
 99 
volume of culture taken at each time point was optimised to reflect the number of 
cells required. 
Briefly, 150 ml of MOPS minimal media was inoculated (4 % inoculum) with overnight 
cultures in 500 ml bottles. The cultures were then incubated at 37°C, shaking for 5 
hours. After 1 hour of growth, 5 ml of culture was added to a universal tube and then 
centrifuged at 3500 x g for 5 minutes at room temperature to harvest the cells. The 
supernatant was removed and the pellet was re-suspended in a further 1 ml of 1 hour 
culture, transferred to a 1.5 ml Eppendorf tube and re-harvested at 14000 x g for 1 
minute. The supernatant was removed and the pellet was snap frozen. At the 3 and 
5- hour time points, only 1 ml of culture was harvested and snap frozen. 
2.9.2 RNA extraction, rRNA depletion, and RNA sequencing 
GENEWIZ Inc. carried out the RNA extraction, quality control, library preparation, 
sequencing and bioinformatic analysis. Total RNA was extracted from S. 
Typhimurium cell pellets using RNeasy Plus Universal kit (Qiagen), following the 
manufacturer’s instructions. RNA quality control was carried out using Qubit 2.0 
Fluorometer to measure total RNA concentration and Agilent TapeStation (an 
automated electrophoresis system) to produce an RNA integrity number (RIN) and a 
DV200 score for the quantity of RNA fragments >200 nucleotides. To remove rRNA, 
the ribozero Removal Kit was used (Illumina). The NEBNext Ultra II RNA Library Prep 
Kit (Illumina) was used for library preparation, following the manufacturer’s protocol. 
For library preparation, cDNA was synthesised, end repaired and adenylated at the 
3’ ends. Universal adapters were ligated to cDNA and library enrichment was carried 
out using limited cycle PCR. Quality control was again carried out using Qubit 2.0 
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and TapeStation but also using the KAPA qPCR assay (KAPA). Sequencing was 
carried out using Illumina HiSeq 4000. The workflow that followed for analysis was: 
evaluate sequence quality, trim reads, map reads to the genome, generate hit counts 
for genes, compare gene hit counts and analyse gene ontology. The reference 
genome used was SL1344 reference FQ312003 found on NCBI 
(https://www.ncbi.nlm.nih.gov/nuccore/FQ312003). Genewiz Ltd then provided the 
raw data files, aligned data and differential gene expression (DGE) results. The 
ArrayExpress database was used to store the raw data from this experiment 
(Accession code: E-MTAB-9679). 
2.9.3 Data analysis 
Using the DGE results provided as a .csv file, the FQ312003 reference genome was 
used to identify gene annotations based on SL1344 RS codes. Scatter plots were 
made using Microsoft excel. Pathway tools software (Karp et al., 2016) was used to 
analyse metabolic pathways that were changed at different time points. RS codes 
from SL1344 were not recognised when using the cellular overview, therefore in this 
case, S. Typhimurium strain LT2 was used as a reference.
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Chapter 3 - Flow cytometry can be used 
to measure intracellular accumulation in 
bacteria 
All the data presented in this chapter has been published as a methods article: 
Whittle EE, Legood SW, Alav I, Dulyayangkul P, Overton TW, Blair JMA. Flow 
Cytometric Analysis of Efflux by Dye Accumulation. Front Microbiol. 2019;10:2319.  
The experiments and data from this publication that are presented in this chapter 
were carried out by the author of this thesis, unless otherwise indicated in this 
chapter. The publication was also written by the author of this thesis (Whittle et al., 
2019).  
3.1 Background 
For many antibiotics, successful and effective treatment of bacterial infections relies 
upon high level accumulation within cells. Antibiotic accumulation is dependent on 
the influx and efflux of antibiotics from cells. Measuring accumulation of antibiotics 
and dyes is well-established in bacterial cells, with various methods previously 
described (Blair and Piddock, 2016).  
One common approach is to measure intracellular accumulation of fluorescent dyes 
that are differentially fluorescent when inside or outside bacterial cells. For example, 
the DNA intercalating dye, EtBr (Olmsted and Kearns, 1977), which fluoresces when 
bound to DNA, is commonly used to measure accumulation level within the entire 
population of bacterial cells. AcrAB-TolC along with other RND pumps have been 
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shown to export EtBr (Nishino and Yamaguchi, 2001). Another DNA intercalating 
dye, Hoechst 33342 has also been used (Coldham et al., 2010). These dyes are used 
as they are well characterised substrates of major efflux systems. The fluorescence 
of cells is measured prior to the addition of the fluorescent dye, and then 
subsequently measured as the dye accumulates within the cells of a bacterial 
population (Blair and Piddock, 2016, Coldham et al., 2010).  
An alternative approach is to directly measure rate of efflux using dyes including EtBr, 
Nile Red (Bohnert et al., 2010) and 1,2-DNA (Bohnert et al., 2011). Cells are 
pre-loaded with the fluorescent dye in the presence of the PMF inhibitor, CCCP, 
followed by re-energising the pumps with glucose and then measuring the reduction 
in fluorescence. This correlates with the fluorescent dye being removed by efflux 
pumps. 
Fluoroquinolones are naturally fluorescing antibiotics and this class includes several 
clinically relevant drugs such as ciprofloxacin. It is more difficult to measure 
accumulation of drugs such as these because cellular localisation does not change 
the fluorescent properties (Piddock et al., 1999, Blair and Piddock, 2016). To 
overcome this, accumulation cannot be measured in live cells but can be measured 
from lysed cells (Asuquo and Piddock, 1993). 
Bacterial populations are heterogeneous. Therefore, it may be considered that 
dye/antibiotic accumulation within bacterial populations is also heterogeneous. 
Heterogeneous accumulation of antibiotics within cells, specifically some cells that 
accumulate antibiotics to a low level, would drive the acquisition of mutations and 
therefore drive AMR. For this reason, it is important to use experimental methods 
Chapter 3 - Flow cytometry can be used to measure intracellular accumulation in bacteria 
103 
 
which measure accumulation of drugs at the single cell level. Flow cytometry has 
previously been used to measure accumulation in single cells (Blair and Piddock, 
2016, Sanchez-Romero and Casadesus, 2014, Hassan et al., 2016, Haynes et al., 
2018), however a detailed method to measure and quantitatively compare 
accumulation using EtBr has not been produced. 
Other than EtBr, Fluorescein diacetate (FDA) has been shown to be effective in dye 
accumulation assays to the single cell level (Haynes et al., 2018). Intracellular 
accumulation of Nile Red and rhodamine 6G has also been measured in 
Saccharomyces cerevisiae and Candida albicans (Ivnitski-Steele et al., 2009). 
Further to this, the natural fluorescent properties of fluoroquinolones have also been 
used to measure accumulation in single cells (Kascakova et al., 2012), but not by 
flow cytometry. Intracellular accumulation using deep ultraviolet microscopy with a 
synchrotron beamline was used to analyse single cell accumulation levels of 
fleroxacin, a fluoroquinolone (Kascakova et al., 2012). Accumulation of drugs, 
tetracycline and ampicillin, to a sub-cellular single cell level has also been shown 
using mass spectrometry, specifically 3D imaging cluster Time-of-Flight secondary 
ion mass spectrometry (ToF-SIMS) (Tian et al., 2017). 
3.2 Hypotheses 
1. Flow Cytometry can be used to measure accumulation of fluorescent 
compounds within single cells  
2. This method can be used to show that efflux mutants accumulate significantly 
more of compounds that are substrates of the pump than WT cells. 




1. Develop a robust assay to measure EtBr accumulation in single cells using 
flow cytometry 
2. Develop this assay to work with different dyes, species and in combination 
with efflux pump inhibitors 
3. Develop this assay to measure EtBr accumulation and GFP fluorescence 
(gene transcription) concurrently. 
3.4 Assay Development 
To measure the level of EtBr in single cells, we developed a novel method using flow 
cytometry. This method was developed using the Gram-negative bacterium 
Salmonella enterica serovar Typhimurium, a model organism which has commonly 
been used in whole population accumulation assays. Briefly, the assay is carried out 
as follows: 
1. Cultures were grown for one hour in LB broth, to reach early-mid exponential 
phase, approximately the time point commonly used in other studies. 
2. To distinguish cells from background cell debris, the fluorescent cell marker 
SYTO-84, which emits orange fluorescence when intercalated with DNA, was 
used. SYTO-84 was a good candidate to use alongside EtBr as there is no 
overlap in excitation and emission of these two dyes. 
3.  Accumulation of EtBr was then measured in 10,000 individual cells 
(SYTO-84+ events) in a population based on fluorescence intensity. 
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3.4.1 Optimisation of dye concentrations 
To find the optimum concentration of SYTO-84, the following range of concentrations 
was tested: 0.1 µM, 0.5 µM, 1 µM, 5 µM and 10 µM. The final concentration of 
SYTO-84 that gave a distinct cell population with the best separation from the 
background was 10 µM (Figure 3-1A).  
The concentration of EtBr that gave the highest mean fluorescence in SL1344 was 
100 µM. Scatter plots showing the optimum concentration of EtBr are shown in 
Figure 3-1B. These dye concentrations were then used for this assay throughout. 
 
Figure 3-1 Concentrations of SYTO-84 and EtBr used in this assay.  
 
Example flow cytometry plots showing optimum concentrations of dyes used in the assay. (A) Staining of cells 
with SYTO-84. 10 µM SYTO-84 fluorescence was measured and displayed as a dot plot. Orange fluorescence 
(YL1-H) was plotted against forward FSC-H and a SYTO-84+ population was gated (R1). (B) Cells stained with 
SYTO-84 and EtBr. EtBr fluorescence (100 µM) was measured and plotted on dot plot showing YL1-H (SYTO-84) 
against BL3-H (EtBr). These plots are also published in Whittle et al. (2019).  
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3.5 EtBr accumulation can be measured in S. Typhimurium  
In order to accurately measure EtBr fluorescence inside cells, a gating strategy 
(shown in Figure 2-1 and in Figure 3-2A-D) was used to analyse EtBr fluorescence. 
Briefly, SYTO-84 fluorescence was plotted against FSC-H on a dot plot (Figure 
3-2A+C) and SYTO-84+ population was then gated collecting 10,000 events within 
the gate (gate name: SYTO 84+). The EtBr fluorescence of the SYTO-84+ population 
was then plotted on a logarithmic histogram for EtBr fluorescence intensity (Figure 
3-2B + E). The median EtBr fluorescence intensity was taken as the level of EtBr 
accumulating within each cell. The median is considered the most appropriate value 
to take as a value of mean fluorescence intensity (MFI) on a logarithmic histogram 
(Illingworth; website accessed 2020). 
To show that the optimised assay worked to quantify intracellular accumulation of 
EtBr in different Salmonella strains, EtBr accumulation was measured in SL1344 and 
various previously studied efflux mutants. The strains used were isogenic mutants of 
SL1344 denoted as DacrB (Eaves et al., 2004b), DtolC (Buckley et al., 2006) and 
D4PAP, a strain which lacks the 4 PAPs in SL1344 (McNeil et al., 2019). As 
previously shown, strains that lack efflux pumps accumulated significantly more EtBr 
that WT. 
Data was summarised in graphs as shown in Figure 3-2E. For the remainder of this 
thesis, data will be presented like this, rather than using dot plots. 
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Figure 3-2 Flow cytometry plots of SL1344 and strains lacking components of efflux pumps. 
 
(A+B) shows plots of SL1344 and (C+D) SL1344 DacrB. (A+C) Cells were separated from background cell debris using channels YL1-H vs. FSC-H. A SYTO-84+ population 
of 10,000 events was gated (red). SYTO 84+ cells were then analysed in (B+D) plots (red peak represents red gate from previous plot) where the BL3-H channel measured 
the EtBr fluorescence median from an EtBr gate (blue). (E) Single circles represent the median of EtBr fluorescence from a SYTO 84+ population of cells within a biological 
replicate. There are 4 biological replicates for each strain. For each strain, the black bar represents the mean of the 4 biological replicates +/- standard error of the mean 
(SEM). The average RFUs were 8024 (WT), 46824 (DacrB), 58321 (DtolC) and 33359 (D4PAP). A one-way ANOVA and Dunnett’s multiple comparison test were used to 
produce p-values. All p-values compared to WT were < 0.0001(represented by **** on the graph). Data also published in Whittle et al. (2019)
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3.6 Adaptation to measure accumulation of Nile Red 
EtBr is not the only dye that has been used to measure accumulation or efflux. 
Hoescht 33342 (Blair and Piddock, 2016) along with Nile Red (Bohnert et al., 2010), 
1,2-DNA (Bohnert et al., 2011) and rhodamine 6G (Ivnitski-Steele et al., 2009) all 
have fluorescent properties inside cells which have been harnessed for these assays. 
The flow cytometry assay was adapted to measure the fluorescence of Nile Red in 
place of EtBr showing that this assay is not limited to EtBr accumulation. 
The fluorescence spectra of Nile Red and SYTO-84 overlap so this assay used 
SYTO-9 to separate cells from background debris. Nile Red was used at a 
concentration of 75 µM. The RFU of Nile Red was much lower than values produced 
when measuring EtBr. SL1344 accumulated a low level of Nile Red (744 RFU) but 
accumulation was 2-fold higher in DacrB and 13-fold higher in the absence of TolC 
function (Figure 3-3). These data confirmed that Nile Red is a substrate of the 
AcrAB-TolC pump and its accumulation can be measured using flow cytometry. 
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Figure 3-3 Accumulation of Nile Red in WT, ∆acrB and tolC::aph in S. Typhimurium 
 
Single circles represent the median RFU value of nile red fluorescence from 10,000 cells in a SYTO 9+ population 
within a biological replicate. Accumulation in WT (pink), DacrB (red) and tolC::aph (dark red) was measured. 
There are 4 biological replicates for each strain, with a long bar to show the mean and SEM error bars. 
Significance values were based on an unpaired T-test comparing the efflux deficient strain to WT. Data taken 
from (Whittle et al., 2019). 
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3.7 The effects of efflux inhibitors on accumulation can be 
measured by flow cytometry 
This assay was also adapted to measure EtBr accumulation in the presence of 
compounds which inhibit efflux, as opposed to disrupting genes coding for efflux 
proteins. 
EtBr accumulation was measured in the presence of the PMF inhibitor, CCCP 
(Mahamoud et al., 2007). RND, MFS, SMR and MATE pumps all rely on the PMF for 
export of substrates. To inhibit efflux without damaging the cells, a sub-inhibitory 
concentration of 100 µM CCCP was incubated with the cells and then SYTO-84 and 
EtBr were added as before. In the presence of CCCP, there was a significant 6-fold 
increase in EtBr fluorescence, from 3936 RFU to 22596 RFU (Figure 3-4). As 
previously shown, this shows that efflux pumps were inhibited and that EtBr could 
not be exported. Importantly, this shows that this assay can be used to detect the 
inhibition of efflux. 
The specific RND efflux pump inhibitor PAbN, was also tested. It has previously been 
shown that PAbN does not significantly change the MIC of or alter the level of EtBr 
accumulation (Lomovskaya et al., 2001, Kern et al., 2006, Viveiros et al., 2008) and 
preliminary experiments using our assay supported this. Therefore, to show that this 
flow cytometry assay could be used with PAbN, it was tested in combination with Nile 
Red. The inhibitor was incubated at 50 µg/mL in SL1344, with the addition of Nile 
Red. The concentration of PAbN did not kill bacterial cells. In the presence of PAbN, 
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there was a 7-fold increase in substrate accumulation because RND pumps were 
unable to export Nile Red. 
Results for CCCP and PAbN show that this assay can be used to show inhibition of 
efflux and therefore, could be adapted for high throughput screening for efflux 
inhibitors. 
Figure 3-4 Accumulation of EtBr in SL1344 in the absence and presence of 100 µM CCCP and 
50 µg/mL of PAbN.  
 
(A) SL1344 dots (-CCCP) are in blue and are green in the presence of CCCP (+CCCP). Single dots represent 
the median of EtBr from 10,000 SYTO 84+ events within a biological replicate. There are 4 biological replicates 
for each strain. The horizontal bar shows the mean +/- standard error of the mean (SEM). (B) SL1344 squares 
(-PaβN) are in white and are grey in the presence of PaβN (+PaβN). Single squares represent the median value 
of nile red fluorescence in the presence and absence of PAβN, from 10,000 SYTO 84+ events within a biological 
replicate. 4 biological replicates for each condition are shown, with a long bar to show the mean and SEM error 
bars. In (A) and (B) an unpaired T-test produced p-values. The p-values were < 0.0001 which was represented 
by **** in this figure. Data also published in Whittle et al. (2019).  
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3.8 Measuring GFP fluorescence and EtBr accumulation in 
parallel in single cells 
GFP fluorescence is used for many molecular biology applications such as 
measuring expression of specific genes. The ability to measure GFP and EtBr 
accumulation in the same cell would be a powerful tool for linking gene expression 
to drug accumulation phenotypes. Therefore, the assay was developed to measure 
GFP and EtBr in parallel. In this case, a GFP transcriptional reporter was used to 
report on the transcription of a specific gene.  
EtBr and GFP use the same excitation wavelength, 488 nm, but emission 
wavelengths differ significantly (Figure 3-5A). Compensation can be set in this assay 
to avoid the spill-over in emissions from both fluorophores. The gating strategy for 
measuring fluorescence of the GFP and EtBr can be found in Chapter 2 (Figure 
2-3). 
In order to show that EtBr and GFP could be measured concurrently, ramA 
transcription in S. Typhimurium was measured in parallel with EtBr accumulation in 
10,000 SYTO-84+ cells. RamA is a transcriptional regulator involved in the regulation 
of acrAB in S. Typhimurium and indole is a known inducer of ramA transcription 
(Nikaido et al., 2008, Lawler et al., 2013). Transcription of ramA was measured using 
a transcriptional reporter plasmid where the ramA promoter was fused to gfp 
(pMW82-ramA).
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Figure 3-5 Accumulation of EtBr and fluorescence of GFP. 
 
(A) The fluorescence emission spectra for EtBr (blue) and GFP (green). The area where there is an overlap in emission peaks is spillover and adds the requirement for 
compensation. Emission values were taken from ThermoFisher SpectraViewer. (B) The median RFU for GFP and EtBr is shown without indole (white) and with 2mM 
indole (orange) from 10,000 SYTO 84+ events using SL1344 + pMW82-ramA. There were 6 biological replicates with and without indole. The long bar represents the mean 
and error bars represent standard error of the mean (SEM). Unpaired T-tests compared fluorescence of GFP and EtBr with and without indole. The p-values were 0.0001 
and 0.0315 for GFP and EtBr respectively. This graph is also published in Whittle et al. (2019). 
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Incubation of cells with indole caused a 2-fold increase in GFP fluorescence, showing 
increased ramA transcription and significantly lower accumulation of EtBr (Figure 
3-5B). This was probably because increased ramA transcription leads to increased 
transcription of acrAB allowing more EtBr to be removed from the cell by efflux 
(Nikaido et al., 2008). This shows that the assay is capable of measuring GFP and 
EtBr fluorescence in parallel. 
3.9 EtBr accumulation in Gram-negative and Gram-positive 
bacteria  
The flow cytometry accumulation assay was initially developed to work with 
Salmonella however, to assess its versatility it was tested with other bacterial 
species. Gram-negative bacteria heavily populate the WHO priority pathogen list and 
from this Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa 
were selected. The assay was performed as before; EtBr was added to parental WT 
strains of each species (E. coli MG1655 (Blattner et al., 1997), K. pneumoniae ecl8 
(Forage and Lin, 1982), P. aeruginosa PA14 (Liberati et al., 2006, 
pa14.mgh.harvard.edu)) and isogenic efflux mutants (MG1655 DacrB (Wang-Kan et 
al., 2017), ecl8 acrB::Gm (Whittle et al., 2019), PA14 DmexA (Liberati et al., 2006, 
pa14.mgh.harvard.edu)) and accumulation was measured. In all three species, the 
accumulation level was significantly higher (4-fold,14-fold and 3-fold respectively) in 
the absence of efflux pump components (Figure 3-6A), comparable to the result 
shown in S. Typhimurium. It has also previously been shown that removing 
AcrAB-TolC in E. coli leads to an increase in EtBr accumulation (Paixao et al., 2009). 
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This shows that this assay works to assess substrate accumulation in a number of 
Gram-negative pathogens. 
It was also important to show that this assay could be used to assess accumulation 
in Gram-positive bacteria, adding to the versatility of the assay that has already been 
shown. EtBr accumulation was measured in Gram-positive Staphylococcus aureus. 
Efflux mutants of this species were not available, so CCCP was used to inhibit the 
pumps that require PMF in S. aureus. Accumulation in S. aureus was low, but in the 
presence of CCCP, there was a significant increase in the level of EtBr accumulation 
(Figure 3-6B).  
This assay has proved versatile when measuring substrate accumulation in both 
Gram-negative and Gram-positive pathogens. 
3.10 Discussion  
The data presented in this chapter shows the development of a novel flow cytometry 
assay to measure accumulation of fluorescent dyes in single bacterial cells. Previous 
studies where EtBr or Hoechst H33342 accumulation has been measured in a 
bacterial population as a whole (rather than single cells) reports on average a 2-3 
fold increase in Salmonella ∆acrB strains compared to parent strains (Blair et al., 
2009, Coldham et al., 2010, Smith and Blair, 2014, Wang-Kan et al., 2017). With a 
4.5-fold increase in EtBr accumulation in SL1344 ∆acrB compared to SL1344 here 
(Figure 3-2), the results when using flow cytometry are comparable to previous 
results that measure accumulation in a population. Bacteria with inhibited efflux 
pumps accumulate more EtBr because they are no longer able to export it. 
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Figure 3-6 Accumulation of EtBr in WT and efflux mutants of E. coli, K. pneumoniae, and P. aeruginosa, and in Staphylococcus aureus with 
CCCP. 
 
All EtBr data points are based on the EtBr median fluorescence from 10,000 SYTO 84+ events. (A) E. coli MG1655 are shown as dark red circles with MG1655 ΔacrB 
shown as red circles. Klebsiella pneumoniae ecl8 was shown as dark blue squares and the inactivated acrB::Gm strain as light blue squares. P. aeruginosa strain PA14 
EtBr fluorescence was shown as dark grey diamonds with ΔmexA shown as light grey diamonds. (B) S. aureus EtBr accumulation was measured in the absence (pink) 
and presence (brown) of CCCP. 4 biological replicates for each strain are shown. The mean was shown with a long bar and error bars showed +/- SEM. Statistical tests 
were unpaired T-tests between individual WT and efflux deficient strain. Results were considered significantly different if p-value ≤ 0.05. Figure is also published in Whittle 
et al. (2019)
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Previously developed assays which measure accumulation or efflux have been 
important in investigating efflux pumps and possible efflux inhibitors which may be 
used clinically. However, these assays are limited by only measuring accumulation 
capacity of a whole population. The limitation with whole population studies is that 
bacterial cell populations are not homogeneous in phenotype. Stochastic gene 
expression is responsible for heterogeneous bacterial cell populations and studies 
have shown the importance of measuring accumulation at the single cell level for this 
reason (Sanchez-Romero and Casadesus, 2014, Davis and Isberg, 2016). Initial data 
using the flow cytometry assay presented in this chapter has shown that there is 
heterogeneity within populations. SL1344 appeared to have a subpopulation which 
accumulates more EtBr, whereas SL1344 ∆4PAP appeared to have a subpopulation 
that accumulates less EtBr (Figure 3-7). This phenomenon was not investigated 
further in this thesis but is a subject of further work.  
For the future development of efflux inhibitors to be used as therapeutics, single cell 
analysis is essential. For example, if a new efflux inhibitor was used in the presence 
of an antibiotic, a population of cells may have their efflux pump inhibited and 
therefore lead to high accumulation of antibiotics. If in the presence of an inhibitor, a 
sub-population developed where antibiotic accumulation was low, it may lead to the 
selection of compensatory mutations, survival of the subpopulation and further 
development of AMR. The assay described in this chapter can therefore also be used 
as a tool to investigate heterogeneity.
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Figure 3-7 Heterogeneity in EtBr accumulation in SL1344 and SL1344 ∆4PAP 
 
The plots shown here only show EtBr accumulation, however the populations shown in A + C represent 10,000 events with a SYTO 84+ gate. (A) The peak (black) shows 
EtBr accumulation in SL1344. On this histogram, there are 2 gates: A – represents the main population (blue) and B – a sub-population (red). The A gate shows median 
EtBr fluorescence at 11215 RFU, but the B gate shows the EtBr accumulation of the sub-population 4-fold higher at 41873 RFU in the same strain. (B) shows both gated 
populations as a dot plot highlighting that they are separate populations. (C) The peak (black) shows EtBr accumulation in SL1344 ∆4PAP. The population and 
sub-population gates are represented the same. The A gate shows median EtBr fluorescence at 32755 RFU, but the B gate shows the EtBr accumulation of the 
sub-population 6.5-fold lower at 5111 RFU in the same strain. (B+D) shows both gated populations as a dot plot highlighting that they are separate populations. 
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Further work and an area for exploration would be identifying the importance of 
heterogeneity and sub-populations when measuring drug accumulation and why and 
how they develop. There are a few possible reasons including transient expression, 
antibiotic tolerance or potentially the upregulation of other efflux pumps in the 
presence of selective pressure. By unpicking whether sub-populations develop via 
mutation or expression changes, environmentally or in the presence of inhibitors, 
would further advance knowledge of how bacterial infections should be treated. It is 
also unknown whether these sub-populations would present during an infection, so 
it is possible that this could be explored further using in vivo experiments. 
The data here shows that this assay can be used to measure accumulation in a range 
of Gram-negative bacteria and the Gram-positive species S. aureus. It was 
unexpected that this assay would work so well for Pseudomonas aeruginosa. Not 
only does P. aeruginosa have 14 RND efflux pump systems, but also has an 
intrinsically impermeable membrane (Hancock, 1998, Breidenstein et al., 2011), so 
may have proved more difficult to measure accumulation in the presence of efflux 
inhibitors. However, this assay showed promise for measuring EtBr accumulation 
and therefore this assay may also be adapted for analysis of the intrinsically 
impermeable priority pathogen, Acinetobacter baumanii. 
As previously mentioned, AcrAB-TolC along with other RND pumps have been 
shown to export EtBr as well as a large range of other substrates (Nishino and 
Yamaguchi, 2001). In E. coli, another pump, MdtEF-TolC also exports EtBr (Nishino 
and Yamaguchi, 2001, Kobayashi et al., 2006). However, efflux pumps can export a 
number of substrates with different chemical structures, different localisations within 
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the cells and different modes of action. For this reason, it was important to confirm 
that this assay could be adapted for other fluorescent substrates. In this case, Nile 
Red accumulation could also be measured in S. Typhimurium. Rhodamine 6G can 
also be measured, however, there was shown to be no significant difference between 
SL1344 and DacrB (Whittle et al., 2019). The intracellular accumulation of both these 
substrates has previously been measured in whole population assays (Bohnert et al., 
2010, Ivnitski-Steele et al., 2009). This shows that this assay could be further adapted 
to measure other substrates of specific efflux pumps or identify new specific 
substrates of the pumps.  
In summary, this chapter describes the development of a novel flow cytometry assay 
to measure the intracellular accumulation of various fluorescent dyes. The work in 
this chapter was published in the following article: Whittle et al., 2019. Flow 
Cytometric Analysis of Efflux by Dye Accumulation. This assay is an important tool 
for furthering our understanding of efflux and drug accumulation in single cells and 
will be used throughout this thesis with further adaptation to answer novel questions.  
3.11 Key Findings: 
• Flow cytometry can be used to measure efflux substrate accumulation in 
single cells (EtBr and Nile Red). 
• Efflux mutants accumulate more dye than parental strains. 
• Transcription of genes can be measured using GFP transcriptional reporters. 
• This assay can be optimised for testing efflux inhibitors and for both 
Gram-negative and Gram-positive bacteria. 
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Chapter 4 - The impact of growth phase 
on the capacity of S. Typhimurium to 
accumulate EtBr 
4.1 Background 
The efflux pump, AcrAB-TolC, can export many structurally varied antibiotics, 
detergents and dyes (Nishino et al., 2006). The RND family exports compounds from 
the periplasmic space to the extracellular environment, decreasing the intracellular 
concentration of these chemicals inside cells. This allows bacteria to survive at higher 
concentrations of drug. Intracellular accumulation is not simply a measure of efflux, 
but is in fact dependent on both how much drug gets into a cell, via influx, and how 
much is removed from a cell, by efflux. 
In almost all published studies, assessment of efflux activity and accumulation is 
based on a mid-exponential phase bacterial culture (e.g. Richmond et al., 2013, 
Bohnert et al., 2010, Coldham et al., 2010, Wang-Kan et al., 2017). However, 
bacterial physiology, and specifically the expression of acrAB, are known to vary 
across the growth curve. A peak in acrAB expression occurs in mid-exponential 
phase (Bailey et al., 2006). However, it is not known how this affects the level of efflux 
and accumulation across the growth curve.  
The flow cytometry assay described in Chapter 3 (Whittle et al., 2019), was adapted 
to measure the capacity of cells from different growth stages to accumulate EtBr. In 
this thesis, the phrase “capacity to accumulate EtBr” is used to describe the relative 
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level of EtBr accumulated by a given sample of cells, taken from different points 
during growth.  
4.2 Hypotheses 
• Accumulation of EtBr in SL1344 will be growth phase dependent and will 
change with acrAB-tolC expression. 
• Accumulation of EtBr in SL1344 DacrB will be high across growth due to the 
absence of efflux pump function. 
4.3 Aims  
1. To adapt the flow cytometry assay to measure EtBr accumulation from 
samples taken during different growth phases. 
2. To measure the accumulation of EtBr in samples of S. Typhimurium SL1344 
taken from across the growth curve and to measure whether it correlates to 
acrAB transcription. 
3. To measure the accumulation of EtBr in samples of S. Typhimurium SL1344 
DacrB taken from across the growth curve. 
4. To determine whether the accumulation phenotype is the same in other 
bacterial species and whether it is dependent on experimental conditions. 
5. To identify other bacterial phenotypes that may vary based on growth phase. 
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4.4 Optimisation of flow cytometry accumulation assay to 
measure accumulation in different growth phases  
The flow cytometry method used to measure EtBr accumulation described in 
Chapter 3 was initially set up to use exponential phase bacteria as most other studies 
in the literature have done. In this chapter, the assay was adapted to analyse EtBr 
accumulation in samples taken from lag phase through to stationary phase. At every 
hour, from 0-6 hours, samples from a growing bacterial culture were taken and EtBr 
accumulation capacity measured every hour. At each time point, the volume of 
culture that was taken was adjusted so that approximately the same cell number was 
in each sample regardless of time point of growth. 
Figure 4-1 shows the experimental set-up where, at each time point, samples were 
removed from a growing culture and then dyes were added to assess the 
accumulation of dye within cells at each time point.  
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Figure 4-1 Schematic of optimised flow cytometry assay to measure EtBr accumulation at 
different time points of the growth curve. 
 
A culture of bacteria was grown for 6 hours. At each time point, a sample was removed, cells harvested and 
added to HBS buffer. At this point, EtBr and SYTO-84 was added to the sample. EtBr accumulation in each 
sample was then measured using flow cytometry. Growing cultures were never incubated or grown with EtBr 
removing the risk of adaptation or developing mutations. 
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As in Chapter 3, these experiments measured the capacity of cells to accumulate 
EtBr so cultures were not grown in the presence of EtBr, and the dyes were only 
added to the removed sample of cells. This means that any changes seen are not 
the result of mutations or adaptation to EtBr. 
It was important that the cell number in each sample was also measured so that 
entrance into different growth phases could be determined. On each histogram used 
to measure median EtBr fluorescence, events per µL was also measured. Using this 
measurement, the cells per mL in the culture were calculated. The equation is shown 
in Section 2.4.2.  
4.5 Low EtBr accumulation in SL1344 is continuous over the 
bacterial growth curve 
To determine whether the accumulation of EtBr was growth phase dependent, the 
optimised flow cytometry assay was first used to measure EtBr accumulation in S. 
Typhimurium SL1344. SL1344 was grown for 6 hours in LB broth, with samples taken 
every hour and EtBr added to the sample. 
As shown previously, accumulation of EtBr was low in SL1344. The time course 
experiment showed that this low level was unchanged across the growth curve 
(Figure 4-2). EtBr accumulation at every hour was compared to the 0 hour time point, 
and there were no significant difference in average EtBr accumulation per cell when 
comparing any other time point (Table 4-1). Cell number was also measured in the 
same sample and showed that cell number increased and showed normal growth in 
LB with stationary phase beginning at around 3 hours.  
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Figure 4-2 EtBr accumulation levels in SL1344 from 0-6 hours 
 
Single grey circles represent the X-median value of EtBr fluorescence per cell (from 10,000 SYTO-84+ cell events) 
within a biological replicate. 4 biological replicates for each strain are shown, with a short mean bar and SEM 
error bars. Grey circle values are plotted on the left Y-axis. Calculated averaged cell number values were plotted 
on the right Y-axis with SEM error bars. EtBr fluorescence was measured every hour between 0 and 6 hours. 
This was based on a one-way ANOVA and Tukey’s multiple comparison test to compare the differences between 
every hour. P-values for comparisons to 0 hour are shown in Table 4-1. 
 
Table 4-1 Statistical analysis of SL1344 at each time point compared to T0 
Comparison P-value Significance 
T0 v T1 >0.9999 ns 
T0 v T2 >0.9999 ns 
T0 v T3 >0.9999 ns 
T0 v T4 0.9991 ns 
T0 v T5 >0.9999 ns 
T0 v T6 >0.9999 ns 
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4.6 EtBr accumulation in SL1344 does not correlate with 
acrAB transcription level 
AcrAB expression level has been shown to correlate with the level of drug or dye 
accumulation. In Section 3.8, indole induced ramA and this led to a significant 
decrease in EtBr accumulation, presumably through the induction of acrAB (Whittle 
et al., 2019). Overexpression of acrAB in clinical isolates through regulatory 
mutations, is also linked to decreased antibiotic susceptibility (Webber and Piddock, 
2001, Schneiders et al., 2003, Chowdhury et al., 2019). Therefore, it was 
hypothesised that the capacity of a growing culture of S. Typhimurium to accumulate 
EtBr would correlate with acrAB transcription. Initial observations in Figure 4-2 
showed that EtBr accumulation remained low, and did not significantly differ between 
time points. A reasonable theory would be that EtBr accumulation would correlate to 
acrAB transcription, e.g. as transcription of acrAB increases, less EtBr would 
accumulate due to the presence of more efflux pumps. To further test this, the flow 
cytometry assay which was previously adapted to measure GFP and EtBr in the 
same cells was utilised. A strain of SL1344 containing pMW82-acrA (a transcriptional 
reporter plasmid on which the acrAB promoter is fused to GFP) was grown for 6 hours 
in LB containing ampicillin, and at each hour, samples were taken, and the EtBr 
accumulation and GFP fluorescence were measured. The median values for both 
GFP and EtBr were analysed. 
As with the previous result, in SL1344 + pMW82-acrA, EtBr accumulation remained 
low across the growth curve. At no time point was there a significantly different level 
of EtBr accumulation (Figure 4-3), based on a one-way ANOVA and Tukey’s multiple 
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comparison test. Using the cell number, which is plotted on the right Y-axis (black 
line) in Figure 4-3, it was shown that acrAB transcription peaked at approximately 
mid-exponential phase (2 hours of growth) based on GFP fluorescence (Figure 4-3). 
Dunnett’s multiple comparison test compared GFP fluorescence at each time point 
to the peak at 2 hours, and all time points had significantly lower fluorescence, except 
for at 3 hours. Transcription of acrAB decreased as the culture entered stationary 
phase.  
This shows that the levels of EtBr accumulation did not correlate with acrAB 
transcription.  
Figure 4-3 EtBr accumulation and acrAB transcription measured in the same cells 
 
EtBr accumulation, acrAB transcription (GFP fluorescence) and cell numbers were measured in 10,000 
SYTO-84+ events. Pink bars represent EtBr accumulation of SL1344 pMW82-acrA at each time point from 0-6 
hours. Bars are based on 4 biological replicates representing the mean +/- SEM. These EtBr accumulation bars 
are plotted on the 1st left X-axis where the axis label ‘EtBr fluorescence (RFU)’ is coloured in red. Green dots 
represent GFP fluorescence and therefore acrAB transcription from each time point from 0-6 hours, based on the 
same 4 replicates with SEM error bars. The dashed connecting line connects transcription across the growth 
curve. GFP RFU is plotted on the left Y-axis (‘GFP Fluorescence (RFU)’ labelled in green. The solid black line 
represents the cell number and therefore growth curve of SL1344 pMW82-acrA and is plotted on the right X-axis.   
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4.7 EtBr accumulation in SL1344 DacrB was growth phase 
dependent 
As acrAB transcription and EtBr accumulation did not correlate, the next step was to 
study the importance of the AcrAB-TolC efflux pump in accumulation of EtBr across 
growth. Using SL1344 as a control, EtBr accumulation in SL1344 DacrB was 
measured from samples taken following 0-6 hours of growth (Figure 4-4).  
After 1 hour of growth, the accumulation was a mean value of 46299 RFU, 6-fold 
greater than SL1344 EtBr accumulation and significantly different. This result was 
comparable to previous mid-log data (Smith and Blair, 2014, Wang-Kan et al., 2017). 
At 2 hours, accumulation of EtBr started to drop with only a 3.5-fold difference to 
SL1344 at 2 hours. By hours 4, 5 and 6, EtBr accumulation in SL1344 DacrB was not 
significantly different to accumulation in SL1344 (Table 4-2).  
Cell numbers compared (Figure 4-4) to SL1344 were also assessed to check for 
potential differences in growth between the strains but there was no significant 
difference. Previous studies show that the deletion of acrB does not lead to a growth 
defect in vitro (Wang-Kan et al., 2017). Based on Figure 4-4, it was deduced that 
entrance to stationary phase began at around 3 hours of growth. 
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Figure 4-4 EtBr accumulation in SL1344 and DacrB from 0-6 hours 
 
Median EtBr fluorescence per cell in 10,000 SYTO-84+ events was measured every hour between 0 and 6 hours. 
Individual grey circles represent the X-median value of EtBr fluorescence in SL1344 (WT) (from 10,000 SYTO-84+ 
cell events) within a biological replicate. Individual red diamonds represent the X-median value of EtBr 
fluorescence in SL1344 DacrB (from 10,000 SYTO-84+ cell events) within a biological replicate. 4 biological 
replicates for each strain are shown, with a short mean bar and SEM error bars. EtBr accumulation is plotted on 
the left Y-axis. Calculated cell number values were plotted on the right Y-axis with corresponding symbols 
equating to strain and a dashed line to show growth of the culture. Cell numbers were based on the mean of the 
same biological replicates and the same gated population that EtBr fluorescence was measured from. Two-way 
ANOVA and Sidak’s multiple comparison test were carried out for statistical analysis. 
 
Table 4-2 Statistical analysis of SL1344 vs ∆acrB at each time point  
Comparison Fold Change (vs WT) P-value Significance 
T0  3-fold <0.0001 **** 
T1 6-fold <0.0001 **** 
T2 4-fold <0.0001 **** 
T3 2-fold 0.0402 * 
T4 NA 0.8675 ns 
T5 NA 0.6112 ns 
T6 NA 0.9971 ns 
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It is well documented that substrate accumulation in efflux mutants is higher than 
corresponding WT strains in mid-exponential phase (Wang-Kan et al., 2017, Smith 
and Blair, 2014, Paixao et al., 2009). SL1344 ∆acrB showed this high level of EtBr 
accumulation after 1 hour of growth. However, EtBr accumulation levels decreasing 
in stationary phase has not been previously shown and was unexpected. It was 
assumed that the absence of AcrB would lead to consistently high EtBr accumulation 
regardless of growth phase. This result suggests that the capacity of cells to 
accumulate EtBr in stationary phase is reduced in an AcrB-independent manner. 
4.8 Non-functional AcrB conferred the same phenotypic effect 
as total AcrB deletion 
In SL1344 ∆acrB, it is possible that decreased EtBr accumulation in stationary phase 
is due to the increased expression of homologous RND pumps, as has previously 
been shown to happen in the absence of AcrB (Blair et al., 2015a). This will be 
explored in Chapter 5. 
Another hypothesis to explain the unexpected accumulation pattern was that the 
absence of a large inner membrane protein, AcrB, could have made the membrane 
more permeable, and prone to EtBr leakage from the cell. This may explain the low 
accumulation in stationary phase. To test this hypothesis, SL1344 DacrB EtBr 
accumulation was compared to EtBr accumulation in a strain in which AcrB was 
present but inactivated by a mutation within the region required for PMF utilisation 
(SL1344 AcrB-D408A) (Wang-Kan et al., 2017).  
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Consistent with previous results, EtBr accumulation in SL1344 DacrB peaked after 1 
hour of growth, and dropped on entry into stationary phase (Figure 4-5). In the 
AcrB-D408A mutant, results were consistent with SL1344 DacrB. EtBr accumulation 
peaked at 1 hour and dropped as cells entered stationary phase. There was no 
significant difference in accumulation between these strains. Cell number was also 
measured and there was no difference in growth between the two strains, as has 
been previously described (Wang-Kan et al., 2017). 
 
Figure 4-5 EtBr accumulation in SL1344 DacrB compared to SL1344 AcrB-D408A  
 
Median EtBr fluorescence per cell in 10,000 SYTO-84+ events was measured every hour between 0 and 6 hours. 
Individual black X’s represent the X-median value of EtBr fluorescence in SL1344 DacrB within a biological 
replicate. Individual blue circles represent the X-median value of EtBr fluorescence in SL1344 AcrB-D408A (within 
a biological replicate. 4 biological replicates for each strain are shown, with a short mean bar +/- SEM error bars. 
EtBr accumulation is plotted on the left Y-axis. Calculated cell number values were plotted on the right Y-axis 
with corresponding symbols equating to strain and a dashed line to show growth of the culture. Cell numbers 
were based on the mean of the same biological replicates and the same gated population that EtBr fluorescence 
was measured from. Two-way ANOVA and Sidak’s multiple comparison test were used for statistical analysis of 
EtBr accumulation.
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This data disproves the hypothesis that the EtBr accumulation phenotype in SL1344 
DacrB is due to the loss of the protein causing membrane damage and in fact 
suggests that the EtBr accumulation phenotype in stationary phase is independent 
of AcrB protein and activity. 
4.9 Cell viability is unchanged throughout the assay 
Another possible explanation for the reduction in EtBr accumulation in stationary 
phase is that bacterial cells were dying during growth. In the flow cytometry assay, 
SYTO-84 is the dye used to gate for a population of cells, and the cell number at 
each time point is then calculated. As it only fluoresces when intercalated with DNA, 
gating SYTO-84+ events does not mean that all cells in this population are alive at 
each time point and could not completely confirm growth. Cell death during batch 
culture has not been previously described for an acrB mutant and seemed unlikely 
because bacterial cultures were grown in drug-free LB. It has previously been shown 
that the growth kinetics of SL1344 ∆acrB are not significantly different from SL1344 
also (Wang-Kan et al., 2017). However, further controls were introduced to exclude 
this possibility. 
Initially, commonly used viability stains such as propidium iodide and 
5-Carboxyfluorescein Diacetate, Acetoxymethyl Ester (CFDA-AM) were considered 
so that cell viability could be measured by flow cytometry. However, it would have 
been difficult to determine the viability of SL1344 DacrB because most dyes such as 
these are substrates of the AcrB efflux pump which may confound results.  
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For this reason, cell viability was assessed by viable cell counts at each time point. 
Table 4-3 showed that SL1344 and the acrB mutant are still alive at each time point 
and confirms that the same number of cells were being measured in each sample by 
flow cytometry. Therefore, the accumulation phenotype was not as a result of cell 
death.  
 
Table 4-3 Viable counts and CFU/mL 
Time point SL1344 –  
CFU/mL in FC sample 
SL1344 DacrB –  
CFU/mL in FC sample 
0 3.20E+06 2.60E+06 
1 2.40E+07 1.60E+07 
2 2.40E+07 2.40E+07 
3 2.20E+07 2.20E+07 
4 3.80E+07 3.00E+07 
5 2.20E+07 1.80E+07 
6 3.00E+07 1.60E+07 
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4.10 The pattern of EtBr accumulation is not changed by 
media type 
Many aspects of bacterial physiology are altered by the type of media in which 
bacteria are grown (Blair et al., 2013). In order to confirm the accumulation pattern 
was not a result of the limitations of LB medium (Nikaido, 2009) the experiments were 
repeated in MOPs minimal media (supplemented with histidine) (Hoiseth and 
Stocker, 1981, Neidhardt et al., 1974). 
The pattern of EtBr accumulation was broadly the same in MOPs minimal media as 
in LB. For SL1344, EtBr accumulation level remained low and did not significantly 
differ between time points. For, SL1344 DacrB, as in LB, accumulation peaked at 1 
hour of growth (~6-fold different to WT with a p-value of <0.0001) and then dropped 
significantly at later time points (Figure 4-6). However, unlike LB, EtBr accumulation 
remained significantly different from SL1344 between 2-6 hours of growth, although 
it was clear that EtBr accumulation dropped with only a 1.4-fold difference at 6 hours. 
Cell number in SL1344 and DacrB was not significantly different and time point for 
entry into different growth phases did not differ.  
Although EtBr accumulation was significantly different in stationary phase, the overall 
EtBr accumulation pattern remained the same as growth in LB. This confirmed that 
the pattern was not just as an effect of the limitations of LB (Nikaido, 2009) and that 
the EtBr accumulation pattern for both SL1344 and ∆acrB is independent of growth 
medium. 
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Figure 4-6 EtBr accumulation in SL1344 and DacrB, grown in MOPs minimal media for 6 hours. 
 
Median EtBr fluorescence per cell in 10,000 SYTO-84+ flow cytometry events was measured every hour between 
0 and 6 hours. Individual black circles represent the X-median value of EtBr fluorescence in SL1344 (WT) (from 
10,000 SYTO-84+ cell events) within a biological replicate, therefore the average accumulation of ethidium per 
cell. Individual pink diamonds represent the X-median value of EtBr fluorescence in SL1344 DacrB (from 10,000 
SYTO-84+ cell events) within a biological replicate. 4 biological replicates for each strain are shown, with a short 
mean bar and SEM error bars. EtBr accumulation is plotted on the left Y-axis. Calculated cell number values were 
plotted on the right Y-axis with corresponding symbols equating to strain and a dashed line to show growth of the 
culture. Cell numbers were based on the mean of the same biological replicates and the same gated population 
that EtBr fluorescence was measured from. Two-way ANOVA and Sidak’s multiple comparison test were carried 
out for statistical analysis. 
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4.11 Accumulation of the lipophilic dye, Nile Red, produced 
the same pattern 
To confirm that the accumulation pattern observed was not an artefact of using EtBr 
as a substrate, a dye with a different localisation and mechanism of action was used. 
The fluorescent dye Nile Red was selected because it localises in the membrane 
rather than in the cytoplasm and is a known substrate of AcrB (Bohnert et al., 2010). 
The method for measuring Nile Red accumulation has already been described in the 
preceding chapter (Whittle et al., 2019) and was adapted here to be measured across 
growth. As shown in Section 3.6, this assay is less sensitive than using EtBr and 
even at 1 hour of growth, only a slight difference could be detected in Nile Red 
accumulation between ∆acrB and SL1344. However, it was possible to measure a 
difference in Nile Red accumulation between SL1344 and ∆tolC (Whittle et al., 2019) 
so ∆tolC was compared to SL1344 in this case (data in Chapter 5 shows that a tolC 
mutant produced a similar pattern of accumulation for EtBr to an acrB mutant). 
Nile Red accumulation was measured in SL1344 DtolC compared to SL1344 across 
6 hours of growth. As with previous data, the cell number at each hour was calculated 
and, in this case, showed that deleting TolC did not lead to a growth defect and that 
different growth phases were entered at the same time in both strains (Figure 4-7).  
Importantly, the alternative dye produced very similar patterns to EtBr. In SL1344, 
Nile Red accumulation remained low at each time point during growth, not reaching 
above 1000 RFU. In SL1344 DtolC, Nile Red fluorescence peaked at 1 hour with an 
8-fold difference to WT and then dropped significantly after 2 hours. From 3-6 hours, 
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accumulation levelled off at an average of 2500 RFU at each time point. However, 
this showed that accumulation of Nile Red was still significantly different to SL1344 
in stationary phase, differing from EtBr.  
The broadly equivalent pattern of Nile Red accumulation in the efflux mutant was 
equivalent to that for EtBr showing the effect was not an artefact of the dye used and 
remained true for other substrates of AcrB. 
Figure 4-7 Nile red accumulation in SL1344 and SL1344 DtolC from 0-6 hours 
 
Median Nile Red fluorescence per cell in 10,000 SYTO-9+ flow cytometry events was measured every hour 
between 1 and 6 hours. 0 hour time points were not included as SYTO-9+ populations could not be gated. Single 
red triangles represent the X-median value of nile red fluorescence in SL1344 (WT) (from 10,000 SYTO-9+ cell 
events) within a biological replicate. Individual orange triangles represent the X-median nile red fluorescence in 
DtolC (from 10,000 SYTO-9+ cell events) within a biological replicate. 4 biological replicates for each strain are 
shown, with a short mean bar and SEM error bars. Nile red accumulation is plotted on the left Y-axis. Calculated 
cell number values were plotted on the right Y-axis with corresponding symbols equating to strain and a dashed 
line to show growth of the culture. Cell numbers were based on the mean of the same biological replicates and 
the same gated population that nile red fluorescence was measured from. Two-way ANOVA and Sidak’s multiple 
comparison test were carried out for statistical analysis and ‘****’ related to P <0.0001.
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4.12 The pattern of EtBr accumulation is not specific to S. 
Typhimurium 
To investigate whether the accumulation phenotype described was a S. Typhimurium 
phenomenon or whether it is more broadly relevant to other Gram-negative 
organisms, three other Gram-negative species, E. coli, Klebsiella pneumoniae and 
Pseudomonas aeruginosa were also tested along with isogenic efflux mutants.  
EtBr accumulation was measured in E coli MG1655 compared to MG1655 DacrB 
(Eaves et al., 2004b). For MG1655, EtBr fluorescence remained low across the 
growth curve (0-6 hours) and this was consistent with the SL1344 pattern (Figure 
4-8A). The pattern of MG1655 DacrB was comparable to SL1344 DacrB. MG1655 
DacrB EtBr accumulation peaking at 1 hour, with a 6-fold difference to MG1655 and 
from hour 3 to 6, there is no significant difference between strains.  
EtBr accumulation was measured in K. pneumoniae ecl8 compared to ecl8 acrB::Gm, 
which has an interruption in the acrB gene using a gentamicin cassette (Whittle et 
al., 2019). As with previous WT strains with fully functioning efflux pumps, in ecl8, 
EtBr accumulation remained low across growth. However, ecl8 acrB::Gm showed the 
same pattern of all efflux mutants (Figure 4-8B). At 1 hour of growth, EtBr 
accumulation peaked with a 14-fold difference to ecl8. At 2 hours and 3 hours of 
growth, EtBr accumulation dropped, but was significantly different from ecl8 (7-fold 
and 6-fold difference respectively). At 4,5 and 6 hours, accumulation of EtBr was low, 
similar to ecl8, but there is still a significant difference in accumulation at 4 and 5 
hours of growth compared to ecl8.
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Figure 4-8 EtBr accumulation in E. coli and K. pneumoniae and their related efflux mutants 
 
(A) shows E. coli MG1655 and DacrB. Median EtBr fluorescence per cell in 10,000 SYTO-84+ flow cytometry events was measured every hour between 0 and 6 hours. 
Individual black Xs (WT) and individual blue triangles (DacrB) represent the median value of EtBr fluorescence within a biological replicate. (B) shows K. pneumoniae ecl8 
and ecl8 acrB::Gm. Median EtBr fluorescence per cell in 10,000 SYTO-84+ flow cytometry events were measured every hour between 0 and 6 hours. Individual blue circles 
(WT) and individual purple diamonds (acrB::Gm) represent the median value of EtBr fluorescence within a biological replicate. 4 biological replicates for each strain are 
shown, with a short mean bar and SEM error bars. EtBr accumulation is plotted on the left Y-axis. Calculated cell number values were plotted on the right Y-axis with 
corresponding symbols equating to strain and a dashed line to show growth of the culture. Cell numbers were based on the mean of the same biological replicates and 
the same gated population that EtBr fluorescence was measured from. Two-way ANOVA and Sidak’s multiple comparison test were carried out for statistical analysis. 
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Pseudomonas aeruginosa PA01 has 14 RND efflux pump systems. The major pump 
related to AMR, MexAB-OprM was chosen with the periplasmic adaptor protein 
component, MexA, deleted from the cell. EtBr is a known substrate of the 
MexAB-OprM pump (Li et al., 2003). A 0 hour data point has not been added to this 
growth curve as it was not possible to reliably separate cells from background in the 
flow cytometer, but it was not known why this happened. Cell number was measured 
again however, compared to previous organisms, the cell number at 1 hour was 
lower. Mid-exponential phase was reached at 2 hours which is comparable to 
previous data. PA01 EtBr accumulation across growth was low and therefore was 
similar to previous data suggesting that EtBr is exported from the cell at each 
timepoint (Figure 4-9). PA01 DmexA reached a peak of EtBr accumulation at 2 hours 
with a 4-fold difference to WT. This was different to previous data where the 
accumulation peak was at 1 hour, where in this case there was only a 3-fold 
difference. This may due to cell number. From 3 hours, the EtBr accumulation level 
started to drop as cells entered stationary phase. At 4 and 6 hours, the capacity to 
accumulate EtBr was not significantly different to PA01, but there was a significant 
different at 5 hours (Figure 4-9).  
The results presented in this section show that the EtBr accumulation pattern of 
SL1344 and DacrB is a robust phenotype consistent across a number of 
Gram-negative species. 
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Figure 4-9 EtBr accumulation in P. aeruginosa PA01 and ∆mexA 
 
Median EtBr fluorescence per cell in 10,000 SYTO-84+ flow cytometry events was measured every hour between 
0 and 6 hours. Individual green circles (WT) and individual blue hexagons (DmexA) represent the median value 
of EtBr fluorescence within a biological replicate.4 biological replicates for each strain are shown, with a short 
mean bar and SEM error bars. EtBr accumulation is plotted on the left Y-axis. Calculated cell number values were 
plotted on the right Y-axis with corresponding symbols equating to strain and a dashed line to show growth of the 
culture. Cell numbers were based on the mean of the same biological replicates and the same gated population 
that EtBr fluorescence was measured from. 
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4.13 Do other phenotypes reflect accumulation pattern? 
To understand what the differences in EtBr accumulation at different points during 
growth might mean, other phenotypes related to efflux were studied. Antimicrobial 
susceptibility, biofilm formation, curli biogenesis, and cell shape were all studied after 
1, 3 and 5 hours of growth. This was to identify if any changes were occurring when 
EtBr accumulation peaks (1 hour), in early exponential phase, compared to late 
exponential (3 hour) and early stationary phase (5 hours). 
4.13.1 Antimicrobial susceptibility across growth 
Previous published data shows that in SL1344 strains where efflux pump 
components are removed, there is increased susceptibility to antimicrobials (Blair et 
al., 2015a). MICs were measured to see whether the pattern of accumulation seen 
across growth correlated or altered antimicrobial susceptibility. Susceptibility to four 
different efflux substrates (EtBr, SDS, vancomycin and ciprofloxacin) were measured 
using cultures taken from 3 different time points of growth.  
The MIC values of EtBr were measured to draw a direct comparison to flow cytometry 
accumulation data. In SL1344, the MIC of an overnight culture was 1024 µg/mL. The 
MIC for cultures grown for 1, 3 and 5 hours remained the same regardless of 
timepoint. The MIC of EtBr in SL1344 DacrB is 64 µg/mL, 5-fold lower than SL1344. 
A large difference in EtBr MIC in these strains has been described previously (Blair 
et al., 2015a). The absence of the efflux pump increases the accumulation of the dye 
meaning the concentration required to kill the bacteria is lower. Using a culture of 
SL1344 DacrB grown for 1 hour, the MIC increased 4-fold to 256 µg/mL, which 
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suggests there was decreased susceptibility to EtBr in actively growing cells (Table 
4-4). At 3 and 5 hours of growth of the initial culture, comparable to the overnight, the 
MIC was 64 µg/mL. 
Sodium dodecyl sulphate (SDS) is a detergent that kills bacterial cells by 
permeabilising its membranes (Shafa and Salton, 1960) and susceptibility has 
previously been shown to be growth phase dependent (Mitchell et al., 2017). In 
SL1344, regardless of time point, the MIC was >1024 µg/mL. The MIC of SDS in 
DacrB was 256 µg/mL, apart from after 3 hours of growth of the initial culture, where 
the value was 512 µg/mL. It was a 2-fold or greater difference between WT and 
DacrB, however there is no difference in MIC at different time points between strains 
(Table 4-4). 
Table 4-4 Susceptibility profiles of SL1344 and ∆acrB at 1, 3 and 5 hours 
Strain Time MIC (µg/mL) 
EtBr SDS Vanc Cip 
SL1344 Overnight 1024 >1024 1024 0.06 
1 >1024 >1024 1024 0.06 
3 1024 >1024 1024 0.06 
5 1024 1024 >1024 0.25 
∆acrB Overnight 64 256 1024 0.008 
1 256 256 1024 0.03 
3 64 512 1024 0.03 
5 64 256 1024 0.015 
EtBr: Ethidium bromide; SDS: Sodium dodecyl sulphate; Vanc: Vancomycin; Cip: Ciprofloxacin 
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Vancomycin is a large glycopeptide antibiotic, mainly used to treat Gram-positive 
infections. Vancomycin is too large to enter through the Gram-negative OM 
(Fernandes et al., 2017). It was important to assess whether this was the same at all 
time points, as the membrane may be weaker and allow the entrance of more 
compounds at certain timepoints. However, the MIC of vancomycin in both strains at 
each timepoint was consistently 1024 µg/mL (Table 4-4). This showed that 
vancomycin was unable to kill Gram-negative cells at the range of concentrations 
used, regardless of growth phase.  
The fluoroquinolone, ciprofloxacin, inhibits bacterial growth by accumulating DNA 
double stranded breaks via binding DNA gyrase (LeBel, 1988). At high 
concentrations, ciprofloxacin is bactericidal. The MIC of ciprofloxacin in SL1344 was 
0.06 µg/mL. This did not change when the initial culture was grown for 1 or 3 hours 
but at 5 hours the MIC increased to 0.25 µg/mL (2-fold). In SL1344 DacrB, the MIC 
was 0.008 µg/mL, 3-fold different to the overnight growth of SL1344. At 1 and 3 hours, 
the MIC values of ciprofloxacin in DacrB strains was 0.03 µg/mL, 2-fold different to 
the overnight control, and at 5 hours was 1-fold different to the overnight control 
(0.015 µg/mL). These results at different timepoints were not considered significant 
(Table 4-4).  
4.13.2 Curli biosynthesis 
Curli are proteins present on the surface of Enterobacteriaceae including S. 
Typhimurium. They are important when considering clinical infection as they have 
been implicated in not only cell adhesion and invasion, but also in inducing the host 
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inflammatory response and in the formation of biofilms (Barnhart and Chapman, 
2006). Curli biogenesis was tested in this case as it is already known that curli 
biogenesis is altered in the absence of efflux (Baugh et al., 2012).  
Curli producing S. Typhimurium can be stained red when grown on LB supplemented 
with the dye, congo red, and grown for 48 hours. The production of red, dry and rough 
colonies indicated the production of curli and cellulose. Strains that formed pink 
colonies produce cellulose but no do not biosynthesise curli, and white colonies 
represent strains that cannot produce curli or cellulose. This assay was performed to 
determine whether curli biogenesis was different at different time points.  
Figure 4-10A shows the control strain 14028s grown from an overnight culture. This 
colony is red and rough showing its production of curli and cellulose. SL1344 
overnight control showed a red rough colony (Figure 4-10B). Inoculation of plates 
with SL1344 grown for 1, 3 or 5 hours produced red smooth colonies, possibly 
suggesting curli formation but to a lesser extent than the overnight control (Figure 
4-10C-E). There was no difference in curli production at 1, 3 and 5 hours in SL1344 
DacrB (Figure 4-10F-I), and there was no substantial difference in the colony 
appearance to SL1344. 
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Figure 4-10 Curli biogenesis of 14028s, SL1344 and SL1344 DacrB stained with congo red 
 
(A) shows the control strain 14028s diluted and regrown on congo red plates from an overnight culture. (B-E) 
represent SL1344 diluted from an overnight (B), 1 hour (C), 3 hour (D) and 5 hour (E) timepoints. (F-I) represent 
SL1344 DacrB diluted from an overnight (F), 1 hour (G), 3 hour (H) and 5 hour (I) time points. Red, dry and rough 
colonies indicate the production of curli and cellulose. Pink colonies represent strains that produce cellulose but 
are not producing curli fibres. White colonies are strains that are not producing curli or cellulose in their 
extracellular matrix.  
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4.13.3 Biofilms 
As with curli biogenesis, biofilm production has been shown to be changed in the 
absence of efflux (Baugh et al., 2012). Biofilm formation can be measured using a 
well described crystal violet method (O'Toole, 2011, Jackson et al., 2002). The strong 
biofilm producing strain 14028s was used as a control. 
This assay, as with MICs and curli is usually analysed based on an overnight culture. 
For this reason, SL1344 and DacrB biofilm formation from an overnight were also 
analysed and compared to 14028s. The average OD600 for biofilms formed from 
overnight cultures was 1.75 in 14028s. There was a significant difference between 
14028s and the SL1344 strains, with an almost 4-fold increase in OD600 in 14028s, 
equating to large production of biofilm. However, there was no significant difference 
between SL1344 and DacrB and the OD600 values did not get past 0.5 for either strain. 
There were also no significant differences between cultures that had grown for 1, 3 
or 5 hours in both strains showing, along with curli data, that SL1344 is not a good 
producer of biofilms (Figure 4-11). 
Using this assay, samples taken after 1, 3 and 5 hours of growth of the initial culture 
were adjusted based on cell number, and then re-grown for 48 hours. For this reason, 
it is likely that these assays are not sensitive enough to show any differences in 
biofilm production that may occur in different growth phases.  
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Figure 4-11 Biofilm formation by crystal violet staining in S. Typhimurium at 1, 3 and 5 hours. 
 
Crystal violet biofilm formation is based on 3 biological replicates. Columns represent the OD600 presented on the 
Y-axis and error bars represent +/- SEM. 14028s is used in the control. SL1344 is grouped to the left with 4 bars 
and DacrB is grouped to the right with 4 bars. Grouped data presented on the graph shows formation from an 
original overnight culture (green), 1 hour growth (light blue), 3 hour growth (dark blue) and 5 hour growth (grey) 
points.  
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4.13.4 Cell morphology 
Previous results in Section 4.13 did not produce any significant changes in 
phenotype between exponentially and stationary phase cells. Changes in 
morphology of Gram-negative bacilli in stationary phase have been previously 
described (Navarro Llorens et al., 2010).  
SL1344 grown for 1, 3 and 5 hours was visualised by microscopy. After 1 hour of 
growth, representing early exponential phase and 3 hours, representing late 
exponential phase, SL1344 were still considered bacilli in shape (Figure 4-12A and 
B). By stationary phase, bacilli change morphology to a shorter coccoid shape 
(Figure 4-12C).  
At 1 hour, the mean cell length was 6.14 µm, and was significantly different to both 3 
and 5 hours according to unpaired T-tests, with p-values of <0.0001. The average 
length at 3 hours was 4.30 µm and 3.02 µm at 5 hours, and cell length was 
significantly different at these time points (p-value <0.0001) (Figure 4-13). This result 
confirms that a change in morphology in SL1344 here is consistent with a well 
described phenotype of stationary phase. 
 
.
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Figure 4-12 Representative image of cell morphology of SL1344 at 1, 3 and 5 hours. 
 
(A) shows a differential interference contrast (DIC) image of SL1344 at 1 hour. (B) shows a DIC image of SL1344 at 3 hours of growth. (C) shows a DIC image of SL1344 at 5 hours of growth. 
The scale bar in the bottom right shows 5 µm. Microscopy images were taken of fixed cells at each time point using the Nikon AxioObserver with a 100x oil objective.
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Figure 4-13 Cell length of SL1344 at 1, 3 and 5 hours. 
 
A sample of 100 SL1344 cells were measured at each time point, using ImageJ and microscopy images. Length 
was measured in µm. 1 hour (dark blue), 3 hour (light blue) and 5 hour (purple) were the statistically analysed by 
multiple unpaired T-tests. All were significantly different from each other with a p-value of <0.0001. The **** 
represents this p-value. 
4.14 Discussion 
The data presented in this chapter challenges the commonly accepted notion that 
deleting efflux pumps in Gram-negative bacteria simply causes an increase in the 
accumulation of antibiotics and dyes. In fact, this concept only appears to be true in 
actively growing cells, implying that intracellular accumulation of drugs is growth 
phase dependent. 
The capacity of SL1344 to accumulate EtBr accumulation remained low in every 
growth phase. The data for EtBr accumulation was slightly unexpected as studies 
have already shown that transcription of efflux pumps, namely acrAB transcription, 
does alter with growth phase and rate (Rand et al., 2002, Bailey et al., 2006). Studies 
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into acrAB transcription have previously drawn different conclusions. In 2002, it was 
shown that acrAB transcription is regulated as a function of growth rate (Rand et al., 
2002). Slow growing E. coli may upregulate the expression of acrAB, which was 
linked to the idea that increased expression increases drug resistance (Rand et al., 
2002). It has also been suggested that acrAB transcription is quite stable across 
growth phases in E. coli (Kobayashi et al., 2006). In contrast, in 2006, it was shown 
that in Salmonella grown in LB medium, acrAB transcription peaked in early 
exponential phase and dropped in late exponential phase (Bailey et al., 2006). Kroger 
et al. (2013) created an interactive online browser called ‘SalCom’ for RNAseq based 
transcriptomic data of S. Typhimurium. This S. Typhimurium SalCom data showed 
that acrAB expression in S. Typhimurium is highest in early exponential phase with 
decreased expression in late exponential and stationary phase cells (Kroger et al., 
2013).  
Following the studies that show growth phase dependent expression of acrAB, it was 
hypothesised that acrAB transcription peaks in early-mid exponential phase, and 
increased transcription would lead to increased efflux activity, therefore lower EtBr 
accumulation. The data in this chapter confirmed that transcription peaked at 
early-mid exponential phase, however, interestingly, transcription and EtBr 
accumulation did not correlate. This may suggest normal transcriptional changes of 
growth do not lead to an increase in efflux activity. It is possible that expression in 
different growth phases is lower than in clinical isolates, where described 
overexpression of pumps leads to AMR (Webber and Piddock, 2001).  
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The low accumulation phenotype across growth may be explained by protein level 
and activity rather than transcription. The half-life of AcrAB is considered long with 
one study suggesting it can be present in stationary phase cells for up to 6 days (Chai 
et al., 2016). In 2017, it was suggested that AcrB protein undergoes biased 
partitioning, in which AcrB protein is localised to an old cell pole during cell division, 
and a new daughter cell needs to make new protein (Bergmiller et al., 2017). One 
hypothesis is that acrAB-tolC transcription peaks in mid-exponential phase because 
cell division rates are high so there are many new daughter cells that require new 
protein to be synthesised. However, accumulation level may not change because this 
doesn’t represent more protein per cell. This hypothesis will be studied further in 
Chapter 5.  
To further investigate the link between efflux expression and EtBr accumulation, the 
growth phase experiment was repeated in a strain lacking AcrB. Previous data in 
many Gram-negative species has shown high accumulation of substrates molecules 
in efflux mutants due to an inability to export the compounds (Blair et al., 2015a, 
Smith and Blair, 2014, Wang-Kan et al., 2017, Paixao et al., 2009, Richmond et al., 
2013). However, these studies were all carried out with mid-exponential phase or in 
actively growing cells. When measuring the EtBr accumulation of SL1344 DacrB 
across the growth curve, the result showed growth phase dependence. As shown 
previously, accumulation of EtBr was significantly higher in the acrB mutant than in 
the WT background strain suggesting that low accumulation in exponential phase is 
dependent on AcrAB-TolC (Wang-Kan et al., 2017, Blair et al., 2009, Smith and Blair, 
2014). However, the decrease in EtBr accumulation seen in stationary phase has not 
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previously been shown in SL1344 DacrB. Importantly, this suggests that the EtBr 
accumulation level in stationary phase may not be efflux dependent. 
In 2015, Blair et al., used RT-PCR to show that in an acrB mutant, acrD and acrF are 
upregulated, partially counteracting the loss of AcrAB-TolC function (Blair et al., 
2015a). It is therefore plausible that low accumulation in SL1344 DacrB in stationary 
phase may be due to other efflux pump systems such as AcrAD-TolC and 
AcrEF-TolC being upregulated to counteract the loss of AcrAB-TolC and this 
hypothesis will be addressed in the next chapter of this thesis. 
It is important to note that accumulation of EtBr is not just the measure of efflux but 
is influenced by the rate of influx of EtBr as well as efflux. Data presented in this 
chapter suggests that efflux is less important to the level of accumulation in stationary 
phase, and possibly, how much dye gets into the cell is a more important factor. In 
2016, it was shown that AcrAB-TolC is only important in surviving the pressure of 
SDS in actively growing cells (Mitchell et al., 2017). The study showed that in nitrogen 
and carbon starved environments, the absence of efflux made no difference to 
survival, and RpoS, the stationary phase sigma factor was suggested to be important 
in activating genes that strengthened the outer membrane barrier. Results presented 
here also suggest that efflux is not important to the level of substrate accumulation 
in stationary phase. This result could suggest that the likelihood of bacteria 
developing efflux-mediated resistance may differ depending on the type of infections 
and its growth state. This result is also important when considering the potential 
treatment of slow- or non-growing infections with efflux inhibitors, as efflux may not 
be the true driver of low drug accumulation in some infections. Therefore, efflux 
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inhibition may prove ineffective in potentiating the activity of antibiotics in some 
infections.  
In Salmonella SL1344, the EtBr accumulation across growth was constant. However, 
this work shows that efflux is only important to accumulation during exponential, but 
not stationary, growth phase. One hypothesis to explain this is that in stationary 
phase, decreased permeability of the OM prevents accumulation of EtBr, explaining 
why accumulation level seems to be efflux independent at this stage. This hypothesis 
will be investigated further in Chapter 6. 
The EtBr accumulation phenotype in SL1344 DacrB is especially important due to its 
robustness in other conditions. EtBr accumulation consistently peaks in early 
exponential phase and drops in stationary phase in MOPs media (more nutrient 
limited), with a differently localised substrate (Nile Red) and with a range of clinically 
relevant Gram-negative bacteria. 
Nile Red is a lipophilic dye which stains triglycerides and phospholipids. It was 
important to show that the accumulation phenotype using EtBr was not just an 
artefact of that particular dye. Measuring efflux using Nile Red has been used 
previously in E. coli (Bohnert et al., 2010). Bohnert et al., 2010, showed that in the 
absence of acrAB, Nile Red efflux was diminished. Data presented in Chapter 3 
showed little difference in Nile Red accumulation in SL1344 compared to DacrB 
(Whittle et al., 2019). It is not known why Nile Red is a less sensitive substrate in this 
assay when used with Salmonella rather than E. coli but to get around this problem, 
a mutant lacking the outer membrane channel TolC was used in these experiments 
as the difference in accumulation was greater. The peak in Nile Red fluorescence in 
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exponential phase in SL1344 DtolC shows the necessity of TolC for export of this 
dye. TolC as the outer membrane component, can form tripartite pumps in a number 
of other systems and may suggest Nile Red is the substrate of another pump. Nile 
Red accumulation does drop as stationary phase is entered, and this may suggest 
that outer membrane permeability does play a role preventing access to drugs in 
stationary phase (Bohnert et al., 2010). However, Nile Red accumulation is always 
significantly different to SL1344 regardless of growth phase, suggesting that either 
efflux pumps export Nile Red in stationary phase, or that low EtBr accumulation in 
stationary phase may rely more on the permeability of the IM. It is also possible that 
the mechanism for export for both these dyes is different.  
Other common substrates for measuring accumulation include Hoechst 33342 and 
1,2-DNA (Blair and Piddock, 2016, Bohnert et al., 2011). However, it was not possible 
to test these here as the flow cytometer was not fitted with a violet laser. Future work 
would include optimising this assay for other dyes, and possibly fluorescent 
antibiotics (Stone et al., 2020) to be able to assess the true clinical relevance of this 
accumulation phenotype. 
Apart from drug accumulation, other phenotypes have been described when AcrB is 
deleted from cells, and so these phenotypes were investigated in different growth 
phases. It is well known that cell shape and length change from exponential to 
stationary phase in Gram-negative bacilli (Navarro Llorens et al., 2010). This was 
confirmed in Salmonella SL1344 in this chapter. For many other efflux related 
phenotypes there was no phenotypic difference between cells from different growth 
phases but this may be due to sensitivity issues associated with the way these assays 
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were performed. The phenotypic assays were adapted to measure the potential 
phenotypes at certain points in growth. For MIC, curli and biofilm assays, the assays 
were set up using cultures grown for different lengths of time (1, 3 or 5 hours) but 
then the assays require incubation for 24-48 hours. This makes these assays 
insensitive so it was unlikely that any difference in phenotype would be identified. 
Further work on this would include optimising these assays to increase sensitivity. 
Assessing antibiotic sensitivity could be measured at different time points if cultures 
were treated with antibiotic in different growth phases and assessed for survival. 
4.15 Key Findings 
• Levels of EtBr accumulation in exponential phase were dependent on the 
presence of AcrAB-TolC. 
• EtBr accumulation in stationary phase in an efflux mutant is low, regardless of 
growth medium, organism and dye, and therefore appears to be a consistent 
phenotype. 
• Low accumulation may be due to the activity of other efflux pumps or reduced 
by outer membrane permeability changes and both these hypotheses will be 




Chapter 5 - Low accumulation in 
stationary phase is efflux independent 
5.1 Background 
In the previous chapter, a novel accumulation phenotype was identified in wild type 
Gram-negative bacteria and in their respective efflux mutant strains, when in different 
growth phases. 
In Gram-negative bacteria, EtBr accumulation remained low regardless of growth 
phase. One obvious hypothesis was that accumulation remains low due to the 
presence of the major efflux pump AcrAB-TolC. However, changing acrAB 
transcription levels across growth had no impact on the level of accumulation. It was 
hypothesised that AcrAB protein level is the key factor in determining the level of 
efflux and therefore maintaining low accumulation. 
There is limited information of the amount of AcrB protein present in the cell and how 
it relates to transcription. It is well known that acrAB is highly and tightly regulated at 
the local and global transcriptional level. The transcription of marA and soxS is 
expressed to a greater extent in early to mid-exponential phase, comparable to 
transcription of acrAB (Bailey et al., 2006).  
Less well understood is the importance of post-transcriptional and translational 
control of AcrAB-TolC. The importance of CsrA and sRNAs has been discussed 
(Chapter 1). Briefly, they direct or prevent translation of acrAB transcripts (Ricci et 
al., 2017, Parker and Gottesman, 2016, Yamada et al., 2010). However, it is not 
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understood how the control of AcrB level differs in different growth phases. It has 
been shown that AcrB has a long half-life and could explain why low EtBr 
accumulation capacity is maintained across growth. This hypothesis will be studied 
further here. 
The hypothesis regarding the levels of AcrB protein may be disproved by the EtBr 
accumulation phenotype of SL1344 ∆acrB. The peak in EtBr accumulation after 1 
hour of growth confirms substrate accumulation is dependent on efflux in actively 
growing cells. However, EtBr accumulation in SL1344 ∆acrB is the same as SL1344 
in stationary phase. This suggests that EtBr accumulation is independent of AcrB in 
stationary phase. One possible explanation for the decrease in accumulation in 
stationary phase is that other efflux pumps could function or indeed have increased 
expression during later growth phases which would ameliorate the effects of losing 
AcrB on accumulation. There are 4 other RND pumps in S. Typhimurium: 
AcrEF-TolC, AcrAD-TolC, MdsABC/TolC and MdtABC/TolC, which may be involved 
in the export of EtBr in stationary phase as well as 4 other MDR pumps from different 
efflux pump classes. Their importance in the EtBr accumulation phenotype will be 
explored here. 
5.2 Hypotheses 
• AcrB protein level and therefore efflux activity remains constant over growth 
• Efflux pumps other than AcrAB, are responsible for the drop in EtBr accumulation 
in stationary phase. 
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5.3 Aims: 
1. To determine whether efflux activity varies across the growth curve 
2. To measure AcrB protein level and study the importance of protein level on 
EtBr accumulation 
3. To investigate whether efflux pumps other than AcrAB are responsible for the 
drop in EtBr accumulation in stationary phase 
4. To measure transcription of all MDR efflux pumps to determine their 
importance in different growth phases 
5.4 Accumulation is low in stationary phase in the absence of 
acrB but efflux capability is constant across growth phases 
In the previous chapter, it was shown that low EtBr accumulation in actively growing 
cells was dependent on the presence of AcrAB-TolC, but this was not the case in 
stationary phase cells. To determine whether efflux activity in SL1344 cells varied in 
different growth phases and could contribute to changing levels of EtBr accumulation, 
the level of efflux activity was measured at different time points during growth. The 
following assay does not directly measure the activity of AcrAB-TolC, but the efflux 
capacity of the cell based on the activity of all efflux pumps that are able to transport 
EtBr in SL1344. 
This assay works by maximally preloading cells with EtBr in the presence of an efflux 
inhibitor, CCCP, which dissipates the PMF. Glucose is then added to restore the PMF 
and re-start efflux. The decrease in fluorescence as EtBr is actively pumped out of 
the cells is then measured. 
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Figure 5-1A shows the drop in EtBr fluorescence in SL1344 grown for 1,3 or 5 hours, 
for the 60 minutes that followed re-energisation by the introduction of glucose. Based 
on this data, it appeared that the levels of EtBr from cells grown for 3 and 5 hours 
began to drop at the same time following addition of glucose. In cells grown for 1 
hour, there is a lag (3.74 and 4.55 minutes later than a culture grown for 3 and 5 
hours respectively) before EtBr starts being exported from the cell. 
To statistically analyse this data, the maximum EtBr fluorescence value was taken 
for each biological replicate at each time point and from this value, the time (minutes) 
for fluorescence to drop by 10%, 25% and 50% was calculated (Figure 5-1B). There 
were three biological replicates for each condition. There was no significant 
difference in the time taken for the fluorescence to drop between cells grown for 1, 3 
or 5 hours. This suggests that regardless of time point, efflux pumps are present and 
still have the capacity to function.  
Taken together, the low EtBr accumulation across time in SL1344 and the data 
presented here, suggests that although acrAB transcription peaks in mid-exponential 
phase, the AcrAB-TolC activity level is constant. It is possible that efflux capacity is 
constant due to the long half-life of AcrAB (Chai et al., 2016) and may explain why 
EtBr accumulation remains low in stationary phase. AcrAB protein level will be 
explored further in Section 5.5. 
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Figure 5-1 Efflux capacity of SL1344 after 1, 3 and 5 hours of growth. 
 
SL1344 (A + B) and SL1344 ∆acrB (C + D) were loaded with EtBr and CCCP after growing for 1, 3 and 5 hours. (A + C) shows the EtBr fluorescence over 60 minutes. 0 
minutes is the time point where glucose is added to the cells to re-energise. The lines represent fluorescence of EtBr as it is being pumped out of the cells. The figure 
legend is shown in in each panel. Starting fluorescence at 0 minutes was normalised to 1. In (C), controls were added, where no glucose had been added to ∆acrB 
therefore efflux was not re-energised (B + D) Bars represent the time taken for EtBr fluorescence to drop by the stated %. There were biological 3 replicates for each 
condition and error bars of +/- SEM. 
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The assay was repeated for SL1344 ∆acrB grown for 1, 3 or 5 hours. Previously, it 
was shown that the EtBr accumulation in ∆acrB peaked at 1 hour of growth and then 
dropped into stationary phase. To understand how efflux activity and the EtBr 
accumulation pattern may relate, the efflux assay described previously was repeated 
with SL1344 ∆acrB. It was clear that efflux activity was reduced compared to SL1344 
for each of the hours where samples were taken. In SL1344 ∆acrB cultures grown 
for 1 hour, there appeared to be more efflux activity than cultures grown for 3 and 5 
hours (Figure 5-1C). There was a significant increase in the time taken for a 25% 
drop in fluorescence after 5 hours of growth compared to 1 hour of growth. Both at 3 
and 5 hours of growth, there was a significant increase in the time taken for 50% drop 
compared to 1 hour (p <0.0001) (Figure 5-1D). Using controls where SL1344 ∆acrB 
was not re-energised with glucose confirmed that these cells can still efflux in the 
absence of AcrAB-TolC but to a lesser extent than SL1344. In S. Typhimurium, AcrEF 
and MdsABC export EtBr (Nishino et al., 2006), and in E. coli, MdfA was also shown 
to export EtBr (Nishino and Yamaguchi, 2001), and it is possible that these pumps 
are involved in EtBr export after 1 hour of growth. The clear difference in time taken 
for fluorescence to drop between 1 and 3/5 hours, may suggest that a cell has higher 
efflux activity in actively growing cells.  
The data presented in Figure 5-1C + D is complex but it could be hypothesised that 
in ∆acrB, other efflux pumps still function to maintain low EtBr accumulation and 
circumvent the requirement for AcrAB-TolC in stationary phase. This hypothesis will 
be explored in this chapter. 
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5.5 Does AcrB protein level stay constant across growth 
contributing to low EtBr accumulation in SL1344? 
It is apparent that efflux pumps are functional in every growth phase in SL1344. 
Constant efflux capacity suggests levels of AcrAB-TolC protein level remains 
constant within the cell. To explore this further, it was important to investigate the 
levels of AcrB within a cell at different growth phases and to identify its role in 
maintaining low EtBr accumulation in stationary phase in SL1344. 
A chromosomal fusion of GFP to the C-terminal end of AcrB with a codon optimised 
poly-linker, has previously been described in E. coli (Bergmiller et al., 2017). To 
measure AcrB protein in single cells by flow cytometry here, a GFP-tagged AcrB 
protein was used. To construct SL1344 AcrB-GFP, the same basic protocol was used 
as presented previously for E. coli by Bergmiller et al. (2017), except that a GFP 
plasmid was optimised by inserting aph directly downstream of msfGFP for use as a 
selectable marker for correct insertion. 
5.5.1 Construction of SL1344 AcrB-GFP strain 
5.5.1.1 Restriction and ligation to produce a gfp + aph plasmid 
To produce a strain with GFP fused to AcrB on the chromosome, first the pET GFP 
LIC cloning vector (u-msfGFP) plasmid was modified by insertion of aph, a 
kanamycin resistance cassette, downstream of gfp. To insert aph, two restriction 
sites downstream of gfp were chosen. The first cutting site enzyme was AscI, 
followed by KpnI, providing targeted directionality of the aph insert gene (Figure 5-2).  
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Figure 5-2 Cloning strategy to construct the modified GFP plasmid. 
 
This schematic shows a plasmid map of the original pET-LIC (u-msfGFP) plasmid which was 5478 bp. Downstream of msfGFP was a multiple cloning site where 2 
restriction sites (AscI and KpnI) were chosen for the ligation of aph downstream of gfp. The final constructed plasmid was 6979 bp.
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To confirm correct cutting, the plasmid was separated by gel electrophoresis. An 
uncut plasmid was used as a control, followed by cuts with a single restriction enzyme 
to confirm each enzyme was linearizing the plasmid. Figure 5-3 showed that both 
single cut plasmids and plasmids ‘1’ and ‘2’ (two candidates cut with both enzymes), 
had slower passage of DNA through the gel than uncut plasmid and confirmed 
successful cutting. 
 
Figure 5-3 Agarose gel electrophoresis image to identify successful restriction digest of 
pET-LIC (u-msfGFP) plasmid 
 
M represents the marker with size of bands in bp labelled. Uncut represents the 5478 bp plasmid that has not 
been digested. All plasmid that has been successfully digested is represented as a larger band on the agarose 
gel. AscI represents a single cut control and KpnI represents a single cut control. 1, 2 represent samples that 
have been digested with both restriction enzymes. 
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Oligonucleotides were designed (Table 2-8) that would amplify the aph gene from 
the pKD4 plasmid with an AscI restriction site on the forward primer, and a KpnI 
restriction site on the reverse primer. Amplified aph was then also digested with both 
restriction enzymes to produce sticky ends that were then ligated into the pET GFP 
LIC plasmid. This new plasmid was successfully transformed into NEB 5-alpha cells 
and grown on LB supplemented with kanamycin. One successful transformant of this 
plasmid was purified and used in the next steps to produce this strain. 
5.5.1.2 Homologous recombination to insert GFP and aph downstream of 
AcrB 
Using the plasmid produced in 5.5.1.1, GFP and the aph cassette could be amplified 
from the plasmid using PCR, and the product recombined downstream of AcrB.  
The forward oligonucleotide was designed such that the first 27 nucleotides had 
homology to AcrB with the stop codon removed, then the codon optimised poly-linker 
and 23 nucleotides of homology to GFP. The reverse oligonucleotide was designed 
with homology to the 3’ end of the aph cassette and the non-coding region 
downstream of AcrB. GFP and aph were successfully amplified from the plasmid and 
confirmed by agarose gel electrophoresis (data not shown). The purified PCR 
product was then inserted chromosomally into SL1344 by homologous 
recombination. Successful insertion of GFP and aph was confirmed by growth on 
agar supplemented with kanamycin and 5 candidates were screened for insertion 
using PCR (Figure 5-4). A DNA product was amplified using oligonucleotides with 
homology to acrB (forward) and gfp (reverse). Successful insertion of GFP 
downstream of acrB was shown in all 5 candidates which produced a 920 bp product. 
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All these products were then sequenced for further confirmation and the full 
sequence alignment for candidate 3 is shown in Appendix III . Figure 5-5 shows the 
sequencing alignment to confirm that the codon-optimised poly-linker was 
successfully inserted. Amplification of a PCR product containing gfp and aph also 
further confirmed correct insertion. 
One candidate (AcrB-GFP ‘3’ with aph) was transformed with pCP20 for successful 
removal of the aph cassette which was confirmed by the inability of the strain to grow 
on kanamycin. 
Figure 5-4 Agarose gel electrophoresis images to confirm successful insertion of GFP 
downstream of acrB 
 
Both (A) and (B) was a negative control (-ve) where no DNA template was added and an SL1344 control (SE01) 
which should no amplify any DNA with the oligonucleotides used. (A) shows 920 bp bands for transductant strains 
1-5 that amplified acrB, the polylinker and GFP. (B) shows 700 bp bands to confirm aph was successfully inserted 
into SL1344 along with GFP. 






Figure 5-5 Gene alignment to show nucleotide sequence of the SL1344 AcrB-GFP candidate strain compared to SL1344 
 
(1) labelled AcrB-polylinker-GFP is the reference strain based on the expected sequence with the correct codon optimised poly-linker. (2) labelled AcrB-GFP 3 F shows 
the 5’ – 3’ sequencing based on PCR amplification shown in Figure 5-4.The strain sequenced was candidate 3. This image was created using Geneious software. 
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5.5.2 C-terminal attachment of GFP to chromosomal AcrB does 
not affect the phenotype of SL1344 
To confirm that this strain could be used to study the AcrB protein, it was first 
necessary to check that the insertion of GFP did not lead to a growth defect or that 
its attachment to AcrB did not interfere with efflux activity. 
5.5.2.1 C-terminal GFP does not affect growth rate 
To confirm that the GFP fusion did not affect the growth rate of SL1344, cultures were 
grown and the OD600 was measured every 20 minutes for 12 hours in LB (Figure 
5-6). 
The generation times based on cell division were calculated for each strain and 
unpaired T-tests compared SL1344 to both SL1344 AcrB-GFP and SL1344 ∆acrB 
(Table 5-1). SL1344 ∆acrB was used as a control as previously published data shows 
∆acrB does not lead to a growth defect (Wang-Kan et al., 2017). None of the 
generation times were over 30 minutes nor were they significantly different from each 
other. 
This shows that fusing GFP to the C-terminal end of AcrB does not confer a 
detectable growth defect. 
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Figure 5-6 Growth kinetics curve of SL1344, SL1344 ∆acrB and SL1344 AcrB-GFP. 
 
SL1344 (brown dashed), SL1344 ∆acrB (blue dashed) and SL1344 AcrB-GFP (green) were grown for 12 hours 
in LB. The OD600 value was measured every 30 minutes and plotted against time. These OD600 values were blank 
corrected by removing the OD600 values of LB from each strain. The data is the mean of 3 biological replicates 
for each strain and presented on a log10 scale. 
Table 5-1 Generation times for SL1344, SL1344 ∆acrB and SL1344 AcrB-GFP in 
LB medium 
Strain Generation Time 
(minutes) (mean ± SD) 
Significance (P-value) 
compared to SL1344 
SL1344 27.347 ± 2.14  
SL1344 AcrB-GFP 30.047± 3.24 ns (0.4393) 
SL1344 ΔacrB 28.507 ± 0.95  ns (0.2955) 
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5.5.2.2 C-terminal GFP does not impede efflux activity 
It was also important to confirm that a protein fusion at the C-terminal end of AcrB 
did not interact or impede the function of export. This is because this strain would be 
used to study efflux and, inhibiting efflux by the positioning of GFP would confound 
any results and conclusions that could be made. 
To analyse the effect on efflux, the efflux assay used previously was repeated, except 
this assay was done at a single growth time (mid-log). Like in Section 5.4, the time 
taken for EtBr fluorescence to drop 10%, 25% and 50% was measured. As shown in 
Figure 5-7 and Table 5-2, SL1344 ∆acrB EtBr fluorescence takes significantly longer 
to decrease, when compared to SL1344. However, for each % drop in fluorescence, 
there was no significant difference in time taken for both SL1344 and SL1344 
AcrB-GFP. This shows that the fusion of GFP to the C-terminus of AcrB does not 
alter efflux activity and could be used for further study.  
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Figure 5-7 Efflux capacity of SL1344, SL1344 ∆acrB and SL1344 AcrB-GFP in mid-exponential 
phase. 
 
EtBr fluorescence was constantly measured for 114 minutes in SL1344 (brown dashed), SL1344 ∆acrB (blue 
dashed) and SL1344 AcrB-GFP (green). EtBr fluorescence values were normalised so that the first value read 
equaled 1. Data is based on 3 biological replicates for each strain. 
Table 5-2 Statistical analysis of time taken for a drop in EtBr fluorescence 
 
Strain Time for fluorescence 
drop (mean ± SD) 
Significance (P-value) 
compared to SL1344 
10% 
drop 
SL1344 3.07 ± 0.38 
 
SL1344 AcrB-GFP 2.69 ± 0.38 ns (0.2895) 
SL1344 ΔacrB 7.79 ± 1.90 Significant (0.0134) 
25% 
drop 
SL1344 4.73 ± 0.61 
 
SL1344 AcrB-GFP 4.35 ± 0.22 ns (0.3596) 
SL1344 ΔacrB 11.75 ± 0.59 Significant (0.0001) 
50% 
drop 
SL1344 6.91 ± 0.69 
 
SL1344 AcrB-GFP 6.77 ± 0.58 ns (0.8118) 
SL1344 ΔacrB 20.81 ± 1.25 Significant (<0.0001) 
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5.5.3 AcrB protein level remains constant across the growth curve 
SL1344 AcrB-GFP was constructed to measure the level of AcrB present in a cell or 
population across growth. It was hypothesised that the level of protein within a cell 
would not increase in line with the increase in acrAB transcription at mid-exponential 
phase, but instead remain constant resulting in constant capacity to efflux EtBr and 
maintain low EtBr accumulation (Section 5.4). 
5.5.3.1 Measuring the levels of GFP using flow cytometry and microscopy 
Initially, the aim was to measure AcrB level using SL1344 AcrB-GFP in single cells 
by flow cytometry. However, the GFP signal from this gfp variant turned out to be too 
low to measure. It was not possible to collect GFP fluorescence using SYTO-84 to 
gate cells and measure GFP from this, using original flow cytometry settings that had 
previously been used to measure GFP, as described in Section 2.3.3.3. For this 
reason, the voltage through the BL1-H channel (for GFP) was increased, but GFP 
could still not be measured from this strain.  
Another approach attempted was to measure AcrB levels in single cells using 
microscopy. Initially, confocal microscopy was used on live samples. However, in 
order see any GFP from cells required a 10 second exposure time. This meant that 
using a confocal laser photobleached cells beyond the field of view, making it difficult 
to consistently measure GFP fluorescence. A new approach was taken, namely to 
fix cells in formaldehyde after growth for 1, 3 and 5 hours, and take images to 
measure fluorescence using LED to achieve a GFP fluorescence emission. The 
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fluorescence signal was low and results too inconsistent to be considered 
quantitative. 
To measure AcrB level using this strain at the single cell level would require a more 
powerful flow cytometer than the Attune NxT and a more powerful microscope than 
100x LED phase microscopes, which were not available at the time. 
5.5.3.2 Measuring AcrB protein level across the growth phase of an entire 
population of cells 
As it had proved difficult to measure AcrB-GFP in single cells due to the GFP signal, 
AcrB-GFP was measured in a whole population of cells grown in MOPs minimal 
media, using a 96-well plate reader. For this assay, SL1344 autofluorescence was 
also measured and this was subtracted from the GFP fluorescence measured in 
SL1344 AcrB-GFP. The gain for GFP was set to account for the low signal. 
Figure 5-8 shows the GFP fluorescence/OD600 over 16 hours of growth, with 
measurements recorded every 20 minutes. The GFP/OD600 value was used to 
correct for increase in cell density. It was clear that for the first 220 minutes of growth, 
GFP/OD600 was highly variable and spiked inconsistently (Appendix IV ). However, 
until around 380 minutes, SL1344 AcrB-GFP was in lag phase in MOPs minimal 
media and therefore was not a reflection of AcrB level across the growth curve. 
Therefore, GFP/OD600 was then plotted starting from 300 minutes to remove the 
spikes at the beginning of lag, and the OD600 was also plotted to compare growth to 
the pattern of GFP/OD600. From 300 to 500 minutes, the GFP/OD600 decreased, 
however +/- SEM was large. From around 600 minutes to the final 16 hours of growth, 
GFP/OD600 level remained constant.  
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The results here show that GFP level and therefore AcrB level is more varied in early 
exponential phase than stationary phase. The fluorescence decreased around 2-fold 
from 300 to 500 minutes, and it is possible that when cells are growing and dividing 
at their highest rate, new AcrB protein production in daughter cells may be at its 
lowest rate. However, AcrB protein level was relatively constant within a cell 
population across the growth curve, and does not correlate to the pattern of acrAB 
transcription. It may suggest that in an entire population of cells, AcrB level remains 
constant across growth and that a peak in transcription in mid-exponential phase is 
as a result of making new proteins in dividing cells so that protein level always does 
remain constant. 
Figure 5-8 GFP/OD600 from SL1344 AcrB-GFP over 16 hours of growth in MOPs minimal media. 
 
This graph shows GFP/OD600 from AcrB-GFP at the end of lag phase (300 minutes) until the last time point at 16 
hours. The dashed black line shows the OD600 whereas the green line error bars +/- SEM shows GFP 
fluorescence. SL1344 autofluorescence was subtracted from this data.  
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5.5.4 Biased partitioning of AcrB to old cells poles could not be 
shown  
The data above suggests that the average level of AcrB protein per cell remains 
relatively stable across growth and this leads to a constant ability to efflux substrates 
from the cell regardless of growth phase in WT.  
One study described that the AcrAB-TolC protein had a strong partitioning bias for 
mother cell poles during cell division (Bergmiller et al., 2017). It is possible that 
transcription peaks in mid-exponential phase only due to requirement of new 
daughter cells to make new AcrAB protein. The study used a microfluidics channel 
to show AcrB biased partitioning (Bergmiller et al., 2017). To reproduce this finding 
and confirm this as the case for AcrB in S. Typhimurium, images of fixed cells 
undergoing binary fission were taken using microscopy (Figure 5-9).  
A dividing cell of SL1344 was shown to compare the difference between 
autofluorescence and AcrB-GFP. The dividing SL1344 cell in Figure 5-9B shows 
limited GFP fluorescence after 10 seconds of exposure. In both examples provided 
for SL1344 AcrB-GFP, it appears that GFP signal is strongest at the cell membrane 
and that fluorescence is not localised to one pole of the dividing cell. This result is 
qualitative, and higher resolution microscopy is required to confirm this result 
however it may suggest that AcrB does not localise at old cell poles in these 
conditions. It is possible that the previous result could be an artefact of the 
microfluidic system and AcrB may in fact be spread across the cell. 
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Figure 5-9 Representative microscope images of dividing SL1344 and SL1344 AcrB-GFP cells. 
 
(1) show SL1344 producing no GFP, and were used as a control. (2) shows AcrB-GFP of which there are 2 representative examples. (1A,2A and 2C) show standard light 
DIC images of both strains. (1B,2B and 2D) show GFP fluorescence of the dividing cells of each strain. Images were taken with the Nikon AxioObserver and 100x oil 
objective.
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5.6 Low accumulation in stationary phase is not due to the 
activity of other efflux pumps 
In SL1344 ∆acrB, EtBr accumulation peaked at 1 hour as expected due to the loss 
of the pump, but in stationary phase, EtBr accumulation was as low as in SL1344. 
This suggests that the stationary phase phenotype is not as a result of AcrB protein. 
One hypothesis to explain this is that other efflux pumps may export EtBr in the 
absence of AcrB. 
5.6.1 The removal of other efflux components maintains the same 
accumulation pattern as SL1344 ∆acrB 
If other efflux pumps play a role in exporting EtBr from cells in stationary phase, then 
measuring EtBr accumulation in different efflux mutant strains should show an altered 
accumulation pattern.  
The EtBr accumulation assay was repeated with SL1344 ∆tolC, a deletion that 
inhibits the efflux function of all RND pumps, and the ABC pump, MacAB-TolC. 
SL1344 was used as a control. Figure 5-10A shows that EtBr accumulation in 
SL1344 remained low as previously shown. In SL1344 ∆tolC, accumulation followed 
a similar pattern to that seen for the acrB mutant; EtBr accumulation peaked after 1 
hour of growth and from 4 – 6 hours the EtBr accumulation level was not significantly 
different to SL1344. This suggests that the low EtBr accumulation in stationary phase 
is not due to any of the pumps that require TolC to function. 
Chapter 5 - Low accumulation in stationary phase is efflux independent 
 181 
Figure 5-10 EtBr accumulation in SL1344 ∆tolC and ∆4PAP across growth. 
 
(A) shows SL1344 vs DtolC. Median EtBr fluorescence per cell in 10,000 SYTO-84+ flow cytometry events was 
measured every hour between 0 and 6 hours. Individual grey circles (WT) and individual blue hexagons (DtolC) 
represent the median value of EtBr fluorescence within a biological replicate. (B) shows SL1344 vs D4PAP. 
Median EtBr fluorescence per cell in 10,000 SYTO-84+ flow cytometry events was measured every hour between 
0 and 6 hours. Individual grey circles (WT) and individual green triangles (∆4PAP) represent the median value of 
EtBr fluorescence within a biological replicate. 4 biological replicates for each strain are shown, with a short mean 
bar and SEM error bars. EtBr accumulation is plotted on the left Y-axis. Calculated cell number values were 
plotted on the right Y-axis with corresponding symbols equating to strain and a dashed line to show growth of the 
culture. Cell numbers were based on the mean of the same biological replicates and the same gated population 
that EtBr fluorescence was measured from. Two-way ANOVA and Sidak’s multiple comparisons test were used 
for statistical analysis. 
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To further confirm that no other RND pumps were causing low EtBr accumulation in 
stationary phase, EtBr accumulation was measured in an SL1344 strain that had all 
the RND PAPs removed, named ∆4PAP, meaning the 5 RND pumps do not function. 
EtBr accumulation peaked at 1 hour, and had high accumulation at 2 hours of growth 
(Figure 5-10B). After 3 hours of growth, EtBr accumulation started to drop and by 4 
to 6 hours, the EtBr accumulation level was not significantly different from SL1344. 
This shows that other RND pumps are not responsible for the export of EtBr in 
stationary phase, either in SL1344 or in the absence of AcrB.  
Together, these results show that RND pumps and the ABC pump, MacAB-TolC, do 
not contribute to low EtBr accumulation in stationary phase. If they did, EtBr 
accumulation would have been high in the absence of the pump function. 
5.6.2 Inhibiting efflux with CCCP leads to a decrease in EtBr 
accumulation in stationary phase 
The EtBr accumulation patterns in the efflux mutants described in Section 5.6.1 
could not rule out that members of the MFS and MATE pumps, EmrA, MdtK or MdfA, 
were exporting EtBr. These remaining pumps, like RND pumps, use the PMF as an 
energy source for the export of substrates. Every pump, with the exception of the 
ABC pump, MacAB-TolC, are inhibited by the addition of PMF inhibitor, CCCP. 
To investigate the role of all PMF-dependent efflux pumps on EtBr accumulation, 
EtBr accumulation was measured at each time point in SL1344 and ∆acrB, when 
CCCP had been added to samples. CCCP was not added to growing culture, only to 
samples being prepared for flow cytometric analysis. Figure 5-11A shows that, as 
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previously, SL1344 EtBr accumulation remained low across growth. When samples 
were incubated with 100  µM CCCP, the EtBr accumulation pattern changed. 
Addition of CCCP to the SL1344 samples gave a broadly similar pattern to deletion 
of AcrB. In the presence of CCCP, EtBr accumulation peaked at 1 hour with a 9-fold 
increase (p <0.0001). These data points can initially be compared to previous EtBr 
accumulation patterns shown in all efflux mutants. The EtBr accumulation decreased 
after 2 hours, into stationary phase, showing a similar pattern that had previously 
been shown in the absence of AcrB. It was unexpected that EtBr accumulation, 
although lower, remained significantly different from SL1344. This might suggest that 
the remaining efflux pumps not tested in the previous section may play a minor role 
in EtBr export in stationary phase. However, the remaining efflux pumps clearly are 
not the major factor responsible for the low EtBr, as the accumulation level did not 
dramatically change to the levels shown at 1 hour. 
The experiment with the addition of CCCP was repeated in SL1344 ∆acrB. It was 
shown that there was no significant difference in EtBr accumulation in the absence 
or presence of CCCP in culture after it had been grown for 1 hour (Figure 5-11). This 
suggests that in early exponential phase, AcrB is fundamental for the level of EtBr 
accumulation. As previously shown, EtBr accumulation in SL1344 ∆acrB drops to 
SL1344 levels in stationary phase, and this was also shown in the presence of CCCP. 
The combined effect of inactivating efflux and inhibiting the PMF did not did not 
massively alter the accumulation phenotype of SL1344 ∆acrB. However, EtBr 
accumulation was significantly different from SL1344 ∆acrB, as with SL1344. 
Although unlikely, this result may also suggest that other efflux pumps that require 
the PMF, may export EtBr in stationary phase.  
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Figure 5-11 EtBr accumulation of SL1344 and SL1344 ∆acrB in the presence of CCCP over 6 
time points. 
 
(A) shows SL1344 vs SL1344 + 100  µM CCCP. Median EtBr fluorescence per cell in 10,000 SYTO-84+ flow 
cytometry events was measured every hour between 0 and 6 hours. Individual green circles (WT) and individual 
green diamonds (+ CCCP) represent the median value of EtBr fluorescence within a biological replicate. (B) 
shows SL1344 ∆acrB vs DacrB + CCCP. Median EtBr fluorescence per cell in 10,000 SYTO-84+ flow cytometry 
events was measured every hour between 0 and 6 hours. Individual pink circles (∆acrB) and individual red 
diamonds (∆acrB + CCCP) represent the median value of EtBr fluorescence within a biological replicate. 2 
biological replicates for the control strains are shown, and 4 replicates for those with CCCP, with a short mean 
bar and SEM error bars. EtBr accumulation is plotted on the left Y-axis. Calculated cell number values were 
plotted on the right Y-axis with corresponding symbols equating to strain and a dashed line to show growth of the 
culture. Cell numbers were based on the mean of the same biological replicates and the same gated population 
that EtBr fluorescence was measured from. Two-way ANOVA and Sidak’s multiple comparisons test were used 
for statistical analysis. 
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This data suggests that high EtBr accumulation in SL1344 ∆acrB at 1 hour, is due to 
the loss of the pump. It can be hypothesised that low EtBr accumulation in actively 
growing cells is dependent of the activity of efflux pumps. It is also clear that inhibiting 
the PMF has less of an effect on EtBr accumulation in stationary phase cells, since 
the accumulation level decreases, and is similar to the SL1344 EtBr accumulation 
level. However, this result could not completely rule out the activity of PMF driven 
pumps in stationary phase due to the significant difference in EtBr accumulation in 
stationary phase, with the addition of CCCP. By measuring transcription in the 
preceding section, it will show the importance of the other efflux pumps in stationary 
phase.  
5.6.3 Transcription levels suggest accumulation levels are 
efflux-dependent in stationary phase. 
Although tightly regulated, acrAB expression is high when grown in laboratory media, 
as previously shown in Figure 4-3. Expression of other efflux pumps is tightly 
regulated, and often requires specific inducers for expression when grown in 
laboratory medium. For example, acrEF expression has been shown in S. 
Typhimurium when H-NS is deleted in a ∆acrAB strain (Nishino et al., 2009a). 
If other pumps are partially responsible for accumulation patterns seen in stationary 
phase, then expression of these pumps would need to increase. Therefore, 
transcription of these pumps was measured across growth.  
Transcription was measured using pMW82 plasmids, where the promoter of each 
efflux pump was fused to GFP. Therefore, the efflux gene promoter activity was 
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driving the transcription and production of GFP protein. The OD600 and GFP 
fluorescence were measured for 12 hours in MOPs minimal media for 18 strains, 
both SL1344 and SL1344 ∆acrB containing pMW82-acrA, pMW82-acrE, 
pMW82-acrD, pMW82-mdsA, pMW82-mdtA, pMW82-mdfA, pMW82-mdtK, 
pMW82-emrA and pMW82-macA. Salmonella autofluorescence was measured and 
subtracted from the fluorescence produced from each strain.  
Figure 5-12A shows that transcription of acrAB peaks in mid-exponential phase. This 
matches the pattern produced by the flow cytometry assay shown in Figure 4-3. The 
other RND pumps in SL1344, acrE, acrD, mdsA and mdtA were not transcribed 
during the 12 hours of growth. In this experiment, the deletion of acrB did not lead to 
compensatory transcription of the other RND pumps (Figure 5-12B-E). This may 
explain why inhibiting the activity of the other RND pumps with CCCP or through 
gene deletion in SL1344 had no effect on EtBr accumulation. These RND pumps are 
tightly regulated and may not be transcribed in normal growth medium, but rather 
under specific environmental conditions. 
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Figure 5-12 Transcription profiles of each efflux pump in SL1344 over 12 hours of growth. 
 
In the following graphs A-I, the GFP/OD600 and therefore transcription of each pump is represented as a solid blue line (SL1344) or a dashed blue line (∆acrB). The OD600 
was also plotted and shown as a solid black line (SL1344) or a dashed black line (∆acrB). Each graph represents the fluorescence of a different transcriptional reporter: 
(A) acrA, (B) acrE, (C) acrD, (E) mdsA, (D) mdtA, (F) emrA, (G) mdfA, (H) mdtK and (I) macA. 
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EmrA and MdfA are MFS efflux pumps in SL1344. Here, it was shown that there was 
no transcription of emrA under these growth conditions therefore showing that low 
EtBr accumulation in stationary phase is not EmrA dependent (Figure 5-12F). The 
MFS pump, mdfA did however show GFP fluorescence with a peak equivalent to 
mid-exponential phase (Figure 5-12G). A similar transcription result was seen with 
mdtK (MATE) with a peak at 9 hours and macA with a peak at 8 hours (Figure 
5-12H-I). Therefore, each of the pumps that are transcribed in normal growth media 
peak in mid-exponential phase. It was also important to note that the GFP/OD600 for 
acrAB transcription peaked at around 100,000 whereas the other 3 pumps have 
peaked at GFP/OD600 values around 30,000. This shows that although transcribed, 
they are less abundant than AcrAB-TolC and it is unlikely they play a large role in 
EtBr accumulation in stationary phase. 
This suggests that other pumps are not involved in EtBr accumulation in stationary 
phase, and it can be hypothesised that low EtBr accumulation in SL1344 in stationary 
phase is efflux independent. 
5.7 Discussion 
In the previous chapter, it was shown that acrAB transcription in SL1344 peaks in 
mid-exponential phase and did not correlate to EtBr accumulation. It was previously 
hypothesised that an increase in transcription in mid-exponential phase, would lead 
to an increase in AcrB protein in the same phase and therefore increased efflux 
capacity. However as this was disproved, it was then hypothesised that efflux activity 
in stationary phase relates to level of protein. 
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Here, it was shown that efflux could function regardless of growth phase, which may 
explain why, in SL1344, EtBr accumulation remains low across growth. In 2016, it 
was shown that AcrA and AcrB have a long half-life, about 6/7 days (Chai et al., 
2016). This data suggests that AcrAB-TolC is present within cells in stationary phase 
and can export EtBr in all growth phases. It was also found that stability of the AcrAB 
protein did not depend on efflux activity but instead, on the presence of AcrA (Chai 
et al., 2016). It can be hypothesised that AcrAB is constantly anchored within the IM 
regardless of growth phase, and does not become degraded if not used. This would 
explain why EtBr may be exported from cells in all growth phases, but does not 
explain why EtBr accumulation remains low in stationary phase in the absence of 
AcrB.  
Using SL1344 AcrB-GFP, it was shown that AcrB protein level remains constant in 
stationary phase, under normal growth conditions. Measuring AcrB protein level by 
western blot (using a strain of SL1344 where AcrB is his tagged) is part of further 
work to confirm that the result produced by the GFP strain is consistent. The question 
remained why transcription of acrAB peaks in mid-exponential phase if protein 
remains constant across growth. In 2017, it was shown that AcrB protein undergoes 
biased partitioning in which AcrB accumulates at old cell poles during binary fission 
and therefore is only present in the parent rather than the daughter cell (Bergmiller 
et al., 2017). This information led to the development of the hypothesis that the peak 
in acrAB transcription in mid-exponential phase is due to the need to produce new 
AcrB protein in new daughter cells that have not inherited existing AcrB protein. 
Transcription drops in stationary phase as each cell within the population has AcrB 
protein with a long half-life. In this chapter, it was not possible to show AcrB localising 
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to old cell poles in free media using microscopy. It is possible that biased partitioning 
is as an effect of using a microfluidic device as differences to normal growth media 
conditions have been described (Yang et al., 2018). However, biased partitioning 
may not have been identified due to limitations in microscopy here. Future work would 
include optimising an assay to measure GFP more consistently using microscopy 
and identifying any localisation. The succinimidyl ester, Texas red, is a fluorescent 
membrane reagent which localises to the poles of cells (de Pedro et al., 2004). Using 
a pulse-chase experimental set-up (Zupan et al., 2013), bacteria may be stained with 
Texas Red, and cultures left to grow meaning that only old cell poles which had been 
originally stained would fluoresce with Texas Red. Used together with SL1344 
AcrB-GFP, it may confirm that AcrB localises at old cell poles but also that new AcrB 
protein is made in daughter cells.  
Although it can be hypothesised that AcrB is present across all growth phases to a 
constant level, this does not explain why EtBr accumulation in the absence of AcrB 
is low in stationary phase. It may suggest low EtBr accumulation depends on a 
mechanism other than efflux.  
Measuring efflux activity of SL1344 ∆acrB after 1,3 and 5 hours of growth suggested 
there was still some efflux activity in the absence of AcrAB-TolC function and this 
was explored further. To completely rule out that efflux pumps were involved in low 
EtBr accumulation in stationary phase, EtBr flow cytometry assays were repeated 
using SL1344 ∆4PAP and SL1344 ∆tolC. The EtBr patterns still maintained low EtBr 
accumulation in stationary phase confirming that the RND pumps in SL1344 played 
no role in accumulation in stationary phase. Previously it has been shown that 
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AcrAB-TolC was the major efflux pump in S. Typhimurium, with deletion of AcrF and 
AcrD having little effect on MICs of clinically relevant drugs (Piddock, 2006). In a 
study where all RND pumps were removed in S. Typhimurium, it was also shown that 
by removing AcrB there was a reduction in MIC of EtBr, but no change of MIC when 
removing any other RND pump (Nishino et al., 2006). Transcription of these RND 
pumps under normal growth conditions using the pMW82 reporters was shown to be 
limited in all growth phases. Previous studies have shown that S. Typhimurium’s suite 
of RND pumps are tightly regulated and are only expressed in the presence of 
specific inducers. AcrEF is H-NS silenced (Nishino et al., 2009a) but AcrAD and 
MdtABC is induced by indole, zinc or copper (Nishino et al., 2007) and MdsABC is 
induced in the presence of gold (Pontel et al., 2007, Song et al., 2015). Data 
presented here suggests that no RND pumps in S. Typhimurium significantly alter 
EtBr accumulation level in stationary phase.  
The EtBr accumulation pattern in ∆tolC confirmed that the ABC, MacAB-TolC was 
also not responsible for the export of EtBr in stationary phase. This pump has only 
be shown to export macrolides (Kobayashi et al., 2001), enterotoxin (Yamanaka et 
al., 2008), protoporphyrin (Turlin et al., 2014) and linearised enterobactin 
(Bogomolnaya et al., 2020) and would explain why this pump plays no role in EtBr 
accumulation.  
Using CCCP, EtBr accumulation in the absence MdfA, MdtK and EmrA function was 
also measured. Importantly, the EtBr accumulation pattern of SL1344 in the presence 
of CCCP remained similar to the pattern of SL1344 ∆acrB. This suggested that all 
efflux pumps in SL1344 were not the key drivers of low EtBr accumulation in 
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stationary phase, and that another mechanism contributes to low EtBr accumulation. 
However, the significant difference between SL1344 and SL1344 + CCCP in EtBr 
accumulation added to the complexity of this set of results. It is possible that other 
PMF dependent efflux pumps are important for maintaining low EtBr accumulation in 
stationary phase. The efflux pump, EmrAB, exports EtBr and CCCP (Lomovskaya et 
al., 1995). CCCP induces transcription of emrAB (Xiong et al., 2000), therefore It is 
possible that CCCP induces the activity the pump, however, with 10 minutes of 
incubation with CCCP, it is unlikely. It is also important to note that CCCP does not 
simply inhibit efflux. As it inhibits the PMF, it also inhibits more cell processes that 
require the PMF, such as motility, but also acts as an inhibitor of oxidative 
phosphorylation and ATP synthesis (Rottenberg and Steiner-Mordoch, 1986). 
Therefore, it is more unlikely that the small difference in EtBr accumulation is simply 
as a result of inhibiting efflux function. The transcription of mdfA and mdtK peaked at 
mid-exponential phase, like acrAB, but to a much lower extent and was therefore still 
difficult to confirm that they did not play a role in EtBr accumulation. MdfA has 
previously been shown to export EtBr in E. coli (Nishino and Yamaguchi, 2001). 
Further work here would include measuring EtBr accumulation in range of strains that 
contained a single knockout of each efflux pump or identifying specific inhibitors to 
each pump.  
Taken together this data suggests that efflux is only important in maintaining low drug 
accumulation in actively growing cells.  
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5.8 Key Findings 
• AcrB protein level and efflux activity are constant regardless of growth phase 
and do not correlate to acrAB transcription. 
• mdtK, mdfA and macAB are the only other antibiotic exporting pumps in S. 
Typhimurium that have transcriptional activity in normal laboratory media. 
• Deleting other efflux components or adding inhibitors does not change the 
overall accumulation pattern. 
• Although AcrB protein level is constant, EtBr accumulation is still low in 
stationary phase and this is not caused by EtBr export from efflux pumps.
 
 194 
Chapter 6 - Outer Membrane Permeability 
explains low accumulation in Stationary 
Phase 
6.1 Background 
Data from previous chapters suggest that across growth, EtBr accumulation levels 
do not correlate with acrAB transcription, and that low EtBr accumulation is 
dependent on AcrAB-TolC in actively growing cells only. Data presented in Chapter 
5 shows that in stationary phase, low EtBr accumulation is independent of efflux. One 
hypothesis to explain this is that the low accumulation in stationary phase may 
instead be due to decreased permeability of the OM. 
Finding methods to measure permeability of S. Typhimurium to EtBr in this study was 
not straightforward. Some studies use EtBr as a probe for outer membrane 
permeability (Miki and Hardt, 2013), however, as EtBr is a substrate of the 
AcrAB-TolC pump (Paixao et al., 2009, Blair and Piddock, 2016), it cannot effectively 
be used as a probe when analysing strains lacking components of AcrAB-TolC. For 
this reason, the level of EtBr within the cell is based on how much gets into the cell, 
as well as how much is removed (i.e. accumulation) and does not measure 
permeability alone. Another dye commonly used to measure permeability is 
1-N-phenylnaphthylamine (NPN) (Muheim et al., 2017). However, NPN is also an 
efflux pump substrate (Misra et al., 2015) and is not suitable for assessing the 
balance between influx and efflux in this study.  
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There is little information about how EtBr enters cells. Some studies suggest that 
EtBr cannot enter through intact Gram-negative cell membranes (Miki and Hardt, 
2013, Aeschbacher et al., 1986), however it has been extensively studied and used 
as an efflux substrate without having to damage the cell envelope. It is more likely 
that EtBr can enter cells but that accumulation level is a balance between influx and 
efflux (Paixao et al., 2009). Porins are channels which allow entrance of several small 
hydrophilic compounds into the cell and it is possible that EtBr may enter through 
these protein channels. Porins in Gram-positive Mycobacterium smegmatis allow the 
entrance of EtBr into cells (Rodrigues et al., 2011). It has also been suggested that 
EtBr just enters cells through passive diffusion (Paixao et al., 2009). Permeabilising 
the cell with EDTA or polymyxin, which displaces divalent cations, also allows the 
entrance of compounds into the cell (Hancock and Bell, 1988). 
There are a number of studies which describe changes in the cell envelope during 
stationary phase (previously described in Chapter 1), however, an integrated 
overview of how bacterial cell membranes change is lacking. Outer membrane 
changes include a decrease in the overall concentration of membrane proteins (Allen 
and Scott, 1979) and an increase in lipoprotein bound to peptidoglycan (Wensink et 
al., 1982) to strengthen the outer barrier. In the IM, the composition of fatty acids 
changes with a decrease in monounsaturated fatty acids (El-Khani and Stretton, 
1981) and an increase in cyclopropane fatty acids, catalysed by cfa (Grogan and 
Cronan, 1997). Increased layers of peptidoglycan have also been described in 
stationary phase (Mengin-Lecreulx and van Heijenoort, 1985). 
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Mitchell et al. (2017) showed that the cell envelope was less permeable in stationary 
phase via RpoS-dependent mechanisms. Using the detergent, SDS, they showed 
that AcrAB-TolC was responsible for SDS resistance in actively growing cells, but not 
in stationary phase. However, in a carbon-limited environment, AcrAB-TolC had no 
impact on SDS resistance, but SDS resistance was dependent on rpoS. This study 
strengthens the hypothesis that low EtBr accumulation in stationary phase is due to 
a strengthening of the membrane barrier leading to reduced permeability. 
6.2 Hypothesis 
The hypothesis is that low EtBr accumulation in stationary phase is 
efflux-independent and due to decreased permeability. 
6.3 Aims 
1. To measure EtBr accumulation in porin mutants and show whether they play 
a role in EtBr accumulation and if EtBr enters cells through porins.  
2. To determine whether the strength of the permeability barrier changes in 
stationary phase. 
3. To measure EtBr accumulation in the absence of RpoS to analyse its 
importance in low accumulation. 
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6.4 EtBr does not enter Gram-negative bacteria through 
porins 
There is no consensus in the literature concerning how EtBr enters Gram-negative 
bacterial cells. Porins are implicated in the development of AMR (Nikaido, 1989), and 
also a porin in Mycobacterium has been shown to import EtBr (Rodrigues et al., 
2011). For this reason, it was hypothesised that downregulation of porins may play a 
role in membrane permeability for influx of EtBr in stationary phase. S. Typhimurium 
has a number of major and minor porins. The major porins, OmpC and OmpF were 
analysed due to their involvement in the development of AMR. 
6.4.1 Removal of major porins in SL1344 
Major porins, OmpC and OmpF were deleted from SL1344 and SL1344 ∆acrB using 
the homologous recombination method (Datsenko and Wanner, 2000). The following 
strains were made: SL1344 ∆ompC, SL1344 ∆ompF, SL1344 ∆ompC ∆ompF, 
SL1344 ∆acrB ∆ompC, SL1344 ∆acrB ∆ompF and SL1344 ∆acrB ∆ompC ∆ompF. 
An aph cassette was inserted into the ompC and ompF genes in each strain by 
homologous recombination using lambda red recombinase encoded on pSIM18 
(Chan et al., 2007), as previously described. Presence of the aph cassette was 
confirmed by growth on kanamycin and PCR for the aph gene. Removal of the 
pSIM18 plasmid was confirmed by the inability to grow on hygromycin. PCR was 
used to amplify ompC::aph and ompF::aph and amplimers were sequenced to 
confirm correct insertion.  
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The aph cassette was removed with pCP20 and the loss confirmed by lack of growth 
on ampicillin and PCR amplification and sequencing to confirm gene deletion. Strains 
with ompC and ompF deleted produced 300 bp and 367 bp products respectively 
(Figure 6-1). 
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Figure 6-1 Agarose gel image to confirm deletion of porins from SL1344 
 
Both A + B show images from gel electrophoresis. PCR products have been separated and DNA bands shown for each strain. (A) using oligonucleotides with homology 
up and down stream of the ompC gene, DNA was separated to confirm the deletion of ompC in each strain. In those strains where ompC was not deleted, the product size 
was 1405bp. Strains containing DompC had a product size of 300 bp. (B) using oligonucleotides with homology up and down stream of the ompF gene, DNA was separated 
to confirm the deletion of ompF in each strain. In those strains where ompF was not deleted, the product size was 1355bp. Strains with DompF had a product size of 367 
bp. 
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6.4.2 The deletion of porins does not alter the EtBr accumulation 
pattern 
It was hypothesised that when the major porins of SL1344 were deleted, EtBr 
accumulation would decrease in stationary phase as the lack of porins would prevent 
access of the dye.  
Alongside measuring EtBr accumulation, the cell numbers of each strain were 
analysed to show that there was no growth defect accompanied with the deletion of 
porins and growth phases are entered at the same time for each strain (Figure 6-3). 
SL1344 was compared to DompC, DompF and DompC DompF (Figure 6-2A). There 
was no significant difference in accumulation level between all strains at each time 
point. This suggested that EtBr does not enter bacterial cells through the major 
porins, OmpC or OmpF. These strains were also compared for EtBr accumulation 
when AcrB was deleted (Figure 6-2B). As common to the phenotype, accumulation 
peaked at 1 hour and dropped as bacterial cells entered stationary phase. An 
increase in EtBr accumulation was seen in SL1344 DacrB DompC DompF and at 2 
hours, EtBr accumulation was significantly higher than SL1344 DacrB with a p-value 
of 0.0226. In 2019, a study showed that deleting porins may in fact damage the 
membrane leading to increased permeability, and the data presented here would also 
suggest that (Choi and Lee, 2019).  
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Figure 6-2 EtBr accumulation in WT and DacrB compared to porin mutant strains 
 
(A+B) 4 biological replicates for each strain are shown, with a short mean bar and SEM error bars. EtBr 
accumulation is plotted on the left Y-axis (A) shows SL1344 WT (individual green dots) vs DompF (green 
triangles), DompC (green square) and DompC DompF (blue diamonds). Median EtBr fluorescence per cell in 
10,000 SYTO-84+ flow cytometry events was measured every hour between 0 and 6 hours. Individual symbols 
represent the median value of EtBr fluorescence within a biological replicate. (B) shows SL1344 DacrB (red dots) 
vs DacrB DompF (red triangles), DacrB DompC (pink square) and DacrB DompC DompF (red diamonds). Median 
EtBr fluorescence per cell in 10,000 SYTO-84+ flow cytometry events was measured every hour between 0 and 
6 hours. Individual symbols represent the median value of EtBr fluorescence within a biological replicate. A 
two-way ANOVA and Dunnett’s multiple comparison test were used for statistical analysis. 
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Figure 6-3 Growth curves for SL1344 compared to porin mutant strains 
 
This graph shows the growth curve of all strains. Calculated cell number values were plotted on a logarithmic 
scale and strains shown in the legend. Cell numbers were based on the mean of the same biological replicates 
and the same gated population that EtBr fluorescence was measured from. 
 
This data suggests that EtBr does not enter the cell through the porins OmpC and 
OmpF and that passive diffusion is a more likely mechanism (Paixao et al., 2009). 
Further work such as MICs could be used to determine whether susceptibility to EtBr 
changes in the absence of these porins. 
6.5 Membrane permeability decreases in stationary phase 
Having shown that EtBr does not enter Gram-negative cells through porins, the 
hypothesis that membrane permeability is reduced in stationary phase was explored. 
As previously discussed, probes that are utilised to measure membrane permeability 
are often efflux substrates. Therefore, membrane permeability was assessed based 
on membrane leakage, using SYTO-84 and using EDTA. 
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6.5.1 The level of EtBr leaking from cells was too inconsistent to 
assess membrane permeability 
It was reasoned that the decreased permeability which leads to reduced influx in 
stationary phase, may also lead to less EtBr leakage through membranes into the 
extracellular environment, than in actively growing cells. To investigate this, the 
previously described efflux assay in Section 5.4, was adapted to measure how much 
EtBr leaks from a population of cells after 1, 3 and 5 hours of growth. To measure 
efflux, cells were pre-loaded with EtBr in the presence of CCCP to inhibit efflux, and 
cells are washed and re-energised with glucose. To measure EtBr leakage, glucose 
was not added, therefore the PMF was not re-energised and the levels of EtBr that 
leak out of cells independently of efflux could be measured.  
Initial results appeared to suggest that more EtBr leaks out of cells at 1 hour of growth 
than at 3 and 5 hours of growth. This would have confirmed the hypothesis that 
actively growing cells have weaker membranes than in stationary phase. However, 
the error bars (not shown) from 6 biological repeats (1 hour) and 3 biological repeats 
(3 and 5 hours) for the data points in Figure 6-4A were large. Therefore, each 
replicate for each hour was plotted and the gradient of the line was calculated as a 
measure of the rate of EtBr leakage (Figure 6-4B-D). At 3 and 5 hours, the average 
rate was not significantly different based on an unpaired T-test, with a rate (m for 
gradient of line) of 0.0003. At 1 hour, 6 replicates were shown because the data from 
each replicate was inconsistent. The rates calculated greatly varied and for this 
reason, EtBr leakage was not significant regardless of time point and could not 
confirm our hypothesis that the membrane is less permeable in stationary phase. 
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Figure 6-4 Membrane EtBr leakage capacity in SL1344 at 1, 3 and 5 hours of growth. 
 
Each graph shows the time taken for EtBr to leak out of a population of cells that have not been re-energised with glucose after CCCP treatment. (A) shows a line graph 
of the rate at which EtBr leaks out of cells in SL1344 at 1 hour (black) based on 6 biological replicates, 3 hours (orange) and 5 hours (blue) based on 3 biological replicates. 
Error bars are not shown but were large. (B) shows the 6 replicates of EtBr leakage at 1 hour. (C) shows the 3 replicates of EtBr leakage at 3 hours. (D) shows the 3 
replicates of EtBr leakage at 5 hours. The rate was determined by measuring the gradient of the line, and y=mx + c was shown next to the end of each line.
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6.5.2 Bacterial cells become less permeable to SYTO-84 in 
stationary phase. 
It has been previously suggested that EtBr enters cells though passive diffusion 
(Paixao et al., 2009). It was hypothesised that if permeability to EtBr is reduced in 
stationary phase, then this would also be the case for the non-efflux substrate 
SYTO-84. Our novel flow cytometry assay uses SYTO-84 dye as a probe for gating 
bacterial cells. Re-analysing data from Figure 4-4, the level of SYTO-84 fluorescence 
was measured to investigate whether bacterial cells become less permeable to this 
dye also. 
There was no significant difference between the accumulation of SYTO-84 in SL1344 
and SL1344DacrB with a peak in SYTO-84 fluorescence at 1 hour of growth (Figure 
6-5). This would suggest that SYTO-84 is not an efflux substrate and shows the 
importance of efflux in maintaining low accumulation of drugs and dyes that are 
substrates in actively growing cells. However, SYTO-84 fluorescence decreases in 
both strains on entrance to stationary phase. This does suggest that a substrate that 
is not exported via efflux, is also less able to accumulate during stationary phase due 
to a strengthening of the permeability barrier. It is important to note that, although the 
SYTO-84 fluorescence does reduce around 2.5-fold, the lowest value is still over 
45,000 RFU, and therefore can still be successfully used to gate cells for the 
measurement of EtBr using flow cytometry. However, as stated in the methods, extra 
gating was used for stationary phase samples to account for the shift in fluorescence 
values of SYTO-84. 
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Together this data suggests that accumulation levels of two DNA intercalating dyes 
in stationary phase are completely independent of efflux activity, and that passive 
diffusion into bacterial cells reduces in stationary phase, due to decreased membrane 
permeability. 
 
Figure 6-5 SYTO-84 accumulation measured every hour for 6 hours in WT and DacrB. 
 
Median SYTO-84 fluorescence per cell in 10,000 flow cytometry events was measured every hour between 0 and 
6 hours. Individual black dots represent the X-median value of SYTO-84+ accumulation in 10,000 events of 
SL1344 (WT) within a biological replicate. Individual blue triangles represent the X-median value of SYTO-84 
accumulation in 10,000 events of DacrB within a biological replicate. 4 biological replicates for each strain are 
shown, with a short mean bar and SEM error bars. SYTO-84 accumulation is plotted on the left Y-axis. Calculated 
cell number values were plotted on the right Y-axis with corresponding symbols equating to strain and a dashed 
line to show growth of the culture. Cell numbers were based on the mean of the same biological replicates and 
the same gated population that EtBr fluorescence was measured from.  
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6.5.3 The outer membrane is more resistant to EDTA 
destabilisation in stationary phase 
Thus far, results based on SYTO-84 accumulation support the hypothesis that 
membrane permeability decreases in stationary phase leading to low EtBr 
accumulation. It is possible that a ‘strengthened’ or impermeable membrane may be 
less susceptible to permeabilisation of compounds such as EDTA.  
To increase the permeability of the OM, EDTA can be used as a ‘permeabiliser’. 
EDTA displaces the divalent cations which crosslink LPS, making the membrane 
more fluid and more permeable to compounds that passively diffuse through cells, 
and to hydrophobic compounds that would usually not enter (Hancock and Bell, 
1988). Using flow cytometry, EtBr accumulation was measured in bacterial cells at 1, 
3 and 5 hours of growth after incubation with increasing concentrations of EDTA to 
permeabilise the membrane (Figure 6-6A). 
As with previous results, EtBr accumulation in SL1344 at 1, 3 and 5 hours with no 
EDTA remained low with no significant difference in accumulation between the time 
points. When cells were incubated with 1 mM, 10 mM or 100 mM EDTA when 
sampled at each time point, there was no significant difference in accumulation 
compared to the no EDTA control. At 1 and 3 hours of growth, cells incubated with 
200 mM or 500 mM EDTA accumulated significantly more EtBr than in the absence 
of EDTA. This suggests that EDTA at these high concentrations destabilises the OM, 
making cells more permeable to EtBr, in actively growing cells. At 5 hours of growth, 
there was no significant difference in EtBr accumulation with the addition of any 
concentration of EDTA, including 500 mM EDTA.  
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Figure 6-6 Accumulation of EtBr in SL1344 and DacrB in the presence of EDTA 
 
Bars represent EtBr accumulation in single cells per 10,000 SYTO-84+ events (A) EtBr accumulation in SL1344. 
EtBr accumulation was measured in the presence of increasing concentrations of EDTA (0, 1, 10, 100, 200 and 
500 mM) from a culture grown for 1 hour (black), 3 hours (dark blue) and 5 hours (light blue). (B) EtBr 
accumulation in DacrB. EtBr accumulation was measured in the presence of increasing concentrations of EDTA 
(0, 1, 10, 100, 200 and 500 mM) from a culture grown for 1 hour (black), 3 hours (dark purple) and 5 hours (light 
purple). For both (A) and (B), error bars show SEM from 3 biological replicates. Dashed lines above the bars with 
asterisks represent significance value when based on a T-test compared to no EDTA added.   
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The experiment was repeated for SL1344 DacrB (Figure 6-6B). As with previous 
data, EtBr accumulation peaked at 1 hour of growth and decreased at 3 and 5 hours 
of growth. At 1 and 3 hours, there was no significant difference in EtBr accumulation 
with addition of 1 mM or 10 mM. EtBr accumulation significantly increased with 100 
mM and 200 mM EDTA but with the addition of 500 mM accumulation was not 
significantly different. Based on viable counts, SL1344 DacrB did not die in the 
presence of 500 mM EDTA. Significant EtBr accumulation with 100 mM EDTA 
suggested that the OM of SL1344 DacrB might be slightly more permeable than 
SL1344. However, the important conclusion is that the OM in actively growing cells 
is weaker in both strains as it was more susceptible to disruption by EDTA. In SL1344 
DacrB after 5 hours of growth, there was no significant difference in EtBr 
accumulation with the addition of any of the EDTA concentrations use, therefore 
suggesting increased strength of the permeability barrier in both strains in stationary 
phase.  
This experiment was also attempted with SDS, a detergent which disrupts the inner 
and outer membrane and denatures membrane proteins at a range of concentrations. 
However, this was unsuccessful because either the SDS concentration added was 
too small to see a difference in EtBr accumulation or the concentration was too high 
that SYTO-84+ cells could not be successfully or consistently gated (data not shown). 
To conclude, the data presented in this section is key to confirming the hypothesis 
that the membrane is more stable in stationary phase, causing cells to accumulate 
less dye. 
 
Chapter 6 - Outer Membrane Permeability explains low accumulation in Stationary Phase 
 210 
6.6 The role of RpoS in strengthening the outer membrane 
barrier in stationary phase. 
It has previously been shown that the OM of E. coli is ‘strengthened’ via 
RpoS-dependent mechanisms (Mitchell et al., 2017). Previous data in Section 6.5, 
confirms the hypothesis drawn that low EtBr accumulation in stationary phase is due 
to outer membrane permeability changes. It was therefore hypothesised that RpoS 
regulated the mechanisms required for reduced permeability to EtBr in stationary 
phase. To establish the importance of RpoS in the EtBr accumulation pattern in 
stationary phase RpoS was deleted from SL1344.  
6.6.1 Removal of RpoS from SL1344 and SL1344 ∆acrB 
The sigma factor gene rpoS was deleted from SL1344 and SL1344 ∆acrB.  
An aph cassette was inserted into the rpoS gene in each strain by homologous 
recombination using the lambda red recombinase encoded on pSIM18 (Chan et al., 
2007). Presence of the aph cassette was confirmed by growth on kanamycin and 
removal of the pSIM18 plasmid confirmed by the inability to grow on hygromycin. 
Successful rpoS::aph candidates produced a PCR product of 1289 bp. The aph 
cassette was removed from each strain and production of ∆rpoS strains was shown 
in Figure 6-7 by the amplification of a 400 base pairs rpoS product.  
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Figure 6-7 Agarose gel image to confirm deletion of rpoS from SL1344 and DacrB 
 
Gel image from agarose gel electrophoresis showing deletion of rpoS in SL1344 and DacrB. PCR products have 
been separated and DNA bands shown for each strain. In those strains where rpoS was not deleted, the product 
size was 1289 bp. Strains containing DrpoS had a product size of 400 bp.  
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6.6.2 Curli is not produced in the absence of RpoS 
The curli operon csgBAC is highly expressed in stationary phase and its expression 
is regulated by RpoS. The sigma factor binding protein, Crl, interacts with RpoS, and 
facilitates RpoS attachment to the promoter region of csgBAC to drive transcription 
(Barnhart and Chapman, 2006). A congo red assay was carried out to assess curli 
and cellulose formation that contribute to the ability of bacteria to form biofilms (Jonas 
et al., 2007). This assay acted as a positive confirmation of the deletion of rpoS from 
strains.  
S. Typhimurium 14028s is a control strain used when assessing curli biogenesis as 
it is a strong producer of biofilms. Figure 6-8A shows 14028s as a red, rough colony 
formation capable of producing curli and cellulose. SL1344 is not a strong biofilm 
producer however the colony appeared red with a rough surface therefore produced 
both curli and cellulose. Efflux deleted strains are known to be less able to form 
biofilms (Baugh et al., 2012). SL1344 ∆acrB still produced a red colony however it 
did not produce a rough colony therefore does not produce curli but did produce 
cellulose (Figure 6-8C). Both strains with RpoS deleted produced white colonies 
meaning that they do not produce curli or cellulose and therefore are unable to form 
biofilms (Figure 6-8D+E).
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Figure 6-8 Curli biogenesis in S. Typhimurium 14028s, SL1344 and ∆acrB versus rpoS mutant strains.  
 
Data shows colonies of (A) 14028s, (B) SL1344, (C) SL1344 DacrB, (D) SL1344 DrpoS, (E) SL1344 DacrB DrpoS grown on congo red to distinguish curli biogenesis. Red 
rough colonies represent strains that can produce curli and cellulose, where white smooth colonies cannot produce curli or cellulose.
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6.6.3 Removing RpoS does not come with a growth defect 
To deduce whether the deletion of rpoS led to a growth defect, growth kinetics of the 
strains were measured in the absence of selective pressure, in both LB and MOPs 
minimal media. There was a significant difference in growth in LB compared to MOPs 
minimal media (All p-values <0.0001). In MOPs, there was a longer lag phase and 
exponential phase began at 5 hours. 
The growth kinetics of SL1344 and SL1344 ∆acrB (Figure 6-9A+B) were measured 
to determine whether there was an effect of deleting efflux pumps on a strain’s 
growth. Deleting efflux pumps made no significant difference to the generation times, 
all of which had generation times of between 20 and 26 minutes (P >0.05). There 
were no significant differences in generation times of SL1344 and SL1344 ∆acrB in 
MOPs minimal media (P >0.05) (Table 6-1). 
 
Table 6-1 Generation times of each strain during cell division and 









SL1344 21.37 ± 3.01  52.28 ± 7.22  
DrpoS 26.76 ± 2.08 ns (p 0.46) 50.90 ± 6.55 ns (p 0.83) 
DacrB 19.23 ± 3.36  51.27 ± 2.38  
DacrB DrpoS 21.59 ± 4.86 ns (p 0.16) 52.09 ± 6.32 ns (p 0.83) 
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Figure 6-9 Growth kinetics of SL1344 and SL1344 ∆acrB and the effect of deleting rpoS on fitness cost. 
 
All above growth curves are based on 3 biological replicates (error bars are not shown). (A) compares the growth curves of SL1344 (black) and ∆acrB (blue) in LB. (B) 
compares SL1344 (grey) and ∆acrB (dark blue) in MOPs minimal media. (C) compares ∆acrB SL1344 in LB and MOPs (light blue; dark blue) to SL1344 ∆acrB ∆rpoS 
(dark purple; light purple. (D) compares SL1344 (black; grey) to SL1344 ∆rpoS (dark green; light green) in LB and MOPs minimal media.
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For all rpoS mutants compared to their parent strains, there was no significant 
difference in generation time between them in LB (All P >0.05) (Figure 6-9C). In 
MOPs minimal media, all ∆rpoS strains grew to a higher OD600 than their parent strain 
(Figure 6-9D). However, the generation times do not differ significantly from ∆rpoS 
strains compared to their parental strain (All P >0.05).  
6.6.4 RpoS deletion did not affect the antimicrobial susceptibility 
profile 
Antimicrobial susceptibility was assessed by measuring the MICs of various 
antibiotics, dyes and detergents to SL1344, ∆acrB, SL1344 ∆rpoS and ∆acrB ∆rpoS 
strains. The agar dilution method was used to identify whether deleting RpoS 
increased the susceptibility to antibiotics. As previously described, the deletion of the 
pump component AcrB increased susceptibility of S. Typhimurium to a number of 
antibiotics (Table 6-2). The MIC of all antibiotics for SL1344 ∆acrB were more than 
2-fold different to SL1344, except rifampicin.  
The MIC of antibiotics for ∆rpoS strains did not differ from the parent significantly 
(more than a 2-fold reduction in MIC), therefore RpoS does not contribute to the 
antimicrobial susceptibility of S. Typhimurium. Rifampicin was tested as it targets the 
RNA polymerase of a bacterial cell which may have interfered with the function of 
RpoS sigma factor. SDS detergent was also tested (Rami et al., 2005) as it has 
previously been described to have a reduced MIC to ∆rpoS strains in E. coli, however 
this result was not reproduced in this study.
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Table 6-2 MICs of antibiotics in rpoS mutant strains  
Strain MIC (µg/ mL) 
 AMP CIP CV ERY EtBr FUS NOR RHO RIF SDS 
SL1344 4 0.03 64 64 >1024 1024 0.06 >1024 8 >1024 
SL1344 ∆acrB  0.12 <0.008 4 4 128 8 0.015 32 8 256 
SL1344 ∆rpoS 4 0.03 64 64 >1024 1024 0.03 >1024 8 >1024 
SL1344 ∆acrB ∆rpoS 0.12 <0.008 4 4 128 8 0.008 32 8 256 
Ampicillin (AMP); Ciprofloxacin (CIP); Crystal violet (CV); Ethidium bromide (EtBr); Fusidic acid (FUS); Norfloxacin (NOR); Rhodamine 6G (RHO); Rifampicin (RIF); Sodium dodecyl sulphate 
(SDS)
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6.6.5 RpoS does not alter the levels of EtBr accumulation in 
stationary phase 
Using the rpoS mutant strains, EtBr accumulation level was measured using flow 
cytometry. It was hypothesised that deletion of RpoS would reduce the gene 
expression of RpoS-dependent genes involved in strengthening the permeability 
barrier and therefore lead to an increase in EtBr accumulation in stationary phase. 
SL1344 EtBr accumulation was compared to SL1344 DrpoS over 6 hours of growth. 
There was no significant difference in accumulation between these strains. Figure 
6-10A shows that EtBr accumulation in both these strains was low at each time point 
and that EtBr fluorescence did not exceed 10000 RFU for any replicate at any time. 
This suggests that RpoS is not an important factor for EtBr accumulation in stationary 
phase. 
To assess the importance of RpoS in the absence of efflux, SL1344 DacrB EtBr 
accumulation was compared to SL1344 DacrB DrpoS (Figure 6-10B). As with 
previous data, EtBr accumulation peaked at 1 hour and the deletion of RpoS did not 
significantly alter the accumulation level. At the 3 hour time point, EtBr fluorescence 
remained significantly higher in SL1344 DacrB DrpoS compared to SL1344 DacrB. It 
could be hypothesised that in the efflux deficient strain, rpoS is involved in directing 
transcription of genes involved in outer membrane permeability, however 
accumulation level does still drop on entrance into stationary phase and is not 
significantly different to SL1344 DacrB from 4 to 6 hours of growth.  
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Figure 6-10 EtBr accumulation in strains lacking RpoS. 
 
(A+B) 4 biological replicates for each strain are shown, with a short mean bar and SEM error bars. EtBr 
accumulation is plotted on the left Y-axis. Calculated cell number values were plotted on right Y-axis. Cell 
numbers were based on the mean of the same biological replicates and the same gated population that EtBr 
fluorescence was measured from. (A) shows SL1344 WT (individual black dots) vs DrpoS (blue dots). Median 
EtBr fluorescence per cell in 10,000 SYTO-84+ flow cytometry events was measured every hour between 0 and 
6 hours. Individual symbols represent the median value of EtBr fluorescence within a biological replicate. (B) 
shows SL1344 DacrB (black diamonds) vs DacrB DrpoS (green diamonds). Median EtBr fluorescence per cell in 
10,000 SYTO-84+ flow cytometry events was measured every hour between 0 and 6 hours. Individual symbols 
represent the median value of EtBr fluorescence within a biological replicate. Significant differences to parent 
strain were measured by a two-way ANOVA and Sidak’s multiple comparison test.  
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As previously shown in Figure 6-9, deletion of RpoS does not impact growth rate, 
and so is not responsible for any significant changes in EtBr accumulation at each 
time point. 
6.7 Discussion 
Data presented in this chapter supports the hypothesis that EtBr enters cells via 
passive diffusion in actively growing cells, but with increasing strength of the 
membrane barrier in stationary phase, less EtBr can enter cells. 
The deletion of porins made no significant difference to EtBr accumulation regardless 
of growth phase. From this it can be hypothesised that the data is in agreement with 
previous data that shows EtBr enters Gram-negative bacterial cells via passive 
diffusion (Paixao et al., 2009). This study also showed that once inside cells, EtBr 
does not leak from cells and supports the result that showed there was no significant 
difference in EtBr leakage based on time points. The rates were so low that it could 
also be suggested that EtBr does not leak through cells, but can only be exported by 
efflux (Paixao et al., 2009). 
Although difficult to directly measure membrane permeability, results presented here 
show that the OM of Salmonella enterica serovar Typhimurium has reduced 
permeability in stationary phase compared to actively growing cells. The addition of 
EDTA had no effect on EtBr accumulation in stationary phase. A similar result has 
been described by Alakomi et al. (2003) but this work concluded that the susceptibility 
of cells to EDTA in actively growing cells was independent of LPS release (Alakomi 
et al., 2003). Similar conclusions about colistin resistance have been made for the 
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Gram-negative Acinetobacter baumanii where resistance to colistin has been shown 
to increase in stationary phase (Soon et al., 2011b). Studies show an increased 
negative charge on the cell surface of colistin-resistant strains in stationary phase 
which could contribute to this resistance (Soon et al., 2011a). The antimicrobial 
peptide (AMP), cecropin A permeabilises the outer and inner membrane at low 
concentrations by penetrating LPS. It has been shown that a 10-fold higher 
concentration of cecropin A is required to permeabilise E. coli cells in stationary 
phase compared to exponential phase cells (Agrawal et al., 2019). The data 
presented in this chapter confirms that membrane permeability decreases in 
stationary phase, and that this in turn decreases the level of accumulation to EtBr in 
an efflux independent manner. 
It was hypothesised that the reduction in passive diffusion of EtBr was due to RpoS 
dependent strengthening of the permeability barrier. Although RpoS has previously 
been implicated in the strengthening the permeability barrier in stationary phase 
(Mitchell et al., 2017), EtBr accumulation in SL1344 DrpoS was not significantly 
different to WT in stationary phase. As RpoS is a sigma factor that directs 
transcription of stationary phase genes, it is possible that this assay was not sensitive 
enough to identify changes in EtBr accumulation based on a single deletion of a 
sigma factor, possibly due to the activity of another sigma factors. This assay may 
have provided more insight if genes directly regulated by RpoS and involved in 
membrane permeability had been deleted.  
There have been a few studies which aimed to identify RpoS dependent genes 
involved in membrane integrity, but these are not extensive. In carbon-limited 
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conditions, three RpoS-dependent genes have been identified which are involved in 
the strengthening the outer membrane barrier and increased resistance to SDS 
(Mitchell et al., 2017). This study was followed up with a detailed study into one of 
the genes, yhdP. Deletion of this gene led to increased susceptibility to vancomycin 
and detergents and was hypothesised to be due to cyclic ECA (enterobacterial 
common antigen). The hypothesis was that cyclic ECA damages the membrane in 
the absence of YhdP leading to increased permeability to the cell (Mitchell et al., 
2018). A more recent study has shown that membrane permeability changes may be 
linked to interconnectivity between ECA and LPS (Klobucar et al., 2020). Further to 
this, RpoS-dependent genes such as cfa and osmB have been shown to be involved 
in resistance to pressure in stationary phase cells further proposing that RpoS plays 
a fundamental role in strengthening the permeability barrier in stationary phase cells 
(Charoenwong et al., 2011). The alternative sigma factor, RpoE, for protection of 
envelope stress, is upregulated on entrance into stationary phase but has also been 
implicated in membrane damage if high activity is too high (Nicoloff et al., 2017). 
Further work would include following up by making RpoS-dependent gene deletions 
in SL1344 and then studying the effects of these deletions on EtBr accumulation in 
stationary phase. RpoS is not the only sigma factor important in stationary phase.  
The membrane is strengthened in stationary phase cells and is more resistant to 
membrane permeabilising agents than in actively growing cells. Specific genes have 
not been identified that cause a direct effect on EtBr accumulation, but RNAseq data 
in the proceeding chapter will identify specific genes and biosynthetic pathways that 
may be responsible for this conclusion.  
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The data presented thus far shows that EtBr accumulation in stationary phase is 
independent of efflux and is low due to decreased membrane permeability. This 
conclusion calls into question the importance of efflux inhibitors in clinical infections 
where bacteria may be slow-growing or non-growing, especially if accumulation is 
independent of efflux. Data presented here does not dispute the importance of the 
development of efflux inhibitors to combat AMR but does provide further insight into 
when and how these inhibitors could be used effectively. 
6.8 Key Findings 
• EtBr does not enter S. Typhimurium through the major porins, OmpC or 
OmpF. 
• SYTO-84, which is not an efflux substrate, showed high accumulation in both 
SL1344 and SL1344 ∆acrB, but low accumulation in stationary phase due to 
decreased permeability. 
• High concentrations EDTA effectively destabilises the outer membrane in 
actively growing cells, increasing EtBr accumulation, but cannot destabilise 
the membrane in stationary phase. 




Chapter 7 - Genes involved in membrane 
changes are identified by RNAseq 
7.1 Background 
The balance between influx and efflux have been shown to change across bacterial 
growth. The hypotheses are that (i) during active growth the membrane is permeable 
and therefore efflux is a critical factor in the control of drug accumulation and (ii) 
accumulation of EtBr in stationary phase is independent of efflux pumps, and has 
been shown to be caused by decreased membrane permeability, thus reducing 
influx.  
As previously discussed in Chapter 1, there are some known changes in physiology 
of the Gram-negative cell envelope that are well described, such as the accumulation 
of cyclopropane fatty acids, the increased thickness of the peptidoglycan layer and 
an overall decrease in the concentration of membrane proteins. However, these 
studies all describe individual aspects of stationary phase, and a more integrated 
review of cell envelope changes in stationary phase is required to understand its 
importance in dictating antibiotic accumulation. 
To better understand the complex phenotypes uncovered in previous chapters, 
RNAseq analysis was performed for both WT SL1344 and the acrB mutant after 1, 3 
or 5 hours growth in MOPs minimal media. In this chapter, the RNAseq data is 
presented to identify genes or metabolic pathways whose expression is changed and 
particular attention was given to those that may be involved in the stationary phase 
strengthening of the membrane barrier. A supplementary chapter (Appendix V ) 
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showing well studied changes in stationary phase, including ribosomal and regulatory 
changes, carbon metabolism and anaerobic metabolism, confirms the validity of this 
dataset. 
7.2 Hypothesis 
Genes involved in controlling the strength of the Gram-negative bacterial membrane 
change in stationary phase. The strength of the membrane leads to reduced influx 
and accumulation of compounds, circumventing the requirement for efflux. 
7.3 Aims 
1. Perform RNAseq analysis on SL1344 and ∆acrB after growth in MOPs 
minimal media for 1, 3 and 5 hours. 
2. Assess the literature for well-studied gene expression changes in stationary 
phase and compare this to the data-set produced  
3. Identify expression changes in genes and pathways that may result in altering 
of the permeability barrier 
4. Compare expression at different growth phases in WT against ∆acrB 
7.4 Results and Discussion 
To fully explore results from this data and derive hypotheses, results and discussion 
have been combined in this chapter. 
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7.4.1 RNAseq analysis of SL1344 elucidates changes in 
transcription on entrance into stationary phase 
RNAseq analysis was used to identify genes and pathways that may be involved in 
changes to Gram-negative cells as they enter stationary phase. Briefly, growing 
cultures of SL1344 were sampled after 1 hour, 3 hours and 5 hours of growth. Cells 
from these time points were harvested and samples were snap frozen. GENEWIZ 
Inc. carried out RNA extraction, rRNA depletion, quality control, library preparation 
and sequencing, followed by bioinformatic analysis.  
SL1344 cultures at 1 hour were used as the control group and compared to cultures 
grown for 3 hours (late exponential/preparation to stationary phase) and 5 hours 
(stationary phase). From these comparisons, genes with expression that was 
increased (log2fold >1) or decreased (log2fold <-1) at 3 or 5 hours compared to 1 
hour, were considered to be significantly changed. For all other analysis, fold 
changes were calculated and used in place of log2fold change with fold change 
>2-fold being considered to have significantly increased expression and <0.5-fold 
being significantly decreased expression. 
The percentage of differentially expressed genes (DEGs) within the genome was 
calculated for both 3 and 5 hours and is shown in Figure 7-1. Each differentially 
expressed gene was then assigned a COG code (Clusters of Orthologous Genes) 
for an overall identification of function. Comparing SL1344 at 1 hour compared to 3 
hours of growth showed that 26% of genes were differentially expressed (Figure 
7-1). Of this 26%, 37% of DEGs were involved in metabolism, 17% were involved in 
information storage and processing (transcription/translation), 19% were involved in 
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cellular processes and signaling and 17% were categorised as poorly characterised 
(Figure 7-1). At 5 hours of growth, 47% of the genes in the genome were differentially 
expressed. At 5 hours, changes in gene expression involved in metabolism were 
again the highest in percentage. However, this analysis has some limitations. Several 
genes were not assigned COGs and a large percentage of genes had unknown 
functions. For this reason, this analysis could only be a guide to show that the largest 
number of genes that had significantly changed expression was after 5 hours of 
growth, and that most changes were involved in metabolism, as may be expected for 
cells transitioning from exponential to stationary phase.
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Figure 7-1 Percentage of genes differentially expressed at 3 and 5 hours of growth and COG characterisation 
 
(A) shows the % of DEGs at 3 hours compared to 1 hour of growth in SL1344. Of the 26% of DEGs at 3 hours, genes were then allocated a COG code based on overall 
function (B). (C) shows the % of DEGs at 5 hours compared to 1 hour of growth in SL1344. Of the 47% of DEGs at 5 hours, genes were then allocated a COG code based 
on overall function (D).  
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Scatter plots were created to visualise the genes for each comparison with the 
greatest increase or decrease in expression (Figure 7-2 and Figure 7-3). Genes and 
operons that had most changed expression could then be used to derive hypotheses 
about which genes may be involved in membrane changes in stationary phase.  
At 3 hours, the scatter plot shows that most genes that were most highly expressed 
were methionine related met genes, which are spread across different operons 
across the genome (Figure 7-2). Expression of genes from the dmsABC and 
frdABCD operons involved in anaerobic metabolism was also increased. Many genes 
from the cbi operon, involved in cobalamin (vitamin B12) biosynthesis, also showed 
increased expression. In terms of genes with decreased expression, the most 
obvious was the abundance of tRNAs. At 5 hours, a larger number of genes had 
increased expression including the ribosomal modulation factor (RMF), rmf, SPI-2 
genes, ompW and dadA and the lsr operon encoding for the import of Autoinducer-2 
(AI-2) involved in quorum sensing (QS). Many ribosomal genes had decreased 
expression, as well as SPI-1 and genes involved in spermidine biosynthesis and lipid 
A modification (Figure 7-3). 
This gave a brief view of the groups of genes whose expression was most changed 
at each time point. However, to successfully address the aims and hypotheses of this 
chapter, the genes considered important for the transition into stationary phase will 
be discussed further in this chapter specifically those that may be involved in 
membrane changes.
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Figure 7-2 Scatter plot showing DEGs at 1 vs 3 hours in SL1344 
 
This scatter plot shows upregulated genes at 3 hours compared to 1 hour in red and downregulated genes in blue. The Y-axis shows the log2fold change and the X-axis 
is based on genome position in SL1344. Genes of interest are labelled and groups of genes are shown in boxes. Many unlabelled downregulated genes are tRNAs. 
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Figure 7-3 Scatter plot showing DEGs at 1 vs 5 hours in SL1344 
 
This scatter plot shows upregulated genes at 5 hours compared to 1 hour in red and downregulated genes in blue. The Y-axis shows the log2fold change and the X-axis 
is based on genome position in SL1344. Genes of interest are labelled and groups of genes are shown in boxes.
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7.4.2 Stationary phase changes in gene expression are consistent 
with previous literature 
Many published studies have explored the role and expression level of genes or 
proteins in stationary phase of various bacterial species but to our knowledge this is 
the first transcriptomic experiment conducted to specifically study all gene expression 
changes in stationary phase in S. Typhimurium SL1344. To validate this dataset, 
genes and pathways that have previously been described that change in stationary 
phase were analysed. This will be described briefly here, but thorough analysis and 
discussion of stationary phase changes previously described can be found in 
Appendix V . 
Firstly, several regulators that had increased expression in stationary phase in 
previous literature also had increased expression in this dataset. RpoS, which had 
previously been described in Chapter 6, but no evidence could be produced into its 
role in EtBr accumulation, had increased expression. The expression of rpoS 
increased 2-fold in this dataset, as to be expected based on previous data (Lange 
and Hengge-Aronis, 1994). Several RpoS dependent genes also showed increased 
expression. Further to this, it could be concluded that there was an increase in ppGpp 
in this dataset based on the change in expression of several ppGpp regulated genes. 
ppGpp and the stringent response are commonly associated with stationary phase 
(Navarro Llorens et al., 2010). Dps has previously been described as one of the most 
abundant proteins in stationary phase (Nair and Finkel, 2004), and the 9.81-fold 
change in expression at 5 hours, validates that this dataset correlates to previously 
described data. 
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Changes in ribosome activity in stationary phase is well studied. Most genes 
encoding 30S and 50S subunits had decreased expression. There was increased 
expression of the rpsV gene which specifically encodes a stationary phase ribosomal 
protein, and this has been shown previously (Izutsu et al., 2001b). The ribosomal 
associated gene which had the most increased expression was rmf. Ribosomal 
modulation factor (RMF) has been described as stationary phase specific (Wada et 
al., 2000) and further validates the dataset presented here. Other 
ribosome-associated genes previously described to have increased expression in 
stationary phase include raiA (Maki et al., 2000) and yqjD (Yoshida et al., 2012) and 
also had increased expression in this dataset.  
Expression of genes involved in responding to carbon starvation also correlated to 
previous studies. Several sugar transporters involved in increased uptake of sugars 
have thoroughly been described in Appendix V , and are required in glucose-limited 
environments. Some genes involved in the glyoxylate cycle had increased 
expression in this dataset and this cycle has previously been described as 
upregulated in stationary phase (Huisman et al., 1996), to circumvent the carbon 
utilising steps of the TCA cycle. Glycogen biosynthesis and accumulation is also 
common to stationary phase and glucose-limited environments, and genes involved 
in its biosynthesis had increased expression in this dataset. 
Anaerobic respiration is key to facultative anaerobes such as S. Typhimurium, and is 
important in stationary phase in batch culture. In the dataset presented here, many 
genes involved in anaerobic metabolism had increased expression at 5 hours and 
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correlates to an oxygen-limited environment. Analysis of anaerobic respiration is 
thoroughly detailed in Appendix V  
7.4.3 L-methionine and S-adenosyl-L-methionine synthesis 
pathways had highly increased expression at 3 hours 
In the dataset presented here, some of the most DEGs at 3 hours compared to 1 
hour were the met genes (increased expression), involved in the biosynthesis of 
L-methionine and S-adenosyl-L-methionine. Due to the fold changes seen in these 
genes, it was possible that they play a significant role in the entrance into stationary 
phase.  
The fold change in expression of the met genes is listed in Table 7-1. These genes 
are not within a single operon and are found across the genome of S. Typhimurium 
SL1344. The metNIQ operon encodes an ABC importer for L-methionine. This 
suggests that there is a requirement for L-methionine in the cell in late exponential 
phase. The following enzymes are involved in the biosynthetic superpathway of 
L-homoserine, L-homocysteine and L-methionine: MetL, MetA, MetB, MetC and 
MetE, shown in Figure 7-4. Of these, the most highly expressed gene at both 3 and 
5 hours was metE, which encodes for a methyltransferase converting 
L-homocysteine into L-methionine. The increased biosynthesis of L-homoserine, 
L-homocysteine and L-methionine highlights that these compounds must be 
important at this stage of growth.  
It has been suggested that L-homoserine may play a role in the induction of stationary 
phase. The overall process is that during starvation, signal molecules may be 
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synthesised due to accumulation of intermediates of amino acid biosynthesis, such 
as L-homoserine, which can then be turned into cyclic compounds by the binding of 
tRNA synthetases (Huisman et al., 1996). L-homoserine has been shown to bind 
tRNA synthetases to produce cyclic homoserine-lactone. Homoserine lactone has 
been shown to be accumulated in high bacterial cell densities such as stationary 
phase and is involved in inducing stationary phase RpoS (Huisman and Kolter, 1994). 
It is possible that this is the reason the genes of the L-methionine pathway were 
highly upregulated. 
Table 7-1 Differentially expressed met genes in the RNAseq dataset 
Gene 1 hr vs 3 hr fold change 1 hr vs 5 hr fold change 
metJ 4.29 2.08 
metQ 4.33 2.30 
metC 10.71 4.15 
metK 11.02 6.20 
metI 12.00 4.36 
metN 17.43 3.79 
metL 27.63 3.20 
metA 42.82 13.61 
metB 48.08 2.21 
metR 51.96 5.54 
metF 155.57 37.62 
metE 236.20 64.66 
Chapter 7 - Genes involved in membrane changes are identified by RNAseq 
 236 
Figure 7-4 The superpathway of L-homoserine, L-homocysteine and L-methionine biosynthesis 
 
This pathway shows the biosynthesis of L-methionine at 1 vs 3 hours. Reactions that are upregulated in this pathway are shown with an orange arrow, and highly 
upregulated reactions are shown with a red arrow. The genes encoding enzymes catalysing each reaction are shown in the boxes next to the reaction arrow. Genes that 
are upregulated are shown in orange/red and unchanged genes are involved in the reaction are shown in black and underlined. The L-cysteine biosynthesis pathway (from 
L-serine) was not included in diagram because genes involved were not differentially expressed. This figure was produced by EE Whittle using Pathway Tools Software 
and databases (Karp et al., 2016, Caspi et al., 2020, Fulcher et al., 2018). 
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However, metE is also a gene involved in the biosynthesis of the major methyl donor, 
S-adenosyl-L-methionine (SAM). The reaction for conversion of L-methionine to SAM 
is facilitated by MetK, an adenosyltransferase. The SAM biosynthesis pathway is 
shown in Figure 7-5. The metK gene also had increased expression at 3 and 5 hours 
compared to 1 hour (Table 7-1). It is therefore possible that SAM accumulates in the 
cell to act as a methyl donor for reactions necessary for stationary phase. Previous 
literature suggests metK is replaced by the metX gene in stationary phase however 
the data presented here did not identify metX as a differentially expressed gene. SAM 
may be involved in several processes important for stationary phase processes 
including the production of cyclopropane fatty acids, which will be discussed further, 
and during molybdenum cofactor biosynthesis (important in anaerobic respiration). 
SAM is involved in the biosynthetic pathway which produces AI-2, a QS molecule. 
Although there was decreased expression in the pfs gene (0.47-fold) which encodes 
a nucleosidase involved in S-adenosyl-L-homocysteine to S-ribosyl-L-homocysteine, 
luxS which encodes for a lyase which converts S-ribosyl-L-homocysteine to AI-2, 
remained unchanged. SAM is also involved in the biosynthesis of polyamines, 
however, genes involved in putrescine and spermidine biosynthesis were 
downregulated at 5 hours in this dataset.  
Assessing the importance of L-methionine and SAM on the cells in preparation for 
stationary phase would require further investigation. To identify why SAM levels 
increased, it would be important to identify in what reactions SAM is acting as a 
methyl donor. This may be possible using stable isotope labelling by amino acids in 
cell culture (SILAC). Identifying proteins where methyl groups have been donated 
using this method has previously been described (Ong et al., 2004) where, a heavy 
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isotope labelled methionine ([13CD3]methionine) could then be converted to 
[13CD3]SAM and then using Mass Spectrometry, heavy isotope labelled proteins that 
have had a methyl group donated by [13CD3]SAM could be analysed.  
It is difficult to hypothesise the importance of SAM to the EtBr accumulation 
phenotype across growth phases, however, there may be some use in either 
measuring the concentrations of SAM over time or to remove these genes from 
SL1344 and determine whether they affect EtBr accumulation on the entrance into 
stationary phase.
Chapter 7 - Genes involved in membrane changes are identified by RNAseq 
 239 
Figure 7-5 The S-adenosyl-L-methionine biosynthesis pathway 
 
This cycle shows the reactions involved in the biosynthesis of SAM at a vs 3 hours. Reactions that are upregulated in this pathway are shown with an orange arrow, and 
highly upregulated reactions are shown with a red arrow. The genes encoding enzymes catalysing each reaction are shown in the boxes next to the reaction arrow. Genes 
that are upregulated are shown in orange/red and unchanged genes are involved in the reaction are shown in black and underlined. It is important to note that the 
conversion of SAM to S-adenosyl-L-homocysteine is not limited to a single reaction, and multiple reactions can occur, depending on where the methyl group is being 
donated. This figure was produced by EE Whittle using Pathway Tools Software and databases (Karp et al., 2016, Caspi et al., 2020, Fulcher et al., 2018)
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7.4.4 Gene expression changes suggest a stationary phase 
decrease in membrane permeability 
This dataset was produced to identify genes and pathways that may be involved with 
the strengthening of the permeability barrier in stationary phase. There was no single 
gene that looked likely to provide a major change in permeability, but many genes 
that could give rise to changes in permeability were found. In addition, genes that 
could be responsible for changes in multiple sites in the envelope including the IM, 
peptidoglycan, OM and ECA were identified. 
Results will be presented here with subsequent discussion of their possible 
involvement in decreasing the permeability of the Gram-negative membrane, and 
therefore possible reasonings for low EtBr accumulation in stationary phase. 
However, no experiments have been carried out to prove or disprove the involvement 
of these pathways in permeability and therefore all results and discussion here will 
be subject to further work. 
7.4.4.1 Increased expression of CFA 
In this dataset, at 3 and 5 hours of growth, cfa had significantly increased expression 
compared to 1 hour of growth in SL1344 (3.17-fold change and 7.27-fold change 
respectively). The cfa gene encodes a synthase which converts linear unsaturated 
fatty acids (attached to phospholipids) to cyclopropane fatty acids (Figure 7-6). This 
CFA reaction relies on SAM as a methyl donor. 
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Figure 7-6 The CFA enzymatic reaction for the biosynthesis of cyclopropane fatty acids 
 
(A) shows the reaction catalysed by CFA (cyclopropane-fatty-acyl-phospholipid synthase) for the biosynthesis of cyclopropane fatty acids from olefinic fatty acids and 
SAM. Genes that are upregulated are shown in orange. (B) shows the difference in the fatty acid structure with the conversion of a carbon-carbon double bond to a 
cyclopropyl group. This figure was produced by EE Whittle using Pathway Tools Software and databases (Karp et al., 2016, Caspi et al., 2020, Fulcher et al., 2018) 
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It has previously been shown that cyclopropane fatty acids accumulate in the IM in 
stationary phase, with the onset of starvation (Huisman et al., 1996). It has also been 
shown that the cfa gene, is in part regulated by RpoS (Wang and Cronan, 1994). An 
increase in these fatty acids has also been hypothesised to lead to a decrease in 
membrane fluidity (Bianco et al., 2019, Qi et al., 2019). Mutants lacking cfa display 
increased susceptibility to acid, heat and pressure in stationary phase, further 
highlighting the importance of cyclopropane fatty acids in tolerating these stresses 
via membrane mediated mechanisms (Chang and Cronan, 1999, Chen and Ganzle, 
2016). Further to this, it was also suggested that CFA is important for ampicillin 
tolerance of Shigella sp. also possibly implicating CFA in resistance to antibiotics in 
stationary phase (Liu et al., 2019). 
This previously published literature highlights the importance of CFA in stationary 
phase and the results in the dataset presented here confirm this. Therefore, the 
hypothesis can be drawn that the increase in cyclopropane fatty acids in stationary 
phase could lead to a decrease in membrane permeability, and therefore a decrease 
in EtBr accumulation. Further work would be required to confirm this hypothesis. 
Confirmation of increased transcription of cfa could be confirmed with RT-PCR. 
Deletion of cfa and subsequent EtBr accumulation assays using flow cytometry may 
lead to a different accumulation phenotype in which EtBr accumulation is increased 
in stationary phase. 
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7.4.4.2 Stationary phase permeability may be independent of lipid A 
biosynthesis and modification  
Many genes related to lipid A biosynthesis and modification had decreased 
expression in stationary phase. LPS is key to the permeability of the OM and its 
crosslinks with divalent cations prevents access to some antibiotics through the OM 
(Hancock and Bell, 1988). However, it is also a target of the polymyxins, and an 
antibiotic of last resort, colistin (Fair and Tor, 2014). LPS is also an antigen of 
bacterial cells and is recognised by Toll-like receptor 4 (TLR-4) on innate immune 
cells for the development of an immune response (Chow et al., 1999). Modifications 
of LPS are key to the development of polymyxin resistance but also allow evasion of 
the immune response (Simpson and Trent, 2019). 
The genes shown in Table 7-2 are involved in lipid A biosynthesis. All DEGs involved 
in lipid A biosynthesis showed decreased expression after 5 hours of growth. This 
suggests that in stationary phase, the cell reduces production of lipid A. It is possible 
that limited turnover in LPS is involved in decreased fluidity and a more stable 
stationary phase OM. An increase in LPS in stationary phase has previously been 
linked to increased cell death (Sutterlin et al., 2016). LPS alongside membrane 
destabilisation through mutations in MlaA leads to membrane blebs, and the loss of 
phospholipids from the OM leads to increased transport of phospholipids from the IM 
to the OM causing cells to shrink. Cells eventually die via mechanical stress due to 
shrinkage and an increase in cytoplasmic concentration (Sutterlin et al., 2016). MlaA 
and the Mla pathway have previously been shown to maintain the asymmetry of the 
OM (Malinverni and Silhavy, 2009).The decrease in expression of genes involved in 
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LPS biosynthesis may be functional in protecting the cell from accumulation of LPS 
and membrane blebbing, and subsequent cell death in stationary phase. 
Many lipid A modification genes are involved in increasing resistance to compounds 
such as colistin (Olaitan et al., 2014). Therefore, it was expected that enzymes 
involved in modification of lipid A and LPS would have increased expression in 
stationary phase, contributing to the decreased permeability of bacterial cells. In the 
preceding chapter, it was shown that a high concentration of EDTA did not make cells 
more permeable to EtBr in stationary phase. It was therefore thought that LPS played 
a role in the strengthening of the permeability barrier. Results from this transcriptomic 
dataset did not confirm this. 
 
Table 7-2 Differentially expressed genes involved in lipid A 
biosynthesis 
Gene 1 hr vs 3 hr fold change 1 hr vs 5 hr fold change 
lpxH 0.28 0.17 
lpxB 0.41 0.21 
lpxK 0.38 0.21 
lpxA - 0.25 
lpxL - 0.30 
lpxD - 0.41 
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Genes involved in lipid A modification that were significantly altered in this dataset 
had decreased expression, meaning that there was less modification of lipid A. All 
genes involved in modification and their fold changes were shown in Table 7-3 and 
how they modify lipid A is shown in Figure 7-7 (Raetz et al., 2007). PhoPQ activates 
the two-component regulator system PmrAB. PmrAB has been shown to be 
important in controlling lipid A modification including incorporation of 
4-amino-4-deoxy-L-arabinose (L-Ara4N) (Farizano et al., 2012) and in this dataset 
had decreased expression at 5 hours. The genes shown in Table 7-3 for L-Ara4N 
modification, are involved in the conversion of glucose to L-Ara4N and the 
subsequent attachment of L-Ara4N to lipid A, catalysed by ArnT (Raetz et al., 2007), 
and all the DEGs involved in this pathway also had decreased expression in 
stationary phase. L-Ara4N has been shown to be fundamental for polymyxin 
resistance (Gunn et al., 1998). The attachment of ethanolamine by EptA is also 
induced by PmrAB with decreased expression in this dataset. Modification of lipid A 
by L-Ara4N and ethanolamine acts to neutralise the negative charges of LPS, 
therefore making cells less susceptible to the action of AMPs and polymyxins. 
Expression of the gene encoding PagP was decreased in this dataset and is involved 
in the incorporation of palmitate into lipid A. PagP has been shown to increase the 
number of acyl chains from 6 to 7, possibly stabilising LPS by increasing 
hydrophobicity of the cell (Goto et al., 2017).  
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Figure 7-7 Lipid A and the genes involved in the modification of lipid A 
 
The chemical structure of lipid A is shown here. In red, EptA and EptB is involved in the attachment of 
ethanolamine, green shows the attachment of L-Ara4N and LpxO (purple) involved in conversion to OH. PagP 
(black) shows palmitate incorporation and PagL (black) for hydroxymyristoyl chain removal. This figure is taken 
from Raetz et al, 2007. 
Table 7-3 Genes involved in lipid A modifications and their changed in expression 
Modification Gene 1 hr vs 3 hr fold 
change 
1 hr vs 5 hr fold 
change 
Two-component system pmrA - 0.18 
pmrB 0.49 0.11 
L-Ara4N modification arnA - 0.07 
arnB - 0.06 
arnC - 0.09 
arnD - - 
udg - 0.10 
arnT 0.46 - 
OH group conversion lpxO - 2.54 
Addition of ethanolamine eptA - 0.06 
Phosphorylation  LpxT 
(YeiU) 
- - 
Palmitate incorporation pagP 0.28 0.11 
Hydroxymyristoyl chain 
removal 
pagL - - 
Palmitoleote Incorporation lpxP 0.13 0.05 
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One gene that had increased expression in this dataset was lpxO, which hydroxylates 
the myristic acid chain of LPS. It has previously been hypothesised that this gene, 
which encodes a hydroxylase/dioxygenase leads to release of 2-hydroxymyristate 
from S. Typhimurium in a macrophage which is subsequently involved in suppression 
of host cell signaling leading to survival of the bacterial (Gibbons et al., 2000). It is 
unknown why expression of this gene had increased while all other lipid A 
modification genes had decreased expression in stationary phase. 
The reduced expression of lipid A modifications in stationary phase was not expected 
but was apparent. It is possible that the expression change is simply due to the 
decreased expression in lipid A biosynthesis, and therefore there is less lipid A to 
modify. It can be hypothesised that although LPS is most likely modified in stationary 
phase, it is not through the mechanisms discussed here. In Figure 6-6, it was shown 
that EDTA could not permeabilise a stationary phase membrane and in addition to 
the data discussed here, may mean that LPS crosslinking is not the most important 
mechanism in decreasing permeability to EtBr. In fact, it could be hypothesised that 
the decrease in membrane permeability has added complexity by a combination of 
changes in the IM, OM and in peptidoglycan. To identify the importance of LPS in 
stationary phase, further work would be needed. Since LPS is a target of EDTA, 
colistin and antimicrobial peptides, it may be possible to test these compounds in 
terms of resistance in actively growing or stationary phase cells. Another idea may 
be to overexpress the PmrAB sensor involved in most modifications that make cells 
resistant to polymyxins. Overexpression of pmrAB may be achieved by cloning onto 
a high copy number plasmid. Overexpressing this system may then lead to increased 
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modification in all growth phases, and the impact these modifications may have on 
stationary phase cells may be assessed, including EtBr accumulation. 
7.4.4.3 Reduced cell wall remodelling may decrease membrane permeability 
A key component of the Gram-negative envelope is the peptidoglycan cell wall. It has 
previously been shown that the dry weight of peptidoglycan increases in stationary 
phase (Mengin-Lecreulx and van Heijenoort, 1985). For this reason, it was 
hypothesised that an increase in peptidoglycan thickness may decrease the 
permeability of the Gram-negative membrane.  
Initial analysis showed that the dadX gene involved in the conversion of L-alanine to 
D-alanine had increased expression. The fold change at 5 hours of growth compared 
to 1 hour was 8.75. It was initially thought that the change in expression of this gene 
would mean that there was an increase in D-alanine and therefore an increase in 
peptidoglycan biosynthesis for an increase in thickness of the cell wall. However, the 
expression of the dadA gene also increased (21.53-fold change), and this encodes 
a dehydrogenase that converts D-ala to pyruvate and ammonium in SL1344. The 
genes involved in the formation of the D-ala-D-ala dipeptide (Lugtenberg and v 
Schijndel-van Dam, 1973), ddlA and ddlB were not significantly changed at 5 hours. 
Since these genes were not significantly altered, it suggests that the increase in D-ala 
was unrelated to peptidoglycan. S. Typhimurium contains two alanine racemases, 
the alr racemase is constitutive in maintaining the D-ala required for growth, and the 
dadX racemase that is inducible, most likely by the presence of L-ala when D-ala is 
required for an energy source (Wild et al., 1985, Barreteau et al., 2008). This is 
common to E. coli and Pseudomonas aeruginosa (Barreteau et al., 2008, Trivedi et 
Chapter 7 - Genes involved in membrane changes are identified by RNAseq 
 249 
al., 2018). The increase in expression of DadA, the dehydrogenase, suggests the 
importance of D-alanine for energy during stationary phase in a nutrient starved 
environment, by conversion to pyruvate (Trivedi et al., 2018). However, it has also 
been shown that the deletion of dadA reduces cell stiffness, so therefore may be 
implicated in stationary phase permeability (Trivedi et al., 2018). However, the 
expression of alaE increased with a fold change of 11.03 at 5 hours compared to 1 
hour. AlaE is an L-alanine exporter, suggested to be powered by the PMF and 
involved in extrusion of L-ala when accumulation of L-ala is at toxic levels (Kim et al., 
2015, Katsube et al., 2019). For this reason, we can hypothesise that the dadX gene 
may not be involved in an increase in peptidoglycan biosynthesis, however the dad 
operon has previously been linked to cell stiffness (Trivedi et al., 2018). It is also 
possible there is too much L-ala in Gram-negative cells in stationary phase, and to 
reduce the accumulation level, it either induces dad genes to convert to D-ala as an 
energy source or L-ala is removed from cells (Figure 7-8). 
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Figure 7-8 Cytoplasmic pathway for the biosynthesis of peptidoglycan and its insertion into the periplasm 
 
This diagram shows the reactions required for the biosynthesis of peptidoglycan in the cytoplasm. The dad operon is also included as well as the AlaE transporter for the 
removal of L-alanine. The enzymes required for each step are shown above each blue reaction arrow. Enzymes that had unchanged expression in the reaction have black 
font, upregulated enzymes are shown in red and downregulated in blue. UDP, uridine diphosphate; C55, undecaprenyl phosphate; MurNAc, N-Acetylmuramic acid; GlcNAc, 
N-Acetylglucosamine; mDAP, meso-diaminopimelic acid. This figure was created by Dr. Tim Overton, adapted from Barreteau et al. (2008), Vollmer et al. (2008) and Karp 
et al. (2014) 
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It was possible that peptidoglycan played a role in membrane permeability through 
the maturation pathway. Briefly, the MurNAc lipid with the pentapeptide chain is 
synthesised in the cytoplasm. Lipid II (MurNAc + GlcNAc) are then flipped on the 
inner membrane into the periplasm by the flippase, MurJ. None of the enzymes 
required for these steps were significantly altered in stationary phase compared to 1 
hour of growth (Figure 7-8). Chain extension of nascent peptidoglycan is produced 
with glycoslytransferases which add lipid II to the peptidoglycan chain. In this dataset, 
mrcA (PBP1A) expression decreased but mtgA expression increased. Since both 
these genes encode glycosyltransferases, it is unlikely that chain extension increases 
in stationary phase. D,D-carboxypeptidation of nascent peptidoglycan strands leads 
to the removal of the terminal D-ala of the pentapeptide. Carboxypeptidases include 
MrcA, MrcB, DacA, DacC and DacD. Of these, only mrcA and dacA had decreased 
expression following 5 hours of growth (Table 7-4). 
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Table 7-4 Genes involved in peptidoglycan maturation and remodelling and the 
changes in expression 
Enzymes Gene 1 hr vs 3 hr fold 
change 
1 hr vs 5 hr fold 
change 
glycosyltransferases mrcA 0.40 0.29 
mrcB - - 
pbpC - - 
mtgA 2.41 2.88 
D,D-carboxypeptidases mrcA 0.40 0.29 
mrcB - - 
dacA 0.46 0.19 
dacC - 2.34 
dacD - - 
D,D-transpeptidases mrcA 0.40 0.29 
mrcB - - 
mrdA 0.47 0.29 
ftsI 0.29 0.45 
L,D-transpeptidases ldtA - 2.50 
ldtB 0.12 0.10 
ldtD - - 
ldtE 2.44 2.96 
Amidases amiC 0.49 0.46 
ybjR - 2.41 
Transglycosylases mltA - 0.26 
mltC - 0.35 
mltD 0.30 0.11 
mltF 0.38 0.39 
D,D-endopeptidases mepS 0.31 0.25 
mepM 0.31 0.26 
pbpG 0.36 0.36 
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Interestingly, transpeptidase enzymes were differentially expressed. In E. coli, the 
majority of peptidoglycan crosslinks are 4,3 or D,D crosslinks, meaning the crosslink 
is between D-ala and meso-diaminopimelic acid (mDAP) (Figure 7-9B). It has 
previously been shown that a small percentage of crosslinks can occur between 
mDAP and mDAP, named L,D crosslinks (Figure 7-9A). Of the 4 
D,D-transpeptidase, mrcA, mrdA and ftsI had decreased expression at 5 hours, and 
mrcB remained unchanged (Table 7-4). LD crosslinks have been shown to increase 
in stationary phase (More et al., 2019). There are two genes encoding 
L,D-transpeptidases, ldtD and ldtE (ynhG) that form LD crosslinks. Transcription of 
ldtD was unchanged at 5 hours of growth compared to 1 hour, but ldtE expression 
increased (Table 7-4). LdtD has previously been shown to increase L,D crosslinks to 
decrease cellular permeability and prevent bacterial cell lysis (More et al., 2019). 
Although it was only ldtE with increased expression, it is possible that the increase in 
L,D crosslinks, produced by LdtE transpeptidase, increases the strength of the 
Gram-negative membrane barrier in stationary phase. In clinical isolates, it has been 
found that bacterial cells can be highly resistant to b-lactams, because they do not 
require PBPs for transpeptidation (Peters et al., 2018). Further to this, it has been 
suggested that in E. coli, the membrane is stabilised by L,D-transpeptidases 
crosslinking Lpp and peptidoglycan, and this may decrease permeability of the outer 
membrane (Peters et al., 2018). The enzymes that attach Lpp to mDAP (More et al., 
2019) include LdtA which had increased expression at 5 hours and LdtB which had 
decreased expression (Table 7-4). Although a Gram-positive organism, 
L,D-crosslinks reached 80% in stationary phase Mycobacterium tuberculosis and it 
was suggested that this may be linked to the cells adapting to stationary phase 
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survival (Lavollay et al., 2008). From this data in addition to previous studies, it can 
be hypothesised that S. Typhimurium has increased L,D-crosslinks in stationary 
phase. It is therefore possible that the increase in the LdtE transpeptidase, and more 
L,D-crosslinks, leads to strengthened and impermeable Gram-negative permeability 
barrier in stationary phase.  
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Figure 7-9 A schematic for LD and DD transpeptidation reactions of peptidoglycan in the periplasm. 
 
This schematic shows the outcomes of nascent peptidoglycan. (A) shows the enzymes required for LD crosslinking. (B) shows the enzymes required for DD crosslinking. 
Enzymes with unchanged expression in the reaction have black font, upregulated enzymes are shown in red and downregulated in blue. C55, undecaprenyl phosphate; 
MurNAc, N-Acetylmuramic acid; GlcNAc, N-Acetylglucosamine; mDAP, meso-diaminopimelic acid. This figure was created by Dr. Tim Overton, adapted from Barreteau 
et al. (2008), Vollmer et al. (2008) and Karp et al. (2014) 
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Expression of several hydrolases described in E. coli decreased in stationary phase 
and hydrolases are involved in the degradation and remodelling of peptidoglycan 
(Table 7-4). 
The amidase encoding gene, amiC, had decreased expression and its role is to 
degrade peptidoglycan by the removal of the pentapeptide chain from peptidoglycan 
units (Figure 7-10A). AmiC is one of three amidases in E. coli and plays the largest 
role in degradation and peptidoglycan remodelling during cell division, by septum 
cleavage (Egan et al., 2020). AmiC is activated by NlpD (Uehara et al., 2010), which 
surprisingly showed an increase in expression in this dataset, even though amiC was 
decreased. However, the decrease in amiC transcripts suggests that there is less 
peptidoglycan remodelling and less cleavage, possibly expected for cells in 
stationary phase. However, another amidase encoding gene named ybjR, had 
increased expression and it was unknown why this would be.  
MltA, MltC, MltD and MltF are lytic transglycosylases (Lommatzsch et al., 1997) 
involved in the hydrolysis of bonds between peptidoglycan units (Figure 7-10A). The 
genes encoding these transglycosylases showed decreased expression in this 
dataset and are also involved in septum cleavage, although it has been suggested 
that their contribution to cleavage and cell division is reduced in comparison to 
amidases in E. coli (Egan et al., 2020). In some organisms, such as Vibrio cholerae, 
amidase activity alone has been shown to be insufficient for cell division and requires 
MltC also (Weaver et al., 2019). Further to this, D,D-endopeptidases, which break 
the pentapeptide crosslinks also had decreased expression (MepS, MepM and 
PbpG) (Figure 7-10B). These endopeptidases are essential for cell elongation, by 
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insertion of new peptidoglycan (Singh et al., 2012, Egan et al., 2020). The genes 
encoding endopeptidases are less required in stationary phase compared to 1 hour 
of growth, and it is most likely because cells are no longer growing and dividing 
exponentially so less peptidoglycan remodelling is required. It is possible that the 
reduction in hydrolysis of peptidoglycan strands in stationary phase makes the 
Gram-negative cell more stable, and the increased thickness of the peptidoglycan 
cell wall makes cells less permeable. 
This analysis suggests that S. Typhimurium makes more L,D-crosslinks than 
D,D-crosslinks, and remodelling of the cell wall is reduced in stationary phase, and 
both may contribute to the decrease in permeability of the cell envelope. The caveat 
is that most studies of peptidoglycan are carried out in E. coli, and S. Typhimurium 
may vary slightly, although most often, there are similarities between these 
organisms. Further work would be required to confirm whether changes in 
peptidoglycan do confer reduced EtBr accumulation in stationary phase. However, 
unpicking the involvement of peptidoglycan will prove challenging because PG 
synthesis and remodelling is highly dynamic, spatially and temporally regulated, and 
many enzymatic steps are catalysed by multiple enzymes with different regulation.
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Figure 7-10 Reactions and enzymes involved in peptidoglycan degradation and remodelling 
 
This schematic shows the steps involved in degrading bonds of peptidoglycan. (A) shows pentapeptide removal by amidases and degradation of peptidoglycan subunits 
by lytic transglycosylases. (B) shows DD crosslinking degradation by endopeptidases. Enzymes with increased expression at 5 hours are shown in red and decreased 
expression is shown in blue. MurNAc, N-Acetylmuramic acid; GlcNAc, N-Acetylglucosamine; mDAP, meso-diaminopimelic acid. This figure was created by Dr. Tim Overton, 
adapted from Barreteau et al. (2008), Vollmer et al. (2008) and Karp et al. (2014)
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7.4.4.4 Decreased expression of the ECA biosynthesis pathway 
In Chapter 6, it was discussed that the RpoS dependent gene yhdP may play a role 
in the strength of the permeability barrier in a carbon limited environment. It was 
hypothesised that cyclic ECA damages the membrane in the absence of YhdP, 
suggesting that an imbalance of cyclic ECA may lead to membrane damage (Mitchell 
et al., 2018). Another study implicated ECA and LPS in membrane damage (Klobucar 
et al., 2020). Increasing evidence from ECA studies, with its previously unknown 
function, link it to membrane permeability in E. coli and S. Typhimurium. 
For this reason, the role of ECA in stationary phase in the dataset presented here 
was analysed. In the dataset, the expression of yhdP was not significantly altered at 
3 or 5 hours of growth compared to 1 hour. However, it was previously shown that 
YhdP deletion caused susceptibility to antibiotics regardless of growth phase 
(Mitchell et al., 2018), and therefore may suggest that it is not a gene that is only 
expressed in stationary phase. YhdP is an unannotated gene with little known about 
its function. Using pathway tools software, it became apparent that the biosynthesis 
of ECA was decreased in stationary phase with 5 genes involved in its biosynthesis 
showing decreased expression. The following genes wecC, rffG, wecD, RS20200 
and wecG have a fold change of 0.40, 0.43, 0.39, 0.21 and 0.47 respectively. The 
pathway is shown in Figure 7-11. This pathway only shows that ECA biosynthesis 
had decreased expression, however, it is possible that less ECA would be converted 
to cyclic ECA in stationary phase, if biosynthetic genes had decreased expression. It 
has previously been shown that ECA is not converted to cyclic ECA in mutants 
lacking wecA, wecF or wecG (Erbel et al., 2003), and as expression of the wecG is 
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decreased in this dataset, it may be deduced that there is less cyclic ECA and less 
ECA in general in stationary phase. 
It is possible that the damage caused by ECA may be eliminated in stationary phase 
to increase the strength of the permeability barrier. To characterise the importance 
of ECA in stationary phase in S. Typhimurium SL1344 would be subject to further 
work. It would be necessary to confirm decreased expression of genes in stationary 
phase by RT-PCR, followed by attempts to calculate the concentration of ECA within 
cells in stationary phase, with subsequent production of mutant strains that cannot 
produce ECA to identify the effect on EtBr accumulation in stationary phase. 
From the results and discussion provided in this section, it is clear that there is a 
decrease in the permeability of the cell envelope in stationary phase. This process is 
multi-layered, with changes in the OM, IM, peptidoglycan and in ECA. It is also highly 
likely that there are more mechanisms involved in altering the membrane, that are 
highly complex and were unidentified in this dataset. From this, we can conclude that 
EtBr accumulation in stationary phase remains low due to reduced influx because of 
decreased permeability (through multiple mechanisms). 
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Figure 7-11 The ECA biosynthesis pathway in S. Typhimurium SL1344 
 
This schematic shows the pathway for biosynthesis of ECA. The genes that were downregulated at 5 hours are shown in blue. Genes that were unchanged are shown in 
black. This figure was produced by EE Whittle using Pathway Tools Software and databases (Karp et al., 2016, Caspi et al., 2020, Fulcher et al., 2018) 
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7.4.5 There are limited changes in expression between SL1344 and 
∆acrB 
RNA extraction and transcriptomic analysis was also carried out on SL1344 ∆acrB at 
1, 3 and 5 hours to determine if there was any differential transcription between the 
strains. It was also possible that the removal of the AcrB from a cell may contribute 
to increased permeability of the cell or differences in physiology and so this strain 
was also analysed. 
7.4.5.1 Initial comparisons of SL1344 vs acrB mutant at each time point 
Commonly, transcriptomic studies compare a bacterial strain against a mutant strain 
at a single time point (commonly mid-log phase). RNA extractions and 
transcriptomics analysed here were done at 1, 3 and 5 hours from a growing culture 
therefore SL1344 ∆acrB was compared to WT at each time point. 
After 1 hour of growth, only 63 genes were differentially expressed in ∆acrB 
compared to SL1344. Of these, acrB had the biggest decrease in expression, and 
other genes with decreased expression mainly encoded hypothetical proteins. The 
genes with the biggest increase in expression in SL1344 ∆acrB were the Salmonella 
Pathogenicity Island-2 (SPI-2) genes as well as ramA and fljAB. At 5 hours of growth, 
only 57 genes were differentially expressed compared to SL1344. Of these, fljAB was 
the most highly expressed in SL1344 ∆acrB. The curli producing gene csgB also had 
increased expression as well as SPI-1 genes. The 3 hour time point, equivalent to 
entrance into stationary phase, was at an OD600 of over 0.6 but was the most closely 
related time point to mid-log phase, the norm for RNAseq analysis. At this time point, 
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548 genes were differentially expressed compared to SL1344 including many tRNAs, 
ribosomal genes and SPI-1 genes with increased expression. The met genes had 
the biggest decrease in expression compared to SL1344.  
In 2009, Webber et al., analysed the transcriptomics of SL1344 acrB::aph compared 
to SL1344 in minimal media at OD600 ~0.7. SL1344 acrB::aph only differs to the ∆acrB 
studied in this dataset by the aph cassette inserted into acrB. It was found that 569 
genes were differentially expressed, similar in number to the 548 genes differentially 
transcribed in this dataset. It was found that 64% of differentially expressed genes 
related to a decrease in expression in SL1344 acrB::aph, showing that genes 
involved in pathogenicity (SPI-1), anaerobic metabolism, chemotaxis and motility had 
decreased expression (Webber et al., 2009). Only 32% of DEGs showed decreased 
expression in this dataset. In comparison to the dataset of this study, genes of 
narGHIJK operon had decreased expression in ∆acrB compared to SL1344 at 3 
hours of growth but napABC and nirBC were increased, differing to previous data. 
There was an overlap in genes with increased expression, as uhpA (3 hours), malT 
(3 hours) and ramA (1 hour) in the ∆acrB and acrB::aph strain in both studies. In this 
dataset, ramA expression only increased at 1 hour, and therefore is common to 
actively growing cells. The increase in ramA expression, a regulator of acrAB, due to 
the inactivation of acrB has previously been described, and is a regulator of the 
production of acrAB transcript (Lawler et al., 2013). Based on data presented in this 
thesis, it is possible that the lack of expression changes in ramA in stationary phase 
compared to SL1344 is due to the lack of dependency on AcrAB-TolC in stationary 
phase for cell survival.  
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In 2017, Wang-Kan et al. compared SL1344 AcrB-D408A to SL1344 using RNAseq. 
The mutation in D408 led to the production of a non-functional protein by impairing 
proton translocation. This study differed to the one presented here because 
transcriptional comparisons were made at a single time point (cells that were grown 
to OD600 of 0.6) but MOPs minimal media was used as the growth medium. 
Similarities to this dataset include upregulation in csgB and nirBD and a 
downregulation in cys genes and tRNA-met. In contrast, SPI-1 and SPI-2 genes had 
decreased expression in the D408A mutant (Wang-Kan et al., 2017) but increased 
expression in the analysis presented here.   
This dataset did not perfectly match previously published data but there could be a 
few reasons for this. The mutants used in the other studies discussed (Webber et al., 
2009, Wang-Kan et al., 2017) were genetically different to ∆acrB. These experiments 
were performed in a different media type which has been shown to cause largescale 
changes to the transcriptome (Blair et al., 2013). In addition, the sampling of the 
previous studies was different to the time points used here, and relied on a single 
time point rather than comparing between three. The SalCom database shows that 
a number of SPI-1 genes have increased expression in late exponential and early 
stationary phase (Kroger et al., 2013). Therefore, this dataset highlights the 
limitations of comparing a mutant strain to WT at a single time point when gene 
expression may differ with growth phase by allowing gene expression to be 
compared across growth. 
The genes with the most decreased expression at 3 hours in SL1344 ∆acrB were 
met genes. It has already been shown in Section 7.4.2 that the met genes had a 
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high increase in expression at 3 hours (late exponential phase) in SL1344. However, 
when comparing SL1344 ∆acrB at each time point, the met genes were highly 
upregulated at 3 hours compared to 1 hour. Therefore, the downregulation of met 
genes in WT vs ∆acrB analysis is misleading, as it suggests that the expression of 
these genes is being switched off by the absence of AcrB, but there is simply less 
increase in expression at 3 hours and 5 hours compared to SL1344. Fold 
comparisons for met genes can be found in Table 7-5. This may be due to the time 
point of RNA extraction, and met gene expression may peak a short time after in 
SL1344 ∆acrB. This analysis highlighted that comparing one strain to another at a 
single time point is misleading because it may be concluded that genes or pathways 
are switched off, rather than just due to changes in expression across growth. 
For this reason, to be able to identify any changes in SL1344 ∆acrB compared to 
SL1344, relating to growth, SL1344 ∆acrB was compared between 1, 3 and 5 hours 
of growth, like the above analysis on SL1344, and magnitudes of change were 
compared to the SL1344 dataset. 
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Table 7-5 Fold changes in met genes when comparing SL1344 to ∆acrB and when comparing time points during growth 
Gene SL1344 vs ∆acrB fold change at 3 hrs 
∆acrB fold change 
at 1 vs 3 hrs 
∆acrB fold change 
at 1 vs 5 hrs 
SL1344 fold change 
at 1 vs 3 hrs 
SL1344 fold change 
at 1 vs 5 hrs 
metJ 0.29 - - 4.29 2.08 
metQ - 2.53 3.11 4.33 2.30 
metC 0.20 - 3.21 10.71 4.15 
metK 0.36 3.71 7.08 11.02 6.20 
metI 0.22 2.40 4.68 12.00 4.36 
metN 0.12 2.03 3.28 17.43 3.79 
metL 0.06 - 3.70 27.63 3.20 
metA 0.05 - 13.18 42.82 13.61 
metB 0.03 - 2.54 48.08 2.21 
metR 0.03 - 4.48 51.96 5.54 
metF 0.03 5.02 33.64 155.57 37.62 
metE 0.03 8.60 104.04 236.20 64.66 
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7.4.5.2 Some genes with highly similar expression in SL1344 and ∆acrB 
To identify genes that were similarly expressed in both SL1344 and SL1344 ∆acrB 
at 3 and 5 hours of growth, first, genes that were >50-fold upregulated in WT at 5 h 
compared to 1h were filtered. Next, the ratio of expression of these genes in SL1344 
and SL1344 ∆acrB after 5 hours of growth was calculated, and genes with <2-fold 
different expression (ratio of 0.5-2) were considered not significantly different. 
Results are shown in Table 7-6.  
Genes that were similarly expressed at 5 hours of growth, highlight their importance 
in survival of both strains. RMF expression was not significantly different in SL1344 
from ∆acrB. The importance of RMF in stabilising ribosomes for stationary phase has 
been discussed in Appendix V This suggests that the shutting down of translation in 
stationary phase was unaltered by the absence of AcrB. Several genes involved in 
anaerobic metabolism (Table 7-6) were unaltered between strains and this highlights 
the importance of anaerobic respiration for SL1344 in stationary phase. Furthermore, 
OmpW was highly expressed to a similar level in both strains, and is another protein 
suggested to be involved in anaerobic respiration through its uptake of fumarate 
(Xiao et al., 2016). Analysis also showed that PTS sugar transporters were highly 
expressed at 5 hours in both strains to a similar level. As previously discussed, sugar 
transporters are important for the scavenging of sugars for carbon metabolism in a 
starved stationary phase environment, and this would be key to survival in both 
strains. 
This analysis produced hypotheses that could be explored further. However, the 
conclusion is that many genes that are differentially expressed at different time points 
Chapter 7 - Genes involved in membrane changes are identified by RNAseq 
 268 
were expressed similarly in SL1344 and SL1344 ∆acrB. This not only highlights the 
importance of these genes in stationary phase, but also shows that but that normal 
expression of many genes across growth phases is not significantly altered by the 
removal of AcrB.
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Table 7-6 Genes that had >50-fold increased expression in SL1344 where ∆acrB DEGs were <2-fold different (fold differences 
were calculated by dividing the ∆acrB fold change by the SL1344 fold change). Genes are ordered based on chromosome 
position 
Gene Product fold change 
WT 1 hr vs 5 
hr 
fold change 
∆acrB 1 hr 
vs 5 hr 
1 hr - 5 hr 
∆acrB vs WT 
fold change 
bssR biofilm formation regulator  48.03004 26.49235 0.551579 
dmsB dimethylsulfoxide reductase subunit B 22.97672 36.79017 1.601193 
rmf ribosome modulation factor 63.97515 48.47616 0.757734 
RS05370 (STM1093) hypothetical protein 28.55417 24.87366 0.871104 
pipD dipeptidase 23.48148 23.37286 0.995374 
RS06580 (STM1324) fructosamine kinase family protein 25.05512 15.38411 0.614011 
orf408 hypothetical protein 118.7844 66.31137 0.55825 
ydfZ putative selenium delivery protein  121.5918 173.8868 1.430087 
RS08035 (STM1612) aminopeptidase 45.15643 26.11991 0.578432 
sseJ SPI-2 type III secretion system effector  22.34555 15.88857 0.71104 
ompW outer membrane protein  42.21751 37.05637 0.877749 
ychH stress-induced protein  122.1334 114.8599 0.940446 
mtfA DgsA anti-repressor MtfA 25.77601 26.90254 1.043704 
thiD bifunctional hydroxymethylpyrimidine 
kinase/phosphomethylpyrimidine kinase 
61.74884 70.22501 1.137269 
RS11230 (STM2186) NAD(P)-dependent oxidoreductase 28.89164 22.79262 0.7889 
mglA galactose/methyl galactoside ABC transporter 
ATP-binding protein  
36.08547 19.16828 0.531191 
mglB methyl-galactoside ABC transporter substrate-binding 
protein 
42.98767 32.82829 0.763668 
galS DNA-binding transcriptional regulator  24.69407 17.37041 0.703424 
glpA anaerobic glycerol-3-phosphate dehydrogenase subunit 
A 
22.85746 14.07548 0.615794 
glpB glycerol-3-phosphate dehydrogenase subunit GlpB 24.80682 12.77082 0.514811 
RS12015 (STM2342) PTS ascorbate transporter subunit IIC 113.2709 74.53101 0.657989 
RS12020 (STM2343) PTS mannitol transporter subunit IIB 167.5642 150.1628 0.896151 
RS12025 (STM2344) PTS ascorbate transporter subunit IIA 45.80246 29.68573 0.648125 
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fadI acetyl-CoA C-acyltransferase  22.35455 14.55297 0.651007 
asrA anaerobic sulfite reductase subunit A 22.3593 27.69181 1.238492 
grcA autonomous glycyl radical cofactor  32.09541 32.33508 1.007468 
RS14180 (STM2740) tyrosine-type recombinase/integrase 230.5484 116.3981 0.504875 
RS14280 (STM2759) peptide ABC transporter substrate-binding protein 44.98997 28.63874 0.636558 
srlA PTS glucitol/sorbitol transporter subunit IIC 30.31045 16.50655 0.544583 
hydN electron transport protein  61.58271 49.39114 0.802029 
RS14730 (STM2844) hypothetical protein  70.50627 56.73931 0.804741 
hycI hydrogenase maturation peptidase  74.77116 69.81799 0.933756 
hycH formate hydrogenlyase maturation protein  58.04262 83.28888 1.434961 
hycG formate hydrogenlyase subunit 7 58.68462 61.77389 1.052642 
hycF formate hydrogenlyase subunit 6 70.05263 73.07097 1.043087 
hycE formate hydrogenlyase subunit 5 87.3801 85.24238 0.975535 
hycD hydrogenase 3 membrane subunit 113.6679 108.3841 0.953515 
hycC formate hydrogenlyase subunit 3 59.04612 57.16628 0.968163 
hycB formate hydrogenlyase subunit 2 113.0147 72.69586 0.643242 
hycA formate hydrogenlyase regulator  109.9628 72.28057 0.657318 
fucP L-fucose:H+ symporter permease 20.20641 17.67293 0.87462 
hybB Ni/Fe-hydrogenase cytochrome b subunit 27.14116 15.93562 0.587138 
hybA hydrogenase 2 operon protein  36.07618 31.83663 0.882483 
hybO hydrogenase 2 small subunit 35.8866 32.96687 0.91864 
dctA dicarboxylate/amino acid:cation symporter 27.79532 19.11987 0.687881 
RS19410 (STM3770) PTS sorbose transporter subunit IIC 31.47596 19.07765 0.606102 
RS19415 (STM3771) PTS sugar transporter subunit IIB 33.72046 45.40774 1.346593 
RS19420 (STM3772) PTS fructose-specific transporter subunit IIA 129.9588 138.7421 1.067585 
RS19470 (STM3782) PTS galactitol transporter subunit IIC 20.01854 10.87683 0.543338 
RS19475 (STM3783) PTS sugar transporter subunit IIB 23.63526 12.24326 0.518008 
RS19480 (STM3784) PTS sugar transporter subunit IIA 26.50835 21.02723 0.79323 
RS19485 (STM3785) GntR family transcriptional regulator 39.41004 42.68038 1.082982 
rbsD D-ribose pyranase 31.32656 32.95951 1.052126 
rbsA ribose ABC transporter ATP-binding protein  26.94843 37.82703 1.403682 
metE 5-methyltetrahydropteroyltriglutamate-- homocysteine 
S-methyltransferase 
64.65527 104.0363 1.609092 
Chapter 7 - Genes involved in membrane changes are identified by RNAseq 
 271 
lsrR transcriptional regulator 23.6257 16.78057 0.710268 
lsrA AI-2 ABC transporter ATP-binding protein  61.40747 42.4575 0.691406 
metF methylenetetrahydrofolate reductase 37.61624 33.64313 0.894378 
frwC PTS fructose-specific transporter subunit EIIC 27.03165 15.52864 0.574461 
thiG thiazole synthase 21.57164 39.5252 1.832276 
thiS sulfur carrier protein  25.80402 29.06791 1.126488 
fdhF formate dehydrogenase H subunit alpha, 
selenocysteine-containing 
40.77211 35.96321 0.882054 
dcuB anaerobic C4-dicarboxylate transporter 46.43089 32.79077 0.706227 
RS22105 molybdopterin-dependent oxidoreductase 23.18101 18.01283 0.777051 
frdD fumarate reductase subunit FrdD 23.23162 11.74676 0.505637 
frdA fumarate reductase (quinol) flavoprotein subunit 28.39094 14.78644 0.520815 
aidB isovaleryl-CoA dehydrogenase 38.12017 25.31198 0.664005 
RS22475 DUF1471 domain-containing protein 25.98272 21.51163 0.827921 
RS22790 (STM4442) putative cytoplasmic protein 23.98084 41.2426 1.719815 
RS22800 (STM4444) hypothetical protein 25.727 30.58074 1.188663 
RS22805 (STM4445) amidohydrolase/deacetylase family metallohydrolase 20.81139 18.09454 0.869454 
idnT Gnt-II system L-idonate transporter  31.75324 20.13884 0.63423 
btsT pyruvate/proton symporter  177.2093 88.61197 0.500041 
traR IncI1-type conjugal transfer protein  22.71466 33.88046 1.491568 
ypfM protein YpfM 86.35504 66.3771 0.768653 
Chapter 7 - Genes involved in membrane changes are identified by RNAseq 
 272 
7.4.5.3 Some genes were not as highly expressed in stationary phase in 
∆acrB compared to SL1344 
A number of genes in SL1344 ∆acrB were not as highly expressed as in SL1344 at 
the time points analysed. However, it is important to note that there were no genes 
identified that showed increased expression in one strain but decreased expression 
in another strain.  
Genes that were more highly induced at 5 hours in SL1344 than ∆acrB, genes were 
identified. First, genes that were >20-fold induced in SL1344 at 5 h compared to 1 h 
were filtered. Next, the ratio of expression of these genes in SL1344 and SL1344 
∆acrB at 5 h was calculated, and genes that were at least two-fold more highly 
expressed in SL1344 were selected, giving a total of 24 genes (Table 7-7).  
Notably, expression of the dadA gene was reduced in the ∆acrB strain. Analysis of 
DadA above, suggested its importance in the production of pyruvate and energy from 
D-alanine and the removal of L-alanine that may accumulate at toxic levels. Its 
downregulation in stationary phase may be due to a shift in the regulation of some 
genes, or that accumulation of alanine was not yet at its peak at 5 hours when AcrB 
is removed. The decreased expression of DadA may also lead to a reduction in cell 
stiffness. It is hard to assess the importance of this difference by transcriptomic 
analysis alone but further work may be required to suggest more function and why it 
may differ in ∆acrB. It may be possible to extract RNA from a growing culture at every 
hour and perform RT-PCR to further investigate if dadA never reaches the fold 
change of SL1344 in the mutant, or if the peak just shifts later. However, previous 
results in this study and in Wang-Kan et al., (2017) show that there is no growth 
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defect on the deletion of acrB or difference on entry to stationary phase, and therefore 
this change is not because of different entry times into stationary phase. 
Several genes shown in Table 7-7 are involved in anaerobic respiration including 
glpC, dmsB, frdC and frdB. In Appendix V , the importance of anaerobic respiration 
in stationary phase SL1344 was discussed. The genes that were significantly 
different in ∆acrB mean it may be possible that SL1344 ∆acrB enters stationary 
phase later than SL1344. The suite of RND efflux pumps in S. Typhimurium and E. 
coli are similar, except that E. coli lacks MdsABC but additionally has RND pumps 
MdtEF and CusABC. The RND pump, MdtEF, is induced in anaerobic environments, 
and promotes growth in this environment due to nitrate derived substrates that it 
exports (Zhang et al., 2011). S. Typhimurium does not encode MdtEF, however it 
does still invade and colonise niches which are oxygen starved. The absence of 
MdtEF in Salmonella may possibly indicate that an RND pump is not required for 
anaerobic respiration. It has been previously shown deletion of AcrB and TolC lead 
to differential expression of anaerobic genes (Webber et al., 2009). In Table 7-6, it 
shows that several anaerobic genes were expressed to the same level in both strains, 
meaning that it is difficult to suggest that the deletion of AcrAB-TolC affects anaerobic 
respiration by this dataset alone. 
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Table 7-7 Genes that had >20-fold increased expression in SL1344 and then >2-fold different to ∆acrB (fold differences were 
calculated by dividing the ∆acrB fold change by the SL1344 fold change). Genes are ordered based on chromosome position. 
Gene Product fold change 
WT 1 hr vs 5 
hr 
fold change 
∆acrB 1 hr vs 
5 hr 
1 hr - 5 hr 
∆acrB vs WT 
fold change 
yafH putative acyl-CoA dehydrogenase  29.11537 13.85526 0.475874 
agp bifunctional glucose-1-phosphatase/inositol 
phosphatase 
28.97562 14.31706 0.494107 
RS06860 (STM1381) hypothetical protein 104.5104 29.17025 0.279113 
RS08040 (STM1613) PTS sugar transporter subunit IIB 63.5429 17.96542 0.282729 
RS08060 (STM1617) epimerase 24.97353 5.071294 0.203067 
dadA D-amino acid dehydrogenase small subunit 21.52745 9.476888 0.440223 
glpC anaerobic glycerol-3-phosphate dehydrogenase subunit 
C 
33.30009 15.21148 0.4568 
RS1419 (STM2741) putative periplasmic protein 102.9484 42.02891 0.408252 
csiD carbon starvation induced protein  145.5768 44.01474 0.302347 
RS16200 (STM3132) xylanase deacetylase 65.53634 15.7886 0.240914 
RS16205 (STM3133) putative amidohydrolase 154.4174 44.66729 0.289263 
ygjG putrescine aminotransferase  63.12128 22.29035 0.353135 
aldB aldehyde dehydrogenase 27.44787 12.37959 0.451022 
RS19395 (STM3767) 2-dehydro-3-deoxy-phosphogluconate aldolase 21.22651 4.918799 0.231729 
fadB fatty acid oxidation complex subunit alpha FadB 37.43257 15.03725 0.401716 
RS20920 cupin domain-containing protein 40.36727 10.54512 0.261229 
lsrK autoinducer-2 kinase 50.99395 16.4998 0.323564 
lsrC autoinducer 2 ABC transporter permease  152.4059 66.3319 0.435232 
lsrD autoinducer 2 ABC transporter permease  223.7729 48.8989 0.21852 
acs acetate--CoA ligase 58.79791 19.95035 0.339304 
dmsB dimethylsulfoxide reductase subunit B 23.46767 8.645667 0.368407 
frdC fumarate reductase subunit F 24.32091 11.89992 0.489288 
frdB succinate dehydrogenase/fumarate reductase 
iron-sulfur subunit 
27.02402 13.27719 0.491311 
RS27410 hypothetical protein 187.7924 91.13337 0.485288 
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Another set of genes which were expressed differently to SL1344 were genes of the 
lsrACDBK operon. The genes lsrK, lsrC and lsrD were expressed with less 
magnitude in SL1344 ∆acrB. This operon encodes products involved in the import 
and phosphorylation of AI-2. It has previously been suggested that the AcrAB-TolC 
efflux pump may export QS signalling molecules, but that it does not export AI-2 
(Yang et al., 2006). Another study showed that the lsrABCDK operon was 
downregulated in an inactivated AcrB mutant (SL1344 AcrB-D408A), and although 
not discussed in detail, a link with SPI-1 was suggested (Wang-Kan et al., 2017). It 
seems clear that the import of AI-2 differs in strains without the function of 
AcrAB-TolC, but it is unknown why this would be.  
Although scientifically interesting, the results and hypotheses that can be drawn from 
Table 7-7 do not implicate any genes or pathways that may be involved in changes 
in membrane permeability. This was a positive result that supports the conclusion 
that the removal of AcrB does not affect permeability and therefore the accumulation 
levels of EtBr in stationary phase. Both SL1344 and SL1344 ∆acrB must strengthen 
their permeability barrier in stationary phase, leading to reduced EtBr influx, 
independent of genes differentially transcribed in the absence of AcrB. 
7.4.5.4 SL1344_RS22090 was highly upregulated in stationary phase in both 
SL1344 and SL1344 ∆acrB 
There were only 4 genes which had higher expression in SL1344 ∆acrB compared 
to SL1344. These genes were identified when selecting genes that had >20-fold 
increased expression and were then more than 2-fold different to SL1344. The results 
of these genes are shown in Table 7-8. Of these genes, 3 encoded hypothetical 
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proteins and one was an unannotated PTS sugar transporter subunit. It is not known 
why a single PTS sugar transporter was more highly expressed in ∆acrB than 
SL1344, but since many PTS transporters were shown to have increased expression 
in SL1344, this was not further analysed. 
In both SL1344 and ∆acrB, an unannotated gene encoding a hypothetical protein 
was the most upregulated at 5 hours of growth compared to one hour. 
SL1344_RS22090 (STM4302 in LT2) has a fold change of 281.37 and 661.43 in 
SL1344 and SL1344 ∆acrB respectively. BLAST analysis of the sequence presented 
the majority of hit alignments with S. enterica and S. bongori but once those 
organisms were removed, there was one 100 % match in E. coli (STEC_180392) and 
a 94 % match with a strain of pathogenic Aerococcus viridans. Previous studies 
regarding this gene are limited with some suggestion of this protein being a secreted 
effector protein (Samudrala et al., 2009, Sato et al., 2011), and  transposon insertion 
studies suggested the gene may be required for colonisation of chicks (Morgan et 
al., 2004). The fact that this gene is so highly upregulated in both strains at 5 hours 
compared to 1, highlights its importance in stationary phase. It would be important to 
carry out further work to identify the function of this gene, through phenotypic checks 
in a gene deleted strain, and to identify its importance in stationary phase and 
whether it contributes to membrane permeability in any way. 
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Table 7-8 Genes that had >20-fold increased expression in ∆acrB and then >2-fold different to SL1344 (fold differences were 
calculated by dividing the ∆acrB fold change by the SL1344 fold change). Genes are ordered based on chromosome position 
Gene Product fold change WT 1 
hr vs 5 hr 
fold change ∆acrB 1 
hr vs 5 hr 
1 hr – 5 hr ∆acrB vs 
WT fold change 
RS22090 (STM4302) hypothetical protein 281.3744 661.431935 2.351 
RS22780 (STM4440) putative cytoplasmic protein 8.2798521 32.9341061 3.978 
RS22785 (STM4441) hypothetical protein 42.672685 108.428007 2.541 
RS23270 (STM4535) PTS sugar transporter subunit IIA 6.61625217 30.8675503 4.665 
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7.4.5.5 MlaA may contribute to an increase in membrane permeability in 
stationary phase 
In SL1344 ∆acrB, several genes were differentially expressed and a list of these 
genes can be found in Appendix VI . The identification of genes that were 
differentially expressed across time in SL1344 ∆acrB must be followed by further 
experimental analysis to confirm whether these changes in the transcriptome are 
directly due to the loss of AcrB. 
However, an interesting finding was that the mlaA gene was downregulated at 5 
hours in SL1344 ∆acrB with a 0.47-fold change. The gene was not differentially 
expressed in SL1344. The mlaA gene encodes a lipoprotein that has previously been 
identified as important in maintaining the asymmetry of the OM in E. coli, by 
transporting phospholipids to the OM (Malinverni and Silhavy, 2009). Previous 
studies have shown that ∆mlaA strains lead to a slight increase in membrane 
permeability (Malinverni and Silhavy, 2009). More recently, it has been shown that a 
mutation in mlaA leads to the production of an even more permeable cell that is 
susceptible to detergents and increased cell death on entrance into stationary phase, 
linked to an increase in LPS in stationary phase (Sutterlin et al., 2016). It is therefore 
possible that decreased expression of mlaA increases the permeability of the 
membrane. However, this gene was only slightly downregulated, and given that 
deletion of the gene leads to only a slight increase in permeability, and that 
accumulation of EtBr was not significantly different from SL1344 in stationary phase, 
it could be suggested that there is very minimal difference in terms of strength of the 
permeability barrier between SL1344 and SL1344 ∆acrB in stationary phase. 
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7.5 Final conclusions  
Novel findings from the transcriptomic analysis here highlighted that met genes were 
highly expressed in late exponential/early stationary phase and this will be the subject 
of further work. Furthermore, hypotheses have been produced from this dataset 
which may begin to unpick genes involved with the strengthening of the permeability 
barrier in stationary phase, which may suggest the reason for reduced EtBr 
accumulation in stationary phase. CFA was upregulated and has previously been 
shown to increase cyclopropane fatty acids in stationary phase and may lead to a 
decrease in membrane permeability. Furthermore, reduced LPS biosynthesis and 
peptidoglycan remodelling may be involved with a more stable membrane barrier in 
stationary phase. All these hypotheses must be explored further to identify their 
contribution to reduced EtBr accumulation.  
This RNAseq analysis has also highlighted that there are limited differences across 
time in transcriptome between SL1344 and SL1344 ∆acrB, and therefore limited 
alterations to the membrane barrier when AcrB is removed. From this, it can be 
concluded that the low EtBr accumulation phenotype in SL1344 ∆acrB in stationary 
phase is caused by the same mechanisms that contribute to low EtBr accumulation 
in SL1344. EtBr accumulation level in stationary phase can be considered 
AcrAB-TolC and efflux independent in SL1344. 
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7.6 Key findings 
• There is a decrease in permeability in stationary phase and that the 
mechanisms underlying this are multi-layered and contribute to changes in the 
OM, IM and PG.  
• Increase in cyclopropane fatty acids and peptidoglycan thickness in stationary 
phase may result in reduced permeability and therefore account for reduced 
EtBr accumulation. 
• There is not an increase in lipid A biosynthesis and modification in stationary 
suggesting permeability decrease is independent LPS crosslinking 
• Methionine genes are upregulated and may be related to the requirement for 
SAM in stationary phase biochemical pathways. 
• It is complex to analyse the differences in SL1344 to SL1344 ∆acrB, but limited 
changes in genes involved in membrane permeability could be identified 




Chapter 8 - Final Discussion and 
Conclusions 
8.1 Flow cytometry is a powerful tool for measuring drug 
accumulation 
In this study, a novel assay was developed to measure EtBr accumulation in single 
bacterial cells (Whittle et al., 2019). Harnessing the fluorescence of RND efflux 
substrates such as EtBr or Hoescht H3342 has long been a measure of efflux activity 
in an entire cell population, often where cells have had efflux pumps removed, 
leading to increased accumulation. The flow cytometry assay presented in this thesis 
could be adapted to measure EtBr accumulation in both Gram-positive and 
Gram-negative bacteria, including pathogens considered a global priority. This assay 
was also able to measure the effect of known efflux inhibitors raising the possibility 
that it may also be adapted as a high throughput method to screen compound 
libraries for potential new efflux inhibitors. The strength and novelty of this assay 
comes from its measurement of accumulation in single cells. A growing body of 
evidence suggests that expression of efflux pumps within a population is 
heterogeneous (Sanchez-Romero and Casadesus, 2014), and this assay can 
identify sub-populations which may accumulate more or less drug than the population 
as a whole. 
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8.2 Drug accumulation is growth phase dependent 
It has previously been shown that acrAB transcription peaks in mid-exponential 
phase and drops in stationary phase, although the reasons for this are not 
understood (Bailey et al., 2006). The transcription pattern for acrAB across the 
growth curve was confirmed in this study. Previous studies have shown that strains 
that overexpress efflux pumps, through mutations in regulators, lead to decreased 
susceptibility to antibiotics i.e. an increase in efflux pumps leads to an increase in 
antibiotic removal from cells (Webber and Piddock, 2001). For this reason, it was 
considered likely that increased transcription of acrAB in mid-exponential phase 
would lead to a decrease in EtBr accumulation. This study is the first to show that 
drug accumulation in different growth phases does not differ according to normal 
fluctuations in acrAB expression over growth in normal laboratory medium. 
Investigating whether transcription of efflux pumps remains growth phase dependent 
in efflux overexpressing strains, and whether this leads to a decrease in drug 
accumulation may be key to understanding how efflux interferes with antimicrobial 
treatment of Gram-negative infections. 
In the absence of efflux pumps, drug accumulation peaked in mid-exponential phase. 
Removal of efflux pump components and the introduction of CCCP as an inhibitor, 
showed the same pattern of accumulation. This clearly highlighted the importance of 
efflux pumps in maintaining low drug accumulation in actively growing cells. This 
supports previous findings (Mitchell et al., 2017). By measuring EtBr accumulation in 
the presence of CCCP, novel findings suggested that efflux inhibition had no impact 
on the level of drug accumulation in stationary phase. CCCP is a PMF inhibitor which 
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inhibits the activity PMF-dependent efflux pumps, rather than an efflux inhibitor, 
therefore it would be important to repeat experimental design with RND specific 
competitive efflux inhibitors. However, if efflux inhibitors do not increase EtBr 
accumulation in stationary phase, it can be hypothesised that the addition of efflux 
inhibitors would have little effect on potentiating the activity of antibiotics for infections 
where bacteria are slow growing or not actively dividing. 
Having shown that low EtBr accumulation in stationary phase was not due to the 
activity of efflux pumps, it is clear that another mechanism must be causing this 
phenotype. It is known that the membrane undergoes changes in stationary phase 
to survive harsh nutrient limited conditions (Huisman et al., 1996), and it has also 
been suggested that strengthening of the membrane barrier is due to RpoS-directed 
gene expression (Mitchell et al., 2017).  
Initially, it was hypothesised that decreased expression of porins was responsible for 
the reduction in EtBr accumulation in stationary phase, however, it became clear that 
EtBr was unlikely to enter cells through porins. It would be interesting to study 
whether accumulation of antibiotics such as b-lactams, which enter through porins 
would show reduced accumulation in stationary phase. 
It was shown that high concentrations of the membrane permeabiliser, EDTA, 
increased EtBr accumulation in actively growing cells of SL1344. Efflux is paramount 
in maintaining low accumulation in actively growing cells, so it is possible that there 
is less requirement for strength in the permeability barrier at this stage. It is likely that 
a more permeable membrane in actively growing cells allows more access to 
nutrients and that a more fluid membrane benefits bacterial cells that are dividing 
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exponentially. However, high concentrations of EDTA could not permeabilise the 
Gram-negative membrane in stationary phase, and therefore EtBr accumulation 
remained low. This shows that a strengthened membrane that has decreased 
permeability in stationary phase, is most likely the key driver of low drug accumulation 
in non-growing cells. It was not possible to show that the mechanisms required to 
strengthen the Gram-negative membrane were RpoS-dependent through deletion of 
rpoS, as suggested by Mitchell et al., 2017. RNAseq analysis highlighted potential 
biochemical pathways that may be involved in decreased permeability to drugs in a 
Gram-negative stationary phase cell. A reduction in lipid A biosynthesis and 
remodelling, as well as a reduction in peptidoglycan remodelling may lead to a 
reduction in membrane lipid turnover, and fluidity and therefore increased strength in 
harsh stationary phase environments. Previously characterised increased 
expression of cfa in stationary phase (Wang et al., 1992) was also shown here, and 
may play a role in reduced influx of drugs in stationary phase cells. This data is 
subject to further experimental work but supports the hypothesis that bacterial cells 
rely on decreased membrane permeability for reduced drug accumulation in 
stationary phase. 
It can be concluded that mechanisms to maintain low drug accumulation differ with 
growth phase. A model of changes to the WT Gram negative bacterial cell (SL1344) 
predicted by the data in this study is shown in Figure 8-1A+B. In exponential phase 
(A), thick blue arrows represent a relatively permeable membrane where drugs and 
EtBr can enter cells. The thick red arrow represents high efflux activity of AcrAB TolC, 
allowing export and therefore maintaining low EtBr/drug accumulation. In stationary 
phase (B), the thick red arrow signifies that there is still efflux activity. However, the 
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dashed blue arrows represent reduced influx of drugs into the cell due to decreased 
permeability, therefore maintaining low accumulation without the activity of AcrAB-
TolC. C+D represent RND efflux mutants such as SL1344 ∆acrB. In exponential 
phase (C), a permeable membrane allows entrance of drugs (thick blue arrows) into 
bacterial cells but the absence of AcrAB-TolC activity leads to high accumulation 
levels. In stationary phase (D), AcrAB-TolC still cannot function to export drugs, 
however drug accumulation is low due to decreased influx and decreased 
permeability (dashed blue arrows). Altogether, this shows that efflux is only important 
in maintaining low drug accumulation in actively growing cells. The decrease in 
membrane permeability in stationary phase tips the balance towards reduced drug 
influx, meaning that accumulation is efflux independent. 
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Figure 8-1 Model for the interplay between membrane permeability and efflux in different 
growth phases and its effect of drug accumulation 
 
This model outlines the overall conclusions drawn from results of this thesis. This schematic does not contain all 
the efflux pumps or porins that may be located in the OM and IM to reduce complexity. 
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8.3 Further Work 
• Optimise the described novel flow cytometry method into a high-throughput 
screen that may be used to identify new efflux inhibitors that lead to an 
increase in EtBr accumulation in both Gram-negative and Gram-positive cells. 
• Investigate sub-populations with different accumulation levels described in 
Section 3.10. Using flow cytometric cell sorting, cells belonging to the 
sub-population could be separated and then sequenced to identify whether 
accumulation differences are due to mutations or phenotypic heterogeneity in 
efflux expression. 
• For EtBr accumulation assays across growth phases, it will be important to 
optimise the assay to measure different fluorescent substrates and fluorescent 
antibiotics (especially those which enter cells via a different mechanism to 
EtBr). If the pattern remains the same for all substrates, it would show that 
membranes strengthen for reduced influx of antibiotics in stationary phase. 
• Measure acrAB transcription, AcrAB protein level and EtBr accumulation in 
parallel in single cells using flow cytometry and microscopy. With more 
powerful flow cytometry and microscopy, it is possible to measure the 
fluorescence of SL1344 AcrB-GFP and EtBr in parallel. A transcriptional 
reporter, similar to pMW82-acrA, could be constructed with a fluorescent 
protein (possibly mPlum), which does not overlap with the fluorescence of 
GFP of EtBr and could be measured alongside them.  
• To investigate how growth phase dependence of efflux and permeability is 
controlled. TraDIS (transposon directed insertion-site sequencing) could be 
used in combination with the EtBr accumulation assay presented here. A 
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TraDIS library of the acrB mutant could be made and EtBr accumulation 
measured to identify genes that do not reduce EtBr. A TraDIS library of 
SL1344 containing a acrAB-gfp promoter fusion could also be used, where 
GFP fluorescence would be measured by flow cytometry in the presence 
of drugs across the grow curve. Cells could be sorted based on increased 
GFP fluorescence and sequenced to identify genes that may regulate 
acrAB expression in different growth phases. 
Further work on RNAseq analysis: 
• To further follow up on hypotheses that cfa, reduced lipid A biosynthesis and 
peptidoglycan remodelling are involved in strengthening the permeability 
barrier, RT-PCR analysis for the genes would have to be carried out using 
extracted RNA to further confirm differences in gene expression in stationary 
phase. 
• Measuring EtBr accumulation in SL1344 ∆cfa across growth may identify the 
role cyclopropane fatty acids play in strengthening the permeability barrier. 
• Lipid A biosynthesis has decreased expression. Lipid A may be quantified in 
SL1344 in different growth phases by Nuclear Magnetic Resonance (NMR) 
spectroscopy. This would determine whether lipid A is at a constant 
concentration in stationary phase or if concentration decreases with 
decreased expression. Previous studies have shown that increased LPS in 
stationary phase may lead to increased cell death and membrane blebbing, 
and decrease in expression of biosynthetic genes may just to prevent this. 
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• Investigating why lipid A modification shows decreased expression in 
stationary phase may be more complex. One possible aim may be to 
overexpress the PmrAB sensor involved in most modifications that make cells 
resistant to polymyxins. Overexpression of pmrAB may be achieved by cloning 
onto a high copy number plasmid. Overexpressing this system may then lead 
to increased modification in all growth phases, the impact this may have on 
stationary phase cells could be assessed. 
• Investigate the importance of reduced peptidoglycan remodelling in stationary 
phase. It may be possible to show that less remodelling leads to decreased 
membrane permeability by overexpressing the genes involved in degrading 
peptidoglycan in stationary phase. It may also be possible to measure EtBr 
accumulation in strains that undergo peptidoglycan remodelling in stationary 
phase and identify if changes occur. 
• Construct SL1344 ∆ldtE to identify whether the increase in L,D-crosslinks 
affects the levels of EtBr accumulation. An increase in EtBr accumulation in 
stationary phase could show that increased L,D-crosslinks leads to decreased 
membrane permeability to EtBr and antibiotics. 
8.4 Clinical implications and impact on AMR 
The model derived from this thesis should lead to a rethink into the way antibiotics 
that pass through the membrane, such as aminoglycosides, are used to treat 
infections. Bacterial infections are complex, and bacterial populations will often not 
be in a single growth phase, therefore more careful consideration may be required 
for the most effective antibiotic treatment. Initial mucosal invasion and acute disease 
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may comprise a population of actively growing cells (Smith, 1998). From the model 
derived from this study, it shows that stationary phase non-growing cells are 
impermeable to EtBr and therefore many drugs. Therefore, treatment of chronic 
infections and biofilms where bacterial cells are slow- or non-growing may need to 
be considered more carefully. Successful treatment of these infections is already 
extremely difficult, and careful consideration is already made for treatment of 
intrinsically impermeable pathogens such as Pseudomonas aeruginosa and 
Acinetobacter baumanii. However, administering antibiotics for this kind of infection, 
with pathogens such as E. coli or Salmonella may lead to low level intracellular 
accumulation of antibiotics, which may simply further drive selection of mutations 
conferring antibiotic resistance. More extensive research into the effects of an 
impermeable membrane in non-growing infections must be carried out to further 
improve antimicrobial stewardship. 
The model has shown that efflux pumps are only important in maintaining low drug 
accumulation in actively growing cells. If an infection is actively growing, it seems 
likely that efflux inhibitors would be effective at increasing the accumulation of 
antibiotics within cells and potentiate their activity. However, if cells are in a 
slow-growing or non-growing state, where membrane permeability is fundamental in 
maintaining low drug accumulation, efflux inhibitors may not be an effective treatment 
option. It is also possible that administering an efflux inhibitor where it has no effect 
on treating an infection, may also lead to the development of new mechanisms of 
AMR.  
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Together, this study highlights that extensive research is required into how different 
types of infection with bacteria in different growth states are treated, regardless of 
whether the infective agent in resistant to antibiotics. The development of efflux 
inhibitors provides hope in the fight against antibiotic resistant infections, but only 
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Chapter 10 Appendices 
Appendix I  Representative scatter plot of EtBr accumulation in SL1344 across 
growth 
 
Representative scatter plots of gating and EtBr accumulation in SL1344 over 6 hours of growth. This is one 
replicate. At each there is initial SYTO-84+ gating, followed by FSC vs SSC gating for a population based on size. 
EtBr accumulation is plotted on a logarithmic histogram where the X-median is shown in the 3rd across plot and 
events/µL is shown in each 4th across plot.
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Appendix II  Representative scatter plot of EtBr accumulation in SL1344 ∆acrB 
across growth 
 
Representative scatter plots of gating and EtBr accumulation in SL1344 ∆acrB over 6 hours of growth. This is 
one replicate. At each there is initial SYTO-84+ gating, followed by FSC vs SSC gating for a population based on 
size. EtBr accumulation is plotted on a logarithmic histogram where the X-median is shown in the 3rd across plot 
and events/µL is shown in each 4th across plot.
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Appendix III  Gene alignment for SL1344 AcrB-GFP 
 
Gene alignment for candidate 3 of SL1344 AcrB-GFP minus the aph cassette. The first sequence line represents 
the expected sequence. Yellow represents AcrB homology, blue represents the poly-linker and green represents 
GFP. The second line is sequencing results and alignment based on the forward strand. The third line is alignment 
based on the reverse strand.
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Appendix IV  Whole population AcrB protein level based on GFP 
fluorescence 
 
This graph shows GFP fluorescence from AcrB-GFP from 0 hours to 16 hours of growth, measuring OD600 and 
fluorescence intensity every 30 minutes. The Green line shows FI/ OD600. SL1344 autofluorescence was 
subtracted from this data.  
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Appendix V  Supplementary chapter detailing stationary phase changes 
identified in the data-described and in previous literature. 
Many published studies have explored the role and expression level of particular 
genes or proteins in stationary phase of various bacterial species but to our 
knowledge this is the first transcriptomic experiment conducted to specifically study 
all gene expression changes in stationary phase in S. Typhimurium. Therefore, the 
dataset is compared to known expression changes allowing broader conclusions 
about stationary phase gene expression to be drawn. 
Genes involved in stationary phase regulation correlate to previous literature 
It is well known that entrance into stationary is controlled by a number of different 
regulators. To confirm that the RNAseq dataset presented here correlated to 
previously published information about regulation in stationary phase, the dataset 
was searched for these known regulators. 
The role of the stationary phase sigma factor, RpoS, was discussed in Chapter 6. 
Table 10-1 shows that at 3 hours, expression of rpoS does not significantly differ 
from one hour. At 5 hours, the fold change of rpoS compared to at 1 hour was 2.06. 
This correlates to previous studies that show that there is increased expression of 
this sigma factor in stationary phase (Lange and Hengge-Aronis, 1994). However, 
the 2-fold difference is lower than expected. This may be due to increased expression 
further into stationary phase, and a limitation to the time when the sample was taken 
or the genes that are regulated by RpoS may show a higher increase in expression 
than the sigma factor itself. In this dataset, rsd which encodes for an anti-RNA 
polymerase s70 factor had a fold increase of 2.45 at 5 hours compared to 1 hour of 
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growth in SL1344 (Table 10-1). Rsd has been shown to remove s70 from RNA 
polymerase and promote the ss bound RNA polymerase holoenzyme (Mitchell et al., 
2007). This shows that there is increased expression of genes involved in the 
transition of s70 to ss. A number of RpoS regulated genes were found to have 
increased expression at 5 hours in this dataset including bolA (Lange and Hengge-
Aronis, 1991a), katG , otsA (Ibanez-Ruiz et al., 2000) and the curli producing csg 
operon (Barnhart and Chapman, 2006, Arnqvist et al., 1994).  
The stringent response is commonly associated with stationary phase. It is a 
phenomenon in which cells respond to starvation by downregulating rRNA 
biosynthesis and ribosomal proteins and increasing expression of RpoS (Navarro 
Llorens et al., 2010). The stringent response includes the accumulation of guanosine 
3’,5’-bispyrophosphate (ppGpp). A recent study showed that ppGpp altered 
transcription of 757 genes including the activation of csgDEF (curli genes), raiA and 
rsd (Sanchez-Vazquez et al., 2019). It has been shown that ppGpp regulates Rsd 
through the sequestering and competition of sigma factor binding the RNA 
polymerase core (Jishage et al., 2002). 
RelA is a protein which synthesises ppGpp when responding to amino acid starvation 
(Navarro Llorens et al., 2010) whereas SpoT can both synthesise and degrade 
ppGpp in response to carbon and phosphorus starvation, as well as fatty acid 
shortage (Xiao et al., 1991, Spira et al., 1995, Seyfzadeh et al., 1993). The 
biosynthetic pathway for ppGpp is shown in Figure 10-1. 
Salmonella sp and E. coli produce both of these proteins however this is not 
conserved across all bacteria (Battesti and Bouveret, 2009). In summary, ppGpp 
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accumulates in stationary phase to further adapt the cell to stationary phase and 
starvation. In this dataset however, the relA gene encoding a ppGpp synthetase did 
not have significantly altered expression at 3 or 5 hours compared to 1 hour. 
However, in E. coli, it was shown that the activity of RelA is subject to allosteric control 
(Turnbull et al., 2019) and therefore explain why transcript level does not differ. The 
spoT gene had decreased expression at 5 hours, which does not correlate to 
previous literature. However, there are a number of genes in this dataset with 
increased expression that respond to increased ppGpp such as rpoS (Gentry et al., 
1993) and with decreased expression in response to ppGpp such as ribosomal genes 
(Lemke et al., 2011). In order to identify whether downregulation of spoT was 
expected in Salmonella enterica serovar Typhimurium, the gene was queried using 
the Salcom online tool (Kroger et al., 2013) which also showed a gradual decrease 
in spoT transcripts from early exponential to late stationary phase. This correlated 
with the RNAseq data. It may be hypothesised that the degrading activity of SpoT 
may contribute to the downregulation of this gene for an increased accumulation of 
ppGpp. . It may be hypothesised that the ppGpp-degrading activity of SpoT 
predominates in these conditions, thus spoT expression is repressed to allow 
increased ppGpp concentrations   
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Figure 10-1 The ppGpp biosynthesis pathway 
 
This pathway shows the biosynthesis pathway of ppGpp. Blue arrows are reactions where genes are 
downregulated. Genes for each reaction are shown in boxes next to their reaction arrow. Genes 
coloured blue are downregulated, and unchanged genes are shown as black and underlined. 
 
Table 10-1 Differentially expressed regulatory genes in stationary phase 
Regulators Gene 1 hr vs 3 hr fold change 1 hr vs 5 hr fold change 
ss rpoS - 2.06 
Lrp lrp - 0.41 
IHF ihfA - - 
ihfB 2.13 - 
Dps dps 3.56 9.81 
ppGpp relA - - 
spoT - 0.25 
Anti-s70 factor rsd - 2.45 
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Other regulators that have been linked to stationary phase are Lrp, IHF and Dps 
(Navarro Llorens et al., 2010). Lrp has been shown to play an important role in 
stationary phase, regulating around 200 E. coli stationary phase genes (Tani et al., 
2002). Table 10-1 shows that in this data set, lrp had decreased expression at 5 
hours, suggesting that it is not playing a role in SL1344 stationary phase. However, 
regulators of stationary phase appear to only have only a slight increase in 
expression and therefore it may be the case that Lrp plays more of a role in the 
preparation for stationary phase in this case, and that experimental design meant the 
point of increased expression was missed. IHF (one subunit, ihfB) had increased 
expression at 3 hours (Table 10-1) and therefore it is possible that it correlates with 
previous data suggesting IHF plays a role in entrance into stationary phase (Mangan 
et al., 2006, Lee et al., 2015). In E. coli, Dps is one of the most abundant proteins in 
stationary phase (Nair and Finkel, 2004). It is induced by RpoS and IHF in stationary 
phase, but also protects from oxidative stress in exponentially growing cells (Altuvia 
et al., 1994). It was clear that in SL1344, at 3 hour and 5 hours, that the expression 
of Dps increased on entrance into stationary phase and is therefore in agreement 
with previous literature. 
The downregulation of ribosomes suggests the shutdown of protein 
translation in stationary phase 
Protein translation is reduced in stationary phase (Navarro Llorens et al., 2010, 
Huisman et al., 1996). Genes required for translation, namely genes that encode 
ribosomal proteins or tRNAs were analysed to determine whether transcript level 
correlated to information previously described in the literature. 
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When comparing SL1344 transcription at 1 vs 3 and 1 vs 5 hours, a large number of 
rps genes encoding 30S ribosomal proteins and rpm and rpl genes encoding 50S 
ribosomal proteins were downregulated in stationary phase. A number of these 
genes in E. coli have been shown to be directly repressed by the dual action of ppGpp 
and the RNA polymerase binding protein, DksA (Lemke et al., 2011), and ppGpp 
increases in stationary phase.  
The ribosomal 30S subunit genes are shown in Table 10-2. Of these genes, only 
one, rpsV, had increased expression. The gene rpsV encodes the 30S ribosomal 
protein S22 and had a 3.27-fold change at 3 hours which increased to 16.57 at 5 
hours. Previously, the rpsV copy number for the ribosomal protein was shown to 
increase in stationary phase and was therefore named the stationary-phase-induced 
ribosome-associated (SRA) protein (Izutsu et al., 2001b). The same study showed 
that increased transcription of rpsV on entrance into stationary phase was partly 
dependent on regulation by RpoS as well as Fis (factor inversion stimulation), IHF 
and ppGpp (Izutsu et al., 2001b). All other 30S subunit genes had a <0.15-fold 
change at 5 hours (decreased expression), except rpsP. Stationary phase bacteria 
shut down protein translation on entrance into stationary phase, and therefore it is 
possible that the decreased expression of these genes may be linked to reduced 
ribosomal activity and entrance into ribosomal hibernation (Yoshida et al., 2019). All 
50S ribosomal subunit genes that were differentially expressed had decreased 
expression (Table 10-3) apart from rpmJ2. This feeds into the well accepted 
hypothesis that 30S and 50S ribosomes are produced in exponentially growing cells, 
and are stable in this phase. In stationary phase, these subunits are mostly degraded 
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or are ‘hibernating’ (Piir et al., 2011), therefore the requirement for transcription of 
these genes is limited.  
Other ribosome associated genes in this dataset are rimM (ribosome maturation 
factor M), with a fold change of 0.05 and rbfA (ribosome binding factor A), with a fold 
difference of 0.23. RimM has been implicated as a factor involved in the late-stage 
assembly of the 30S ribosome (Guo et al., 2013), as well as RimM and RfbA also 
being essential for 16S processing (Bylund et al., 1998). Again, if ribosomes are 
shutting down in stationary phase, it would be expected that genes involved in 
ribosomal processing would show decreased expression.  
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Table 10-2 Differentially expressed genes that encode for 30S ribosomal 
subunits 
Genes Protein unit 1 hr vs hr 3 fold change 1 hr vs 5 hr fold change 
rpsA S1 0.16 0.08 
rpsB S2 0.40 0.05 
rpsC S3 - 0.06 
rpsD S4 0.38 0.08 
rpsE S5 0.41 0.08 
rpsF S6 0.28 0.05 
rpsG S7 0.36 0.10 
rpsH S8 0.42 0.09 
rpsI S9 0.28 0.04 
rpsJ S10 0.35 0.09 
rpsK S11 0.35 0.07 
rpsL S12 0.32 0.10 
rpsM S13 0.38 0.11 
rpsN S14 0.38 0.09 
rpsO S15 0.23 0.08 
rpsP S16 0.26  
rpsQ S17 0.49 0.06 
rpsR S18 0.30 0.05 
rpsS S19 0.49 0.06 
rpsT S20 0.19 0.06 
rpsU S21 0.10 0.10 
rpsV S22 3.27 16.57 
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Table 10-3 Differentially expressed genes that encode for 50S ribosomal 
subunits 
Genes Protein unit 1 hr vs 3 hr fold 
change 
1 hr vs 5 hr fold change 
rplA L1 0.44 0.09 
rplB L2 0.48 0.07 
rplC L3 0.33 0.06 
rplD L4 0.38 0.06 
rplE L5 0.36 0.08 
rplF L6 0.39 0.08 
rplI L9 0.29 0.05 
rplJ L10 0.44 0.10 
rplK L11 0.43 0.12 
rplL L7/L12 0.42 0.11 
rplM L13 0.31 0.06 
rplN L14 0.35 0.08 
rplO L15 0.39 0.06 
rplP L16 - 0.06 
rplQ L17 0.31 0.05 
rplR L18 0.39 0.08 
rplS L19 0.35 0.04 
rplT L20 0.49 0.32 
rplU L21 0.18 0.11 
rplV L22 0.45 0.05 
rplW L23 0.44 0.07 
rplX L24 0.35 0.08 
rplY L25 0.39 0.08 
rpmA L27 0.24 0.07 
rpmB L28 0.21 0.06 
rpmC L29 - 0.07 
rpmD L30 0.40 0.07 
rpmE L31 0.30 0.24 
rpmF L32 0.45 0.11 
rpmG L33 0.19 0.05 
rpmH L34 0.20 0.06 
rpmI L35 - 0.36 
rpmJ L36 0.44 0.16 
rpmJ2 L36 - 2.12 
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The most upregulated gene at 5 hours in this dataset that was ribosome associated 
was rmf which encodes the ribosome modulation factor (RMF). Expression of rmf 
was increased by 63-fold at 5 hours compared to 1 hour. RMF is directly activated by 
ppGpp (Izutsu et al., 2001a) and is considered stationary phase specific (Wada et 
al., 1995). Previously it has been shown that RMF promotes the production of 100S 
ribosome dimers from 70S subunits (Wada et al., 2000). 100S ribosomes are 
considered inactive and their formation leads to the inhibition of translation. 
Stationary phase RMF inhibits translation and inactivates ribosomes by binding the 
100S ribosome and blocking the peptidyl transferase centre and peptide exit tunnel 
(Yoshida et al., 2002). Mutations in the rmf gene prevent survival in prolonged 
stationary phase (Wada et al., 2000) and deletion of this gene in E. coli leads to 
increased susceptibility to gentamicin (McKay and Portnoy, 2015), highlighting that 
cells can be more tolerant of antibiotics in stationary phase.  
Other genes associated with stationary phase ribosomes are raiA (also known as 
yfiA) and ybhH. They were shown to have increased copy number in stationary phase 
compared to exponential phase (Maki et al., 2000) with YbhH in E.coli involved in the 
stabilisation of 100S ribosomes and RaiA preventing 70S dimer formation in 
stationary phase (Ueta et al., 2005). With regards to the RNAseq dataset presented 
here, raiA had increased expression in stationary phase (at 5 hours) with 15.07-fold 
change, in agreement to previous literature. However, ybhH was not a differentially 
expressed.  
The final ribosome related gene that is associated with stationary phase is yqjD, 
which produces the protein YqjD. Proteins paralogous to YqjD in E. coli include ElaB 
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and YgaM (Yoshida et al., 2012). YqjD has been identified as an inner membrane 
protein, however it has also been found to associate with 70S and 100S ribosomes 
in stationary phase (Yoshida et al., 2012). The function of YqjD is unknown but it has 
been suggested that it may inactivate ribosomes. Both yqjD and elaB had increased 
expression in the data presented in this chapter (fold change: 3.06 and 4.63 
respectively at 5 hours when compared to 1 hour). 
This data suggests that at 5 hours, stationary phase has been entered and that in 
SL1344 in stationary phase, translation is shut down and ribosomes hibernate as 
previously described in the literature. 
Responding to carbon starvation in stationary phase 
Stationary phase in batch culture signifies the start of nutrient starvation, namely 
glucose limitation or carbon starvation, and the Gram-negative cell response to 
carbon starvation has been extensively studied. 
Carbon metabolism requires the uptake of sugars such as glucose into the 
cytoplasm, for progression of glycolytic pathways. Phosphotransferase systems 
(PTS) couple the transport of sugars across the membrane with phosphorylation of 
sugars (Vastermark and Saier, 2014). PTS sugars include glucose, fructose, 
mannose and mannitol. Briefly, the PTS transport system is a phosphorylation 
cascade which begins with a kinase, named Enzyme II, which catalyzes the transfer 
of phosphate from phosphoenolpyruvate to HPr, a phosphoryl carrier (Vastermark 
and Saier, 2014) (This first phosphorylation step is not specific to different sugars). 
From this, the first of 3 PTS subunits is then phosphorylated (subunit IIA), followed 
subunit IIB and the sugar is phosphorylated and transported to the cytoplasm by IIC 
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(Vastermark and Saier, 2014). These subunits are specific to different sugars. These 
phosphorylated sugars are then converted to fructose-1,6-bisphospate and utilised 
in the glycolytic pathways (Jeckelmann and Erni, 2020, Vastermark and Saier, 2014). 
Glycolysis then produces phosphoenolpyruvate which further facilitates sugar 
transport (Vastermark and Saier, 2014). In a glucose rich environment, cells will 
favourably transport glucose, and if PTS-glucose specific transporters are expressed, 
will only take up glucose even in the presence of other sugars (Jeckelmann and Erni, 
2020). In this dataset, at 5 hours, ptsG, which encodes for a glucose specific PTS 
transporter subunit IIBC, had decreased expression (fold change of 0.22). This gene 
has previously been shown to be induced by the presence of glucose in the 
environment (Plumbridge, 2002) and therefore at 5 hours when glucose is limited in 
stationary phase, ptsG is not being induced. It has also been shown that SgrT acts 
to inhibit the expression of ptsG (Lloyd et al., 2017), and sgrT had increased 
expression in this dataset (2.46-fold change). It is possible that it may be 
unfavourable to express glucose specific transporters in stationary phase as they 
prevent the uptake of other sugars (Jeckelmann and Erni, 2020), and this may be 
why SgrT was upregulated.  
Table 10-4 shows other sugar transporters that had highly increased transcription in 
this dataset. For example, genes of the frwABCD fructose PTS transporter were had 
increased expression as well as and alternative sugar transporter, uhpT, a hexose 
transport protein. Furthermore, expression of several unannotated PTS sugar 
transporters increased, possibly due to these transporters being non-specific in 
scavenging for sugars in a glucose limited environment. Increased expression of the 
transporter for galactose, MglABC, has previously been shown in glucose limited 
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batch culture (Death and Ferenci, 1993), and can also uptake glucose. Expression 
of mglABC was significantly increased in this dataset, possibly due to this transporter 
being able to uptake glucose if still present without inhibiting the uptake of other 
sugars.  
The glycolytic pathways allow the utilisation of sugars following uptake into the cell. 
The glycolytic pathways of SL1344 include glycolysis and the Entner-Doudoroff 
pathways, the TCA cycle and the pentose phosphate pathway. At 5 hours, the genes 
involved in the Entner-Doudoroff pathway were not significantly changed from 1 hour. 
However, 2 genes had increased expression in the glycolysis pathway: pfkB (6-
phosphofructokinase II) involved in the conversion of β-D-fructofuranose 6-
phosphate to β-D-fructose 1,6-bisphosphate and fbaB (fructose bisphosphate 
aldolase) involved in the conversion of β-D-fructose 1,6-bisphosphate to D-
glyceraldehyde 3-phosphate. These genes may be upregulated for the catabolism of 
carbon for energy in nutrient limiting conditions, however, it is also possible that the 
involvement of fbaB in gluconeogenesis is the reason for increased expression 
during starvation. Other than fbaB, maeB and pckA also had increased expression 
in the gluconeogenesis pathway. Gluconeogenesis is an important pathway in the 
production of sugars from pyruvate a carbon starved environment. Since genes in 
both the glycolytic and gluconeogenic pathways have increased expression at 5 
hours, it is possible that the balance between the two is important in stationary phase. 
The TCA cycle also contains a number of genes with increased expression, notably 
mdh of the gluconeogenesis pathway and but also gltA and acnA, and all genes are 
required for the glyoxylate cycle.  
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Table 10-4 The differential expression of sugar transporters at 3 
and 5 hours in SL1344 
Transporters Gene 1 hr vs 3 hr fold 
change 




frwA - - 
frwB - 5.62 
frwC 2.79 27.03 
frwD - 3.64 
Hexose 
transporter 
uhpT - 0.42 
Galactose 
transporter 
mglA - 36.09 
mglB - 42.99 
mglC - 13.45 
PTS sugar 
transporters 
RS08040 - 63.54 
RS08055 2.16 31.85 
RS19415 - 33.72 
RS19475 - 23.64 
RS19480 - 26.51 
RS23270 - 6.62 
RS23275 - 14.58 
RS23280 - 14.31 
 
Table 10-5 Differentially expressed genes of carbon metabolism 
pathways in stationary phase 
Pathway Gene 1 hr vs 3 hr fold 
change 




glgC - 7.98 
glgA - 5.27 
glgB - 3.17 
glgX - 4.32 
glgP - 4.05 
Glyoxylate Cycle aceB 5.64 4.58 
mdh - 4.87 
gltA - 2.84 
acnB - - 
acnA - 5.23 
aceA 2.92 2.69 
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The upregulation of the glyoxylate cycle in stationary phase has been discussed 
previously (Huisman et al., 1996). It has been suggested that this pathway is more 
favourable than the TCA cycle because it circumvents the need for carbon producing 
conversion of isocitrate to 2-oxoglutarate to succinyl-CoA. Instead, isocitrate is 
converted to glyoxylate which can then be converted to malate, and further be used 
in gluconeogenesis. The genes involved in the glyoxylate cycle are shown in Table 
10-5 and those which had increased expression include mdh, gltA and acnA. The 
upregulation of this pathway in stationary phase agrees with previous literature 
(Huisman et al., 1996). It is also suggested that in glucose rich environments, where 
cells are rapidly dividing, glucose can be stored as acetate, which can then feed into 
the glyoxylate cycle during carbon starvation (Huisman et al., 1996). 
At 5 hours, the genes involved in glycogen biosynthesis and accumulation, glgC, glgA 
and glgB, had increased expression (Table 10-5). This data correlates to previous 
studies that show that glycogen accumulates during nutrient deprived stationary 
phase, so that it can act as a sugar storage molecule (Huisman et al., 1996). 
However, in this dataset, glgX, encoding a debranching enzyme and glgP, encoding 
a phosphorylase, also showed increased expression. These genes are involved in 
the degradation of glycogen to glucose (Dauvillee et al., 2005, Alonso-Casajus et al., 
2006). It is likely that they were also upregulated to provide glucose to the cell in 
glucose-limited environments. 
Fatty acid b-oxidation genes in this dataset also showed increased expression. The 
genes include fadA, fadB, fadD, fadE, fadI and fadJ. Products from this oxidation can 
be utilised within the TCA cycle (Munoz-Elias and McKinney, 2006). It is possible that 
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the upregulation of oxidation in stationary phase is due to the increased need for 
energy in a nutrient deprived environment. 
Genes involved in anaerobic respiration were upregulated in oxygen starved 
stationary phase 
Within batch culture, stationary phase can lead to an oxygen limited environment. 
Anaerobic respiration is also required for Salmonella infection of a host (Paiva et al., 
2009, Winter et al., 2010). In the dataset presented here, a large number of genes 
involved in anaerobic respiration had increased expression at 5 hours and these 
results will be discussed.  
The genes required for glycerol utilisation were upregulated and are shown in Error! 
Reference source not found.. Glycerol can be used in both anaerobic and aerobic 
respiration. The transporters for glycerol-3-phosphate include glpF and glpT. GlpT 
decreased in expression at both 3 and 5 hours suggesting glycerol-3-phosphate does 
not use this transporter in stationary phase. GlpF also imports glycerol, which is then 
phosphorylated by GlpK, and both these genes had increased expression at 5 hours 
and allow for glycerol-3-phosphate to be utilised by glycolysis. However, sn-glycerol-
3-phosphate can also be transported into the cell via the ABC transporter with 
subunits including UgpA, UgpB, UgpC and UgpE, where expression also increased 
in stationary phase. It is likely that the transport of sn-glycerol-3-phosphate 
accumulates more within the cell as it can be used as an electron donor directly in 
the electron transport chain during anaerobic respiration (Karp et al., 2016, Caspi et 
al., 2020, Iuchi et al., 1990). Using the GlpCBA glycerol dehydrogenase, sn-glycerol-
3-phosphate can donate 2 electrons into chain, and 2 H+ where fumarate can then 
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be used as the terminal electron acceptor, where succinate is produced to feed into 
the TCA cycle (Iuchi et al., 1990, Caspi et al., 2020). The upregulation of glycerol 
utilisation genes suggest its importance in anaerobic respiration in stationary phase. 
Table 10-6 Differentially expressed genes of involved in glycerol 
utilisation in stationary phase 
Gene Product 1 hr vs 3 hr fold 
change 






glpB 4.95 24.81 
glpA 5.99 22.86 
glpF glycerol kinase 0.30 7.47 




glpT transporter 0.28 0.28 
ugpA sn-glycerol 3-phosphate 
transport system permease 
protein 
- 5.91 
ugpB - 14.48 
ugpC - 2.97 
ugpE - 4.58 
gldA glycerol dehydrogenase 3.86 4.93 
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The expression of the formate dehydrogenase, FdhF, was increased by 40.77-fold 
change at 5 hours, suggesting that formate could be another electron donator for the 
production of energy during anaerobic respiration. This enzyme is a molybdenum 
and selenium containing enzyme (Boyington et al., 1997) and may be linked to the 
upregulation in genes encoding the molybdenum cofactor pathway and the 
upregulation of ydfZ which is involved in selenium scavenging. 
S. Typhimurium can use several terminal electron acceptors in place of O2 during 
anaerobic respiration, due to a number of alternative terminal reductases. As 
previously mentioned, fumarate is a terminal electron acceptor, but other terminal 
acceptors include dimethyl sulphoxide (DMSO), trimethylamine N-oxide (TMAO), 
nitrate, nitrite and thiosulphate/tetrathionate. The reductases for these are FrdABCD, 
DmsABC, NarGHIJ and NarXYZ and TtrABC respectively (Table 10-7 and Table 
10-8). The frd and dms operons contain some of the most highly increased expressed 
in the dataset at 5 hours. Not only does the fumarate reductase have highly increased 
expression but also, at 5 hours, ompW, had a 42.22-fold change. This porin has been 
implicated in the uptake of fumarate and the cells transition to an anaerobic lifestyle 
(Xiao et al., 2016). The DmsABC operon has previously been shown to have 
increased expression in stationary phase (Nosek and Misek, 2019). The NarGHIJ 
and NarZ reductases also had increased expression at 5 hours (Table 10-7). This 
highlights the requirement for anaerobic growth at 5 hours or during stationary phase. 
These reductases have also been shown to be required for anaerobic respiration in 
Salmonella when infecting the intestinal tract of an avian host (Paiva et al., 2009). 
Further to this, operons encoding hydrogenases (hyp and hyb) increased in 
expression at 5 hours. These hydrogenases accept electrons off H2 that can then be 
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accepted by fumarate or DMSO-trimethylamine N-oxide (Laurinavichene and 
Tsygankov, 2001). 




Gene 1 hr vs 3 hr fold 
change 
1 hr vs 5  hr fold 
change 
Fumarate Reductase frdA 9.70 28.39 
frdB 10.86 27.02 
frdC 12.20 24.32 
frdD 12.33 23.23 
DMSO-trimethylamine N-
oxide reductase 
dmsA 15.08 18.45 
dmsB 17.54 22.98 
dmsC 9.60 10.90 
Nitrate/nitrite reductase narG 2.37 2.58 
narH 4.09 4.50 
narI 2.79 2.01 
narJ 5.47 5.15 
narX - - 
narY - - 
narZ - 3.19 
 
Table 10-8 Genes involved in anaerobic respiration using tetrathionate 
operon Gene 1 hr vs 3 hr fold 
change 
1 hr vs 5 hr fold 
change 
ttrRSABC ttrR - 2.77 
ttrS - 4.02 
ttrA - 2.49 
ttrB - - 
ttrC - - 
phsABC phsA - 4.52 
phsB - 3.41 
phsC - 5.53 
asrABC asrA - 22.36 
asrB 2.07 12.98 
asrC 2.45 16.50 
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Ethanolamine and 1,2-propanediol can be used as a carbon source in anaerobic 
environments. Ethanolamine has been shown to be abundant in mammalian cells 
and is utilised by Salmonella during infection in the intestine (Anderson et al., 2015, 
Thiennimitr et al., 2011). Genes involved in the degradation of these compounds had 
increased expression in this dataset. EutC and EutB had increased expression for 
the degradation of ethanolamine, and PduC, PduD and PduP had increased 
expression for the degradation of L-1,2-propanediol. The pdu genes are also involved 
in the degradation of glycerol to 3,4-propanediol. However, it has been shown that 
neither of these compounds alone can be used for cells to grow anaerobically. 
Utilisation of both is reliant of the production of vitamin B12, which is produced de 
novo in S. Typhimurium in anaerobic conditions (Price-Carter et al., 2001). It was 
shown that in the presence of the terminal electron acceptor, tetrathionate, 
ethanolamine and 1,2-propanediol could be used as a carbon energy source 
anaerobically (Price-Carter et al., 2001). The tetrathionate reductase, TtrABC, did not 
have significantly changed gene expression in this dataset. However, the TtrRS 
sensor histidine kinase had increased expression at 5 hours (Table 10-8), required 
for sensing tetrathionate and production of the tetrathionate reductase. The cascade 
of reactions that allow tetrathionate to produce energy involve two further operons. 
Tetrathionate is converted to thiosulphate with the ttr operon, followed by 
thiosulphate conversion to sulphite and sulphide (using the phs operon). Sulphite and 
NADH are then converted to sulphide, H2O and NAD+ using the asr operon. Both the 
phsABC and the asrABC operons had highly increased expression at 5 hours 
compared to 1 hour in this dataset (Table 10-8). It has previously been shown that 
tetrathionate can be produced in an inflamed host intestine when S. Typhimurium 
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causes infection which allows the pathogen to survive anaerobically (Winter et al., 
2010). 
All these genes, operons and pathways relating to anaerobic respiration have 
increased expression showing the importance of anaerobic respiration in stationary 
phase in batch culture, where oxygen becomes limited
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Appendix VI  Table DEGs only changed in SL1344 ∆acrB and not found changed in SL1344 
Gene 
 Gene 
 Product Fold change (1 hr vs 5 hr) 
glnA glutamate--ammonia ligase 0.25 
lamB maltoporin 0.28 
sucC ADP-forming succinate--CoA ligase subunit beta 0.34 
iraM anti-adapter protein IraM 0.36 
btuB TonB-dependent vitamin B12 receptor BtuB 0.36 
yifK amino acid permease 0.36 
odhB 2-oxoglutarate dehydrogenase complex dihydrolipoyllysine-residue succinyltransferase 0.37 
yfaZ putative inner membrane protein 0.39 
recF DNA replication/repair protein RecF 0.41 
dapE succinyl-diaminopimelate desuccinylase 0.41 
bacA undecaprenyl-diphosphate phosphatase 0.42 
dsbI protein-disulfide oxidoreductase DsbI 0.42 
sucD succinate--CoA ligase subunit alpha 0.42 
amiA N-acetylmuramoyl-L-alanine amidase AmiA 0.42 
lipB lipoyl(octanoyl) transferase LipB 0.43 
pheT phenylalanine--tRNA ligase subunit beta 0.43 
lpxM lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase 0.44 
msgA virulence protein 0.45 
ispB octaprenyl diphosphate synthase 0.45 
yiaH acetyltransferase 0.45 
cmoA carboxy-S-adenosyl-L-methionine synthase CmoA 0.45 
fre NAD(P)H-flavin reductase 0.45 
sdaA L-serine ammonia-lyase 0.46 
yneJ putative LysR family transcriptional regulator 0.46 
rlmI 23S rRNA (cytosine(1962)-C(5))-methyltransferase RlmI 0.46 
rfaQ lipopolysaccharide core heptosyltransferase RfaQ 0.46 
hybD HyaD/HybD family hydrogenase maturation endopeptidase 0.46 
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pldA phospholipase A 0.46 
minE cell division topological specificity factor MinE 0.46 
stpA DNA-binding protein StpA 0.47 
nudB dihydroneopterin triphosphate diphosphatase 0.47 
sitB iron/manganese ABC transporter ATP-binding protein SitB 0.47 
minD septum site-determining protein MinD 0.47 
nudE ADP compounds hydrolase NudE 0.47 
mlaA phospholipid-binding lipoprotein MlaA 0.47 
cpoB cell division protein CpoB 0.47 
glpG rhomboid family intramembrane serine protease GlpG 0.47 
slmA nucleoid occlusion factor SlmA 0.47 
asnC transcriptional regulator AsnC 0.48 
hslO Hsp33 family molecular chaperone HslO 0.48 
nikR nickel-responsive transcriptional regulator NikR 0.48 
ftsN cell division protein FtsN 0.48 
epmA elongation factor P--(R)-beta-lysine ligase 0.48 
smpB SsrA-binding protein SmpB 0.48 
zipA cell division protein ZipA 0.48 
coaBC phosphopantothenoylcysteine decarboxylase/phosphopantothenate--cysteine ligase  0.48 
tyrP tyrosine transporter TyrP 0.49 
lolE lipoprotein-releasing ABC transporter permease subunit LolE 0.49 
pyrG CTP synthase (glutamine hydrolyzing) 0.49 
yrdA gamma carbonic anhydrase family protein 0.49 
lolB lipoprotein localization protein LolB 0.49 
gshA glutamate--cysteine ligase 0.49 
citC [citrate (pro-3S)-lyase] ligase 0.49 
mobB molybdopterin-guanine dinucleotide biosynthesis protein B 0.50 
creD cell envelope integrity protein CreD 0.50 
traC type IV secretion system protein TraC 0.50 
ygcY putative d-glucarate dehydratase 2.00 
ssrA hybrid sensor histidine kinase/response regulator 2.01 
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iroB salmochelin biosynthesis C-glycosyltransferase IroB 2.02 
ymdB O-acetyl-ADP-ribose deacetylase 2.03 
traU conjugal transfer pilus assembly protein TraU 2.03 
mtlD mannitol-1-phosphate 5-dehydrogenase 2.04 
pdxK pyridoxine/pyridoxal/pyridoxamine kinase 2.05 
hdeB acid-activated periplasmic chaperone HdeB 2.05 
traB conjugal transfer protein TraB 2.08 
pmrD signal transduction protein PmrD 2.08 
traR conjugal transfer protein TraR 2.09 
lrgA murein hydrolase regulator LrgA 2.09 
yfcF glutathione transferase 2.10 
pduK propanediol utilization microcompartment protein PduK 2.12 
rtcA RNA 3'-terminal phosphate cyclase 2.13 
rhtC threonine export protein RhtC 2.13 
trpS2 AraC family transcriptional regulator 2.16 
ydiP colanic acid biosynthesis acetyltransferase WcaB 2.17 
wcaB homoserine/homoserine lactone efflux protein 2.18 
rthB major pilin PefA 2.18 
pefA curli production assembly/transport protein CsgF 2.20 
csgF 2-keto-myo-inositol isomerase IolI1 2.23 
iolI1 citrate lyase holo-[acyl-carrier protein] synthase 2.23 
citX2 exodeoxyribonuclease V subunit alpha 2.24 
recD cobalamin reductase PduS 2.25 
pduS cobalt ABC transporter substrate-binding protein CbiN 2.27 
cbiN acetylglutamate kinase 2.27 
argB homoserine kinase 2.28 
thrB fimbrial minor subunit StfF 2.29 
stfF DNA-binding response regulator 2.34 
ssrB acetolactate synthase 2 catalytic subunit 2.65 
ilvG threonine synthase 2.68 
thrC bifunctional aspartate kinase/homoserine dehydrogenase I 2.75 
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thrA branched-chain-amino-acid transaminase 2.91 
ilvE ketol-acid reductoisomerase 2.93 
ilvC dihydroxy-acid dehydratase 3.20 
ilvD acetolactate synthase 2 small subunit 3.43 
ilvM acetolactate synthase 2 small subunit 3.52 
  4.00 
  4.22 
  4.38 
  7.03 
 
